id	sid	tid	token	lemma	pos
aiua-13642	1	1	stesura	stesura	PROPN
aiua-13642	1	2	seveso	seveso	PROPN
aiua-13642	1	3	archivio	archivio	PROPN
aiua-13642	1	4	italiano	italiano	X
aiua-13642	1	5	di	di	X
aiua-13642	1	6	urologia	urologia	PROPN
aiua-13642	1	7	e	e	PROPN
aiua-13642	1	8	andrologia	andrologia	NOUN
aiua-13642	1	9	2025	2025	NUM
aiua-13642	1	10	;	;	PUNCT
aiua-13642	1	11	97(2):13642	97(2):13642	NUM
aiua-13642	1	12	1	1	NUM
aiua-13642	1	13	review	review	NOUN
aiua-13642	1	14	dition	dition	NOUN
aiua-13642	1	15	continues	continue	VERB
aiua-13642	1	16	to	to	PART
aiua-13642	1	17	increase	increase	VERB
aiua-13642	1	18	.	.	PUNCT
aiua-13642	2	1	according	accord	VERB
aiua-13642	2	2	to	to	ADP
aiua-13642	2	3	the	the	DET
aiua-13642	2	4	recent	recent	ADJ
aiua-13642	2	5	epidemiologic	epidemiologic	ADJ
aiua-13642	2	6	studies	study	NOUN
aiua-13642	2	7	,	,	PUNCT
aiua-13642	2	8	the	the	DET
aiua-13642	2	9	incidence	incidence	NOUN
aiua-13642	2	10	of	of	ADP
aiua-13642	2	11	urolithiasis	urolithiasis	NOUN
aiua-13642	2	12	increased	increase	VERB
aiua-13642	2	13	from	from	ADP
aiua-13642	2	14	77.78	77.78	NUM
aiua-13642	2	15	million	million	NUM
aiua-13642	2	16	incident	incident	NOUN
aiua-13642	2	17	cases	case	NOUN
aiua-13642	2	18	in	in	ADP
aiua-13642	2	19	1990	1990	NUM
aiua-13642	2	20	to	to	ADP
aiua-13642	2	21	115.55	115.55	NUM
aiua-13642	2	22	million	million	NUM
aiua-13642	2	23	in	in	ADP
aiua-13642	2	24	2019	2019	NUM
aiua-13642	2	25	(	(	PUNCT
aiua-13642	2	26	1	1	NUM
aiua-13642	2	27	)	)	PUNCT
aiua-13642	2	28	.	.	PUNCT
aiua-13642	3	1	highest	high	ADJ
aiua-13642	3	2	incidence	incidence	NOUN
aiua-13642	3	3	rate	rate	NOUN
aiua-13642	3	4	of	of	ADP
aiua-13642	3	5	kidney	kidney	NOUN
aiua-13642	3	6	stones	stone	NOUN
aiua-13642	3	7	were	be	AUX
aiua-13642	3	8	reported	report	VERB
aiua-13642	3	9	in	in	ADP
aiua-13642	3	10	saudi	saudi	PROPN
aiua-13642	3	11	arabia	arabia	PROPN
aiua-13642	3	12	,	,	PUNCT
aiua-13642	3	13	kuwait	kuwait	PROPN
aiua-13642	3	14	,	,	PUNCT
aiua-13642	3	15	south	south	PROPN
aiua-13642	3	16	korea	korea	PROPN
aiua-13642	3	17	,	,	PUNCT
aiua-13642	3	18	china	china	PROPN
aiua-13642	3	19	,	,	PUNCT
aiua-13642	3	20	thailand	thailand	PROPN
aiua-13642	3	21	,	,	PUNCT
aiua-13642	3	22	spain	spain	PROPN
aiua-13642	3	23	,	,	PUNCT
aiua-13642	3	24	greece	greece	PROPN
aiua-13642	3	25	and	and	CCONJ
aiua-13642	3	26	the	the	DET
aiua-13642	3	27	united	united	PROPN
aiua-13642	3	28	states	states	PROPN
aiua-13642	3	29	of	of	ADP
aiua-13642	3	30	america	america	PROPN
aiua-13642	3	31	which	which	PRON
aiua-13642	3	32	raise	raise	VERB
aiua-13642	3	33	concerns	concern	NOUN
aiua-13642	3	34	about	about	ADP
aiua-13642	3	35	the	the	DET
aiua-13642	3	36	cause	cause	NOUN
aiua-13642	3	37	of	of	ADP
aiua-13642	3	38	kidney	kidney	NOUN
aiua-13642	3	39	stone	stone	NOUN
aiua-13642	3	40	and	and	CCONJ
aiua-13642	3	41	whether	whether	SCONJ
aiua-13642	3	42	it	it	PRON
aiua-13642	3	43	is	be	AUX
aiua-13642	3	44	linked	link	VERB
aiua-13642	3	45	to	to	ADP
aiua-13642	3	46	certain	certain	ADJ
aiua-13642	3	47	foods	food	NOUN
aiua-13642	3	48	,	,	PUNCT
aiua-13642	3	49	faulty	faulty	ADJ
aiua-13642	3	50	habitats	habitat	NOUN
aiua-13642	3	51	and	and	CCONJ
aiua-13642	3	52	the	the	DET
aiua-13642	3	53	nature	nature	NOUN
aiua-13642	3	54	of	of	ADP
aiua-13642	3	55	these	these	DET
aiua-13642	3	56	countries	country	NOUN
aiua-13642	3	57	(	(	PUNCT
aiua-13642	3	58	2	2	NUM
aiua-13642	3	59	,	,	PUNCT
aiua-13642	3	60	3	3	NUM
aiua-13642	3	61	)	)	PUNCT
aiua-13642	3	62	.	.	PUNCT
aiua-13642	4	1	medical	medical	ADJ
aiua-13642	4	2	treatment	treatment	NOUN
aiua-13642	4	3	of	of	ADP
aiua-13642	4	4	kidney	kidney	NOUN
aiua-13642	4	5	stones	stone	NOUN
aiua-13642	4	6	includes	include	VERB
aiua-13642	4	7	life	life	NOUN
aiua-13642	4	8	style	style	NOUN
aiua-13642	4	9	modification	modification	NOUN
aiua-13642	4	10	,	,	PUNCT
aiua-13642	4	11	high	high	ADJ
aiua-13642	4	12	water	water	NOUN
aiua-13642	4	13	intake	intake	NOUN
aiua-13642	4	14	,	,	PUNCT
aiua-13642	4	15	weight	weight	NOUN
aiua-13642	4	16	reduction	reduction	NOUN
aiua-13642	4	17	and	and	CCONJ
aiua-13642	4	18	exercise	exercise	NOUN
aiua-13642	4	19	(	(	PUNCT
aiua-13642	4	20	4	4	NUM
aiua-13642	4	21	)	)	PUNCT
aiua-13642	4	22	.	.	PUNCT
aiua-13642	5	1	oral	oral	ADJ
aiua-13642	5	2	or	or	CCONJ
aiua-13642	5	3	intravenous	intravenous	ADJ
aiua-13642	5	4	non	non	ADJ
aiua-13642	5	5	-	-	ADJ
aiua-13642	5	6	steroidal	steroidal	ADJ
aiua-13642	5	7	anti	anti	ADJ
aiua-13642	5	8	-	-	ADJ
aiua-13642	5	9	inflammatory	inflammatory	ADJ
aiua-13642	5	10	drugs	drug	NOUN
aiua-13642	5	11	(	(	PUNCT
aiua-13642	5	12	nsaids	nsaid	NOUN
aiua-13642	5	13	)	)	PUNCT
aiua-13642	5	14	may	may	AUX
aiua-13642	5	15	be	be	AUX
aiua-13642	5	16	used	use	VERB
aiua-13642	5	17	to	to	PART
aiua-13642	5	18	relieve	relieve	VERB
aiua-13642	5	19	pain	pain	NOUN
aiua-13642	5	20	.	.	PUNCT
aiua-13642	6	1	medical	medical	ADJ
aiua-13642	6	2	expulsive	expulsive	PROPN
aiua-13642	6	3	therapy	therapy	NOUN
aiua-13642	6	4	(	(	PUNCT
aiua-13642	6	5	met	meet	VERB
aiua-13642	6	6	)	)	PUNCT
aiua-13642	6	7	with	with	ADP
aiua-13642	6	8	alpha	alpha	ADJ
aiua-13642	6	9	blockers	blocker	NOUN
aiua-13642	6	10	has	have	AUX
aiua-13642	6	11	showed	show	VERB
aiua-13642	6	12	promising	promising	ADJ
aiua-13642	6	13	results	result	NOUN
aiua-13642	6	14	on	on	ADP
aiua-13642	6	15	stone	stone	NOUN
aiua-13642	6	16	expulsion	expulsion	NOUN
aiua-13642	6	17	with	with	ADP
aiua-13642	6	18	tamsulosin	tamsulosin	NOUN
aiua-13642	6	19	being	be	AUX
aiua-13642	6	20	the	the	DET
aiua-13642	6	21	most	most	ADV
aiua-13642	6	22	commonly	commonly	ADV
aiua-13642	6	23	used	use	VERB
aiua-13642	6	24	of	of	ADP
aiua-13642	6	25	this	this	DET
aiua-13642	6	26	family	family	NOUN
aiua-13642	6	27	of	of	ADP
aiua-13642	6	28	drugs	drug	NOUN
aiua-13642	6	29	(	(	PUNCT
aiua-13642	6	30	5	5	NUM
aiua-13642	6	31	)	)	PUNCT
aiua-13642	6	32	.	.	PUNCT
aiua-13642	7	1	silodosin	silodosin	PROPN
aiua-13642	7	2	is	be	AUX
aiua-13642	7	3	a	a	DET
aiua-13642	7	4	selective	selective	ADJ
aiua-13642	7	5	alpha	alpha	NOUN
aiua-13642	7	6	blocker	blocker	NOUN
aiua-13642	7	7	drug	drug	NOUN
aiua-13642	7	8	that	that	PRON
aiua-13642	7	9	works	work	VERB
aiua-13642	7	10	by	by	ADP
aiua-13642	7	11	binding	bind	VERB
aiua-13642	7	12	to	to	ADP
aiua-13642	7	13	the	the	DET
aiua-13642	7	14	extracellular	extracellular	ADJ
aiua-13642	7	15	domain	domain	NOUN
aiua-13642	7	16	of	of	ADP
aiua-13642	7	17	the	the	DET
aiua-13642	7	18	alpha	alpha	NOUN
aiua-13642	7	19	receptors	receptor	NOUN
aiua-13642	7	20	,	,	PUNCT
aiua-13642	7	21	which	which	PRON
aiua-13642	7	22	inhibits	inhibit	VERB
aiua-13642	7	23	activation	activation	NOUN
aiua-13642	7	24	of	of	ADP
aiua-13642	7	25	g	g	NOUN
aiua-13642	7	26	protein	protein	NOUN
aiua-13642	7	27	and	and	CCONJ
aiua-13642	7	28	prevents	prevent	VERB
aiua-13642	7	29	phosphorylation	phosphorylation	NOUN
aiua-13642	7	30	of	of	ADP
aiua-13642	7	31	phospholipase	phospholipase	PROPN
aiua-13642	7	32	c	c	NOUN
aiua-13642	7	33	,	,	PUNCT
aiua-13642	7	34	giving	give	VERB
aiua-13642	7	35	a	a	DET
aiua-13642	7	36	net	net	ADJ
aiua-13642	7	37	result	result	NOUN
aiua-13642	7	38	of	of	ADP
aiua-13642	7	39	smooth	smooth	ADJ
aiua-13642	7	40	muscle	muscle	NOUN
aiua-13642	7	41	relaxation	relaxation	NOUN
aiua-13642	7	42	(	(	PUNCT
aiua-13642	7	43	6	6	NUM
aiua-13642	7	44	)	)	PUNCT
aiua-13642	7	45	.	.	PUNCT
aiua-13642	8	1	silodosin	silodosin	PROPN
aiua-13642	8	2	is	be	AUX
aiua-13642	8	3	50	50	NUM
aiua-13642	8	4	times	time	NOUN
aiua-13642	8	5	more	more	ADV
aiua-13642	8	6	potent	potent	ADJ
aiua-13642	8	7	and	and	CCONJ
aiua-13642	8	8	selective	selective	ADJ
aiua-13642	8	9	on	on	ADP
aiua-13642	8	10	alpha	alpha	NOUN
aiua-13642	8	11	1	1	NUM
aiua-13642	8	12	receptors	receptor	NOUN
aiua-13642	8	13	than	than	ADP
aiua-13642	8	14	tamsulosin	tamsulosin	NOUN
aiua-13642	8	15	,	,	PUNCT
aiua-13642	8	16	which	which	PRON
aiua-13642	8	17	made	make	VERB
aiua-13642	8	18	most	most	ADJ
aiua-13642	8	19	urologists	urologist	NOUN
aiua-13642	8	20	and	and	CCONJ
aiua-13642	8	21	researchers	researcher	NOUN
aiua-13642	8	22	believe	believe	VERB
aiua-13642	8	23	that	that	SCONJ
aiua-13642	8	24	it	it	PRON
aiua-13642	8	25	might	might	AUX
aiua-13642	8	26	be	be	AUX
aiua-13642	8	27	more	more	ADV
aiua-13642	8	28	useful	useful	ADJ
aiua-13642	8	29	than	than	ADP
aiua-13642	8	30	tamsulosin	tamsulosin	NOUN
aiua-13642	8	31	considering	consider	VERB
aiua-13642	8	32	the	the	DET
aiua-13642	8	33	specifically	specifically	ADV
aiua-13642	8	34	high	high	ADJ
aiua-13642	8	35	density	density	NOUN
aiua-13642	8	36	of	of	ADP
aiua-13642	8	37	alpha	alpha	NOUN
aiua-13642	8	38	1	1	NUM
aiua-13642	8	39	receptors	receptor	NOUN
aiua-13642	8	40	in	in	ADP
aiua-13642	8	41	the	the	DET
aiua-13642	8	42	lower	low	ADJ
aiua-13642	8	43	ureter	ureter	NOUN
aiua-13642	8	44	(	(	PUNCT
aiua-13642	8	45	7	7	NUM
aiua-13642	8	46	)	)	PUNCT
aiua-13642	8	47	.	.	PUNCT
aiua-13642	9	1	tadalafil	tadalafil	PROPN
aiua-13642	9	2	also	also	ADV
aiua-13642	9	3	is	be	AUX
aiua-13642	9	4	a	a	DET
aiua-13642	9	5	promising	promising	ADJ
aiua-13642	9	6	drug	drug	NOUN
aiua-13642	9	7	for	for	ADP
aiua-13642	9	8	met	meet	VERB
aiua-13642	9	9	that	that	PRON
aiua-13642	9	10	acts	act	VERB
aiua-13642	9	11	by	by	ADP
aiua-13642	9	12	inhibiting	inhibit	VERB
aiua-13642	9	13	the	the	DET
aiua-13642	9	14	phosphodiesterase-5	phosphodiesterase-5	NUM
aiua-13642	9	15	enzyme	enzyme	NOUN
aiua-13642	9	16	(	(	PUNCT
aiua-13642	9	17	pde-5	pde-5	X
aiua-13642	9	18	)	)	PUNCT
aiua-13642	9	19	leading	lead	VERB
aiua-13642	9	20	to	to	ADP
aiua-13642	9	21	accumulation	accumulation	NOUN
aiua-13642	9	22	of	of	ADP
aiua-13642	9	23	cyclic	cyclic	ADJ
aiua-13642	9	24	guanosine	guanosine	NOUN
aiua-13642	9	25	mono	mono	NOUN
aiua-13642	9	26	phosphate	phosphate	NOUN
aiua-13642	9	27	and	and	CCONJ
aiua-13642	9	28	subsequent	subsequent	ADJ
aiua-13642	9	29	smooth	smooth	ADJ
aiua-13642	9	30	muscle	muscle	NOUN
aiua-13642	9	31	relaxation	relaxation	NOUN
aiua-13642	9	32	(	(	PUNCT
aiua-13642	9	33	8)	8)	NUM
aiua-13642	9	34	.	.	PUNCT
aiua-13642	10	1	although	although	SCONJ
aiua-13642	10	2	the	the	DET
aiua-13642	10	3	exact	exact	ADJ
aiua-13642	10	4	mechanism	mechanism	NOUN
aiua-13642	10	5	of	of	ADP
aiua-13642	10	6	tadalafil	tadalafil	NOUN
aiua-13642	10	7	on	on	ADP
aiua-13642	10	8	lower	low	ADJ
aiua-13642	10	9	ureter	ureter	ADJ
aiua-13642	10	10	relaxation	relaxation	NOUN
aiua-13642	10	11	is	be	AUX
aiua-13642	10	12	not	not	PART
aiua-13642	10	13	yet	yet	ADV
aiua-13642	10	14	fully	fully	ADV
aiua-13642	10	15	understood	understand	VERB
aiua-13642	10	16	,	,	PUNCT
aiua-13642	10	17	it	it	PRON
aiua-13642	10	18	has	have	AUX
aiua-13642	10	19	proven	prove	VERB
aiua-13642	10	20	to	to	PART
aiua-13642	10	21	be	be	AUX
aiua-13642	10	22	a	a	DET
aiua-13642	10	23	considerable	considerable	ADJ
aiua-13642	10	24	option	option	NOUN
aiua-13642	10	25	for	for	SCONJ
aiua-13642	10	26	met	meet	VERB
aiua-13642	10	27	especially	especially	ADV
aiua-13642	10	28	in	in	ADP
aiua-13642	10	29	patients	patient	NOUN
aiua-13642	10	30	with	with	ADP
aiua-13642	10	31	erectile	erectile	ADJ
aiua-13642	10	32	dysfunction	dysfunction	NOUN
aiua-13642	10	33	(	(	PUNCT
aiua-13642	10	34	9	9	NUM
aiua-13642	10	35	)	)	PUNCT
aiua-13642	10	36	.	.	PUNCT
aiua-13642	11	1	natural	natural	ADJ
aiua-13642	11	2	stone	stone	NOUN
aiua-13642	11	3	passage	passage	NOUN
aiua-13642	11	4	is	be	AUX
aiua-13642	11	5	enabled	enable	VERB
aiua-13642	11	6	with	with	ADP
aiua-13642	11	7	tadalafil	tadalafil	NOUN
aiua-13642	11	8	by	by	ADP
aiua-13642	11	9	ureter	ureter	ADJ
aiua-13642	11	10	lumen	luman	NOUN
aiua-13642	11	11	dilation	dilation	NOUN
aiua-13642	11	12	,	,	PUNCT
aiua-13642	11	13	whereas	whereas	SCONJ
aiua-13642	11	14	alpha-1	alpha-1	NUM
aiua-13642	11	15	adrenergic	adrenergic	ADJ
aiua-13642	11	16	receptor	receptor	NOUN
aiua-13642	11	17	antagonists	antagonist	NOUN
aiua-13642	11	18	induce	induce	VERB
aiua-13642	11	19	stone	stone	NOUN
aiua-13642	11	20	passage	passage	NOUN
aiua-13642	11	21	by	by	ADP
aiua-13642	11	22	reducing	reduce	VERB
aiua-13642	11	23	muscle	muscle	NOUN
aiua-13642	11	24	spasms	spasm	NOUN
aiua-13642	11	25	(	(	PUNCT
aiua-13642	11	26	10	10	NUM
aiua-13642	11	27	,	,	PUNCT
aiua-13642	11	28	11	11	NUM
aiua-13642	11	29	)	)	PUNCT
aiua-13642	11	30	.	.	PUNCT
aiua-13642	12	1	in	in	ADP
aiua-13642	12	2	this	this	DET
aiua-13642	12	3	study	study	NOUN
aiua-13642	12	4	we	we	PRON
aiua-13642	12	5	aimed	aim	VERB
aiua-13642	12	6	to	to	PART
aiua-13642	12	7	compare	compare	VERB
aiua-13642	12	8	tadalafil	tadalafil	PROPN
aiua-13642	12	9	and	and	CCONJ
aiua-13642	12	10	silodosin	silodosin	VERB
aiua-13642	12	11	for	for	ADP
aiua-13642	12	12	met	meet	VERB
aiua-13642	12	13	in	in	ADP
aiua-13642	12	14	lower	low	ADJ
aiua-13642	12	15	ureter	ureter	ADJ
aiua-13642	12	16	stones	stone	NOUN
aiua-13642	12	17	below	below	ADP
aiua-13642	12	18	10	10	NUM
aiua-13642	12	19	mm	mm	NOUN
aiua-13642	12	20	through	through	ADP
aiua-13642	12	21	a	a	DET
aiua-13642	12	22	comprehensive	comprehensive	ADJ
aiua-13642	12	23	systematic	systematic	ADJ
aiua-13642	12	24	review	review	NOUN
aiua-13642	12	25	and	and	CCONJ
aiua-13642	12	26	meta	meta	ADJ
aiua-13642	12	27	-	-	PUNCT
aiua-13642	12	28	analysis	analysis	NOUN
aiua-13642	12	29	and	and	CCONJ
aiua-13642	12	30	to	to	PART
aiua-13642	12	31	assess	assess	VERB
aiua-13642	12	32	the	the	DET
aiua-13642	12	33	incidence	incidence	NOUN
aiua-13642	12	34	of	of	ADP
aiua-13642	12	35	any	any	DET
aiua-13642	12	36	adverse	adverse	ADJ
aiua-13642	12	37	effects	effect	NOUN
aiua-13642	12	38	for	for	ADP
aiua-13642	12	39	each	each	DET
aiua-13642	12	40	drug	drug	NOUN
aiua-13642	12	41	.	.	PUNCT
aiua-13642	13	1	objective	objective	NOUN
aiua-13642	13	2	:	:	PUNCT
aiua-13642	13	3	this	this	DET
aiua-13642	13	4	meta	meta	ADJ
aiua-13642	13	5	-	-	PUNCT
aiua-13642	13	6	analysis	analysis	NOUN
aiua-13642	13	7	aims	aim	VERB
aiua-13642	13	8	to	to	PART
aiua-13642	13	9	compare	compare	VERB
aiua-13642	13	10	the	the	DET
aiua-13642	13	11	efficacy	efficacy	NOUN
aiua-13642	13	12	and	and	CCONJ
aiua-13642	13	13	safety	safety	NOUN
aiua-13642	13	14	of	of	ADP
aiua-13642	13	15	tadalafil	tadalafil	PROPN
aiua-13642	13	16	and	and	CCONJ
aiua-13642	13	17	silodosin	silodosin	NOUN
aiua-13642	13	18	as	as	ADP
aiua-13642	13	19	medical	medical	ADJ
aiua-13642	13	20	expulsive	expulsive	PROPN
aiua-13642	13	21	therapy	therapy	NOUN
aiua-13642	13	22	(	(	PUNCT
aiua-13642	13	23	met	meet	VERB
aiua-13642	13	24	)	)	PUNCT
aiua-13642	13	25	for	for	ADP
aiua-13642	13	26	lower	low	ADJ
aiua-13642	13	27	ureteric	ureteric	ADJ
aiua-13642	13	28	stones	stone	NOUN
aiua-13642	13	29	below	below	ADP
aiua-13642	13	30	10	10	NUM
aiua-13642	13	31	mm	mm	NOUN
aiua-13642	13	32	.	.	PUNCT
aiua-13642	14	1	the	the	DET
aiua-13642	14	2	study	study	NOUN
aiua-13642	14	3	also	also	ADV
aiua-13642	14	4	assesses	assess	VERB
aiua-13642	14	5	the	the	DET
aiua-13642	14	6	incidence	incidence	NOUN
aiua-13642	14	7	of	of	ADP
aiua-13642	14	8	adverse	adverse	ADJ
aiua-13642	14	9	effects	effect	NOUN
aiua-13642	14	10	associated	associate	VERB
aiua-13642	14	11	with	with	ADP
aiua-13642	14	12	each	each	DET
aiua-13642	14	13	drug	drug	NOUN
aiua-13642	14	14	.	.	PUNCT
aiua-13642	15	1	methods	method	NOUN
aiua-13642	15	2	:	:	PUNCT
aiua-13642	15	3	a	a	DET
aiua-13642	15	4	comprehensive	comprehensive	ADJ
aiua-13642	15	5	search	search	NOUN
aiua-13642	15	6	of	of	ADP
aiua-13642	15	7	electronic	electronic	ADJ
aiua-13642	15	8	databases	database	NOUN
aiua-13642	15	9	was	be	AUX
aiua-13642	15	10	conducted	conduct	VERB
aiua-13642	15	11	up	up	ADP
aiua-13642	15	12	to	to	ADP
aiua-13642	15	13	october	october	PROPN
aiua-13642	15	14	,	,	PUNCT
aiua-13642	15	15	2024	2024	NUM
aiua-13642	15	16	.	.	PUNCT
aiua-13642	16	1	the	the	DET
aiua-13642	16	2	study	study	NOUN
aiua-13642	16	3	included	include	VERB
aiua-13642	16	4	randomized	randomize	VERB
aiua-13642	16	5	controlled	control	VERB
aiua-13642	16	6	trials	trial	NOUN
aiua-13642	16	7	(	(	PUNCT
aiua-13642	16	8	rcts	rct	NOUN
aiua-13642	16	9	)	)	PUNCT
aiua-13642	16	10	and	and	CCONJ
aiua-13642	16	11	cohort	cohort	NOUN
aiua-13642	16	12	studies	study	NOUN
aiua-13642	16	13	that	that	PRON
aiua-13642	16	14	compared	compare	VERB
aiua-13642	16	15	tadalafil	tadalafil	PROPN
aiua-13642	16	16	and	and	CCONJ
aiua-13642	16	17	silodosin	silodosin	VERB
aiua-13642	16	18	in	in	ADP
aiua-13642	16	19	patients	patient	NOUN
aiua-13642	16	20	with	with	ADP
aiua-13642	16	21	lower	low	ADJ
aiua-13642	16	22	ureteric	ureteric	ADJ
aiua-13642	16	23	stones	stone	NOUN
aiua-13642	16	24	(	(	PUNCT
aiua-13642	16	25	5	5	NUM
aiua-13642	16	26	-	-	SYM
aiua-13642	16	27	10	10	NUM
aiua-13642	16	28	mm	mm	NOUN
aiua-13642	16	29	)	)	PUNCT
aiua-13642	16	30	.	.	PUNCT
aiua-13642	17	1	the	the	DET
aiua-13642	17	2	primary	primary	ADJ
aiua-13642	17	3	outcomes	outcome	NOUN
aiua-13642	17	4	assessed	assess	VERB
aiua-13642	17	5	were	be	AUX
aiua-13642	17	6	stone	stone	NOUN
aiua-13642	17	7	expulsion	expulsion	NOUN
aiua-13642	17	8	time	time	NOUN
aiua-13642	17	9	(	(	PUNCT
aiua-13642	17	10	set	set	NOUN
aiua-13642	17	11	)	)	PUNCT
aiua-13642	17	12	,	,	PUNCT
aiua-13642	17	13	stone	stone	NOUN
aiua-13642	17	14	expulsion	expulsion	NOUN
aiua-13642	17	15	rate	rate	NOUN
aiua-13642	17	16	(	(	PUNCT
aiua-13642	17	17	ser	ser	NOUN
aiua-13642	17	18	)	)	PUNCT
aiua-13642	17	19	,	,	PUNCT
aiua-13642	17	20	and	and	CCONJ
aiua-13642	17	21	adverse	adverse	ADJ
aiua-13642	17	22	effects	effect	NOUN
aiua-13642	17	23	.	.	PUNCT
aiua-13642	18	1	data	datum	NOUN
aiua-13642	18	2	were	be	AUX
aiua-13642	18	3	analyzed	analyze	VERB
aiua-13642	18	4	using	use	VERB
aiua-13642	18	5	a	a	DET
aiua-13642	18	6	random	random	ADJ
aiua-13642	18	7	-	-	PUNCT
aiua-13642	18	8	effects	effect	NOUN
aiua-13642	18	9	model	model	NOUN
aiua-13642	18	10	for	for	ADP
aiua-13642	18	11	heterogeneity	heterogeneity	NOUN
aiua-13642	18	12	and	and	CCONJ
aiua-13642	18	13	a	a	DET
aiua-13642	18	14	fixed	fix	VERB
aiua-13642	18	15	-	-	PUNCT
aiua-13642	18	16	effect	effect	NOUN
aiua-13642	18	17	model	model	NOUN
aiua-13642	18	18	for	for	ADP
aiua-13642	18	19	non	non	ADJ
aiua-13642	18	20	-	-	ADJ
aiua-13642	18	21	heterogeneity	heterogeneity	ADJ
aiua-13642	18	22	.	.	PUNCT
aiua-13642	19	1	results	result	NOUN
aiua-13642	19	2	:	:	PUNCT
aiua-13642	19	3	eight	eight	NUM
aiua-13642	19	4	studies	study	NOUN
aiua-13642	19	5	involving	involve	VERB
aiua-13642	19	6	797	797	NUM
aiua-13642	19	7	patients	patient	NOUN
aiua-13642	19	8	were	be	AUX
aiua-13642	19	9	included	include	VERB
aiua-13642	19	10	.	.	PUNCT
aiua-13642	20	1	the	the	DET
aiua-13642	20	2	pooled	pooled	ADJ
aiua-13642	20	3	analysis	analysis	NOUN
aiua-13642	20	4	showed	show	VERB
aiua-13642	20	5	no	no	DET
aiua-13642	20	6	significant	significant	ADJ
aiua-13642	20	7	difference	difference	NOUN
aiua-13642	20	8	in	in	ADP
aiua-13642	20	9	set	set	NOUN
aiua-13642	20	10	between	between	ADP
aiua-13642	20	11	tadalafil	tadalafil	PROPN
aiua-13642	20	12	and	and	CCONJ
aiua-13642	20	13	silodosin	silodosin	PROPN
aiua-13642	20	14	(	(	PUNCT
aiua-13642	20	15	md	md	PROPN
aiua-13642	20	16	=	=	PROPN
aiua-13642	20	17	0.15	0.15	NUM
aiua-13642	20	18	,	,	PUNCT
aiua-13642	20	19	95	95	NUM
aiua-13642	20	20	%	%	NOUN
aiua-13642	20	21	ci	ci	NOUN
aiua-13642	21	1	[	[	X
aiua-13642	21	2	-0.28	-0.28	NUM
aiua-13642	21	3	,	,	PUNCT
aiua-13642	21	4	0.57	0.57	NUM
aiua-13642	21	5	]	]	PUNCT
aiua-13642	21	6	,	,	PUNCT
aiua-13642	21	7	p	p	X
aiua-13642	21	8	=	=	NOUN
aiua-13642	21	9	0.50	0.50	NUM
aiua-13642	21	10	)	)	PUNCT
aiua-13642	21	11	,	,	PUNCT
aiua-13642	21	12	with	with	ADP
aiua-13642	21	13	significant	significant	ADJ
aiua-13642	21	14	heterogeneity	heterogeneity	NOUN
aiua-13642	21	15	.	.	PUNCT
aiua-13642	22	1	similarly	similarly	ADV
aiua-13642	22	2	,	,	PUNCT
aiua-13642	22	3	the	the	DET
aiua-13642	22	4	pooled	pooled	ADJ
aiua-13642	22	5	analysis	analysis	NOUN
aiua-13642	22	6	showed	show	VERB
aiua-13642	22	7	no	no	DET
aiua-13642	22	8	significant	significant	ADJ
aiua-13642	22	9	difference	difference	NOUN
aiua-13642	22	10	in	in	ADP
aiua-13642	22	11	ser	ser	NOUN
aiua-13642	22	12	between	between	ADP
aiua-13642	22	13	the	the	DET
aiua-13642	22	14	two	two	NUM
aiua-13642	22	15	drugs	drug	NOUN
aiua-13642	22	16	(	(	PUNCT
aiua-13642	22	17	rr	rr	NOUN
aiua-13642	22	18	=	=	NUM
aiua-13642	22	19	0.92	0.92	NUM
aiua-13642	22	20	,	,	PUNCT
aiua-13642	22	21	95	95	NUM
aiua-13642	22	22	%	%	NOUN
aiua-13642	22	23	ci	ci	NOUN
aiua-13642	23	1	[	[	X
aiua-13642	23	2	0.80	0.80	NUM
aiua-13642	23	3	to	to	ADP
aiua-13642	23	4	1.05	1.05	NUM
aiua-13642	23	5	]	]	PUNCT
aiua-13642	23	6	,	,	PUNCT
aiua-13642	23	7	p	p	NOUN
aiua-13642	23	8	=	=	NOUN
aiua-13642	23	9	0.22	0.22	NUM
aiua-13642	23	10	)	)	PUNCT
aiua-13642	23	11	,	,	PUNCT
aiua-13642	23	12	with	with	ADP
aiua-13642	23	13	heterogeneity	heterogeneity	NOUN
aiua-13642	23	14	.	.	PUNCT
aiua-13642	24	1	however	however	ADV
aiua-13642	24	2	,	,	PUNCT
aiua-13642	24	3	after	after	ADP
aiua-13642	24	4	excluding	exclude	VERB
aiua-13642	24	5	one	one	NUM
aiua-13642	24	6	study	study	NOUN
aiua-13642	24	7	,	,	PUNCT
aiua-13642	24	8	silodosin	silodosin	PROPN
aiua-13642	24	9	was	be	AUX
aiua-13642	24	10	favored	favor	VERB
aiua-13642	24	11	over	over	ADP
aiua-13642	24	12	tadalafil	tadalafil	PROPN
aiua-13642	24	13	for	for	ADP
aiua-13642	24	14	ser	ser	NOUN
aiua-13642	24	15	(	(	PUNCT
aiua-13642	24	16	rr	rr	NOUN
aiua-13642	24	17	0.88	0.88	NUM
aiua-13642	24	18	,	,	PUNCT
aiua-13642	24	19	95	95	NUM
aiua-13642	24	20	%	%	NOUN
aiua-13642	24	21	ci	ci	NOUN
aiua-13642	25	1	[	[	X
aiua-13642	25	2	0.79	0.79	NUM
aiua-13642	25	3	to	to	ADP
aiua-13642	25	4	0.98	0.98	NUM
aiua-13642	25	5	]	]	PUNCT
aiua-13642	25	6	,	,	PUNCT
aiua-13642	25	7	p	p	X
aiua-13642	25	8	=	=	NOUN
aiua-13642	25	9	0.02	0.02	NUM
aiua-13642	25	10	)	)	PUNCT
aiua-13642	25	11	.	.	PUNCT
aiua-13642	26	1	there	there	PRON
aiua-13642	26	2	were	be	VERB
aiua-13642	26	3	no	no	DET
aiua-13642	26	4	significant	significant	ADJ
aiua-13642	26	5	differences	difference	NOUN
aiua-13642	26	6	in	in	ADP
aiua-13642	26	7	headache	headache	NOUN
aiua-13642	26	8	,	,	PUNCT
aiua-13642	26	9	backache	backache	NOUN
aiua-13642	26	10	,	,	PUNCT
aiua-13642	26	11	or	or	CCONJ
aiua-13642	26	12	dizziness	dizziness	NOUN
aiua-13642	26	13	.	.	PUNCT
aiua-13642	27	1	silodosin	silodosin	PROPN
aiua-13642	27	2	was	be	AUX
aiua-13642	27	3	associated	associate	VERB
aiua-13642	27	4	with	with	ADP
aiua-13642	27	5	a	a	DET
aiua-13642	27	6	higher	high	ADJ
aiua-13642	27	7	incidence	incidence	NOUN
aiua-13642	27	8	of	of	ADP
aiua-13642	27	9	orthostatic	orthostatic	ADJ
aiua-13642	27	10	hypotension	hypotension	NOUN
aiua-13642	27	11	,	,	PUNCT
aiua-13642	27	12	but	but	CCONJ
aiua-13642	27	13	this	this	PRON
aiua-13642	27	14	was	be	AUX
aiua-13642	27	15	resolved	resolve	VERB
aiua-13642	27	16	by	by	ADP
aiua-13642	27	17	excluding	exclude	VERB
aiua-13642	27	18	one	one	NUM
aiua-13642	27	19	study	study	NOUN
aiua-13642	27	20	.	.	PUNCT
aiua-13642	28	1	a	a	DET
aiua-13642	28	2	significant	significant	ADJ
aiua-13642	28	3	difference	difference	NOUN
aiua-13642	28	4	for	for	ADP
aiua-13642	28	5	abnormal	abnormal	ADJ
aiua-13642	28	6	ejaculation	ejaculation	NOUN
aiua-13642	28	7	favored	favor	VERB
aiua-13642	28	8	tadalafil	tadalafil	PROPN
aiua-13642	28	9	(	(	PUNCT
aiua-13642	28	10	rr	rr	PROPN
aiua-13642	28	11	=	=	SYM
aiua-13642	28	12	0.16	0.16	NUM
aiua-13642	28	13	,	,	PUNCT
aiua-13642	28	14	95	95	NUM
aiua-13642	28	15	%	%	NOUN
aiua-13642	28	16	ci	ci	NOUN
aiua-13642	29	1	[	[	X
aiua-13642	29	2	0.09	0.09	NUM
aiua-13642	29	3	to	to	PART
aiua-13642	29	4	0.29	0.29	NUM
aiua-13642	29	5	]	]	PUNCT
aiua-13642	29	6	,	,	PUNCT
aiua-13642	29	7	p	p	X
aiua-13642	29	8	=	=	NOUN
aiua-13642	29	9	0.01	0.01	NUM
aiua-13642	29	10	)	)	PUNCT
aiua-13642	29	11	.	.	PUNCT
aiua-13642	30	1	conclusions	conclusion	NOUN
aiua-13642	30	2	:	:	PUNCT
aiua-13642	30	3	while	while	SCONJ
aiua-13642	30	4	the	the	DET
aiua-13642	30	5	pooled	pool	VERB
aiua-13642	30	6	results	result	NOUN
aiua-13642	30	7	initially	initially	ADV
aiua-13642	30	8	showed	show	VERB
aiua-13642	30	9	no	no	DET
aiua-13642	30	10	significant	significant	ADJ
aiua-13642	30	11	difference	difference	NOUN
aiua-13642	30	12	in	in	ADP
aiua-13642	30	13	set	set	NOUN
aiua-13642	30	14	and	and	CCONJ
aiua-13642	30	15	ser	ser	NOUN
aiua-13642	30	16	,	,	PUNCT
aiua-13642	30	17	silodosin	silodosin	PROPN
aiua-13642	30	18	demonstrated	demonstrate	VERB
aiua-13642	30	19	a	a	DET
aiua-13642	30	20	superior	superior	ADJ
aiua-13642	30	21	stone	stone	NOUN
aiua-13642	30	22	expulsion	expulsion	NOUN
aiua-13642	30	23	rate	rate	NOUN
aiua-13642	30	24	after	after	ADP
aiua-13642	30	25	adjusting	adjust	VERB
aiua-13642	30	26	for	for	ADP
aiua-13642	30	27	heterogeneity	heterogeneity	NOUN
aiua-13642	30	28	silodosin	silodosin	NOUN
aiua-13642	30	29	showed	show	VERB
aiua-13642	30	30	a	a	DET
aiua-13642	30	31	trend	trend	NOUN
aiua-13642	30	32	towards	towards	ADP
aiua-13642	30	33	shorter	short	ADJ
aiua-13642	30	34	set	set	NOUN
aiua-13642	30	35	.	.	PUNCT
aiua-13642	31	1	however	however	ADV
aiua-13642	31	2	,	,	PUNCT
aiua-13642	31	3	silodosin	silodosin	PROPN
aiua-13642	31	4	was	be	AUX
aiua-13642	31	5	associated	associate	VERB
aiua-13642	31	6	with	with	ADP
aiua-13642	31	7	a	a	DET
aiua-13642	31	8	higher	high	ADJ
aiua-13642	31	9	risk	risk	NOUN
aiua-13642	31	10	of	of	ADP
aiua-13642	31	11	orthostatic	orthostatic	ADJ
aiua-13642	31	12	hypotension	hypotension	NOUN
aiua-13642	31	13	and	and	CCONJ
aiua-13642	31	14	abnormal	abnormal	ADJ
aiua-13642	31	15	ejaculation	ejaculation	NOUN
aiua-13642	31	16	.	.	PUNCT
aiua-13642	32	1	further	further	ADJ
aiua-13642	32	2	high	high	ADJ
aiua-13642	32	3	-	-	PUNCT
aiua-13642	32	4	quality	quality	NOUN
aiua-13642	32	5	rcts	rct	NOUN
aiua-13642	32	6	with	with	ADP
aiua-13642	32	7	larger	large	ADJ
aiua-13642	32	8	sample	sample	NOUN
aiua-13642	32	9	sizes	size	NOUN
aiua-13642	32	10	are	be	AUX
aiua-13642	32	11	needed	need	VERB
aiua-13642	32	12	to	to	PART
aiua-13642	32	13	confirm	confirm	VERB
aiua-13642	32	14	these	these	DET
aiua-13642	32	15	findings	finding	NOUN
aiua-13642	32	16	.	.	PUNCT
aiua-13642	33	1	key	key	ADJ
aiua-13642	33	2	words	word	NOUN
aiua-13642	33	3	:	:	PUNCT
aiua-13642	33	4	ureter	ureter	ADJ
aiua-13642	33	5	stones	stone	NOUN
aiua-13642	33	6	;	;	PUNCT
aiua-13642	33	7	tadalafil	tadalafil	NOUN
aiua-13642	33	8	;	;	PUNCT
aiua-13642	33	9	silodosin	silodosin	VERB
aiua-13642	33	10	;	;	PUNCT
aiua-13642	33	11	alpha	alpha	NOUN
aiua-13642	33	12	blockers	blocker	NOUN
aiua-13642	33	13	;	;	PUNCT
aiua-13642	33	14	medical	medical	ADJ
aiua-13642	33	15	expulsive	expulsive	PROPN
aiua-13642	33	16	therapy	therapy	NOUN
aiua-13642	33	17	.	.	PUNCT
aiua-13642	33	18	submitted	submit	VERB
aiua-13642	33	19	17	17	NUM
aiua-13642	33	20	january	january	NOUN
aiua-13642	33	21	2025	2025	NUM
aiua-13642	33	22	;	;	PUNCT
aiua-13642	33	23	accepted	accept	VERB
aiua-13642	33	24	6	6	NUM
aiua-13642	33	25	february	february	PROPN
aiua-13642	33	26	2025	2025	NUM
aiua-13642	33	27	introduction	introduction	NOUN
aiua-13642	33	28	despite	despite	SCONJ
aiua-13642	33	29	recent	recent	ADJ
aiua-13642	33	30	advances	advance	NOUN
aiua-13642	33	31	of	of	ADP
aiua-13642	33	32	endoscopic	endoscopic	ADJ
aiua-13642	33	33	techniques	technique	NOUN
aiua-13642	33	34	for	for	ADP
aiua-13642	33	35	management	management	NOUN
aiua-13642	33	36	of	of	ADP
aiua-13642	33	37	urinary	urinary	ADJ
aiua-13642	33	38	stones	stone	NOUN
aiua-13642	33	39	,	,	PUNCT
aiua-13642	33	40	the	the	DET
aiua-13642	33	41	prevalence	prevalence	NOUN
aiua-13642	33	42	of	of	ADP
aiua-13642	33	43	this	this	DET
aiua-13642	33	44	conis	conis	NOUN
aiua-13642	33	45	silodosin	silodosin	VERB
aiua-13642	33	46	better	well	ADV
aiua-13642	33	47	than	than	ADP
aiua-13642	33	48	tadalafil	tadalafil	PROPN
aiua-13642	33	49	as	as	ADP
aiua-13642	33	50	a	a	DET
aiua-13642	33	51	medical	medical	ADJ
aiua-13642	33	52	expulsive	expulsive	NOUN
aiua-13642	33	53	therapy	therapy	NOUN
aiua-13642	33	54	in	in	ADP
aiua-13642	33	55	lower	low	ADJ
aiua-13642	33	56	ureter	ureter	ADJ
aiua-13642	33	57	stones	stone	NOUN
aiua-13642	33	58	?	?	PUNCT
aiua-13642	34	1	mohab	mohab	PROPN
aiua-13642	34	2	alsaid	alsaid	PROPN
aiua-13642	34	3	saad	saad	PROPN
aiua-13642	34	4	abdalaziz	abdalaziz	PROPN
aiua-13642	34	5	1	1	NUM
aiua-13642	34	6	,	,	PUNCT
aiua-13642	34	7	yousif	yousif	PROPN
aiua-13642	34	8	ahmad	ahmad	PROPN
aiua-13642	34	9	hanafi	hanafi	PROPN
aiua-13642	34	10	1	1	NUM
aiua-13642	34	11	,	,	PUNCT
aiua-13642	34	12	belal	belal	PROPN
aiua-13642	34	13	mohamed	mohamed	PROPN
aiua-13642	34	14	hamed	hamed	PROPN
aiua-13642	34	15	1	1	NUM
aiua-13642	34	16	,	,	PUNCT
aiua-13642	34	17	omar	omar	PROPN
aiua-13642	34	18	fayez	fayez	VERB
aiua-13642	34	19	abbas	abbas	PROPN
aiua-13642	34	20	1	1	NUM
aiua-13642	34	21	,	,	PUNCT
aiua-13642	34	22	khaled	khaled	PROPN
aiua-13642	34	23	omar	omar	PROPN
aiua-13642	34	24	mahmoud	mahmoud	PROPN
aiua-13642	34	25	khader	khader	PROPN
aiua-13642	34	26	2	2	NUM
aiua-13642	34	27	,	,	PUNCT
aiua-13642	34	28	mohammad	mohammad	PROPN
aiua-13642	34	29	kh	kh	PROPN
aiua-13642	34	30	.	.	PROPN
aiua-13642	34	31	alzawahreh	alzawahreh	PROPN
aiua-13642	34	32	3	3	NUM
aiua-13642	34	33	,	,	PUNCT
aiua-13642	34	34	hesham	hesham	PROPN
aiua-13642	34	35	ghzayel	ghzayel	PROPN
aiua-13642	34	36	4	4	NUM
aiua-13642	34	37	,	,	PUNCT
aiua-13642	34	38	rashed	rashe	VERB
aiua-13642	34	39	yousef	yousef	PROPN
aiua-13642	34	40	al	al	PROPN
aiua-13642	34	41	sharqi	sharqi	PROPN
aiua-13642	34	42	5	5	PROPN
aiua-13642	34	43	,	,	PUNCT
aiua-13642	34	44	zaid	zaid	PROPN
aiua-13642	34	45	f.	f.	PROPN
aiua-13642	34	46	altawallbeh	altawallbeh	NOUN
aiua-13642	34	47	6	6	NUM
aiua-13642	34	48	1	1	NUM
aiua-13642	34	49	faculty	faculty	NOUN
aiua-13642	34	50	of	of	ADP
aiua-13642	34	51	medicine	medicine	NOUN
aiua-13642	34	52	,	,	PUNCT
aiua-13642	34	53	al	al	PROPN
aiua-13642	34	54	-	-	PUNCT
aiua-13642	34	55	azhar	azhar	PROPN
aiua-13642	34	56	university	university	PROPN
aiua-13642	34	57	,	,	PUNCT
aiua-13642	34	58	cairo	cairo	PROPN
aiua-13642	34	59	,	,	PUNCT
aiua-13642	34	60	egypt	egypt	PROPN
aiua-13642	34	61	;	;	PUNCT
aiua-13642	34	62	2	2	NUM
aiua-13642	34	63	internship	internship	NOUN
aiua-13642	34	64	at	at	ADP
aiua-13642	34	65	specialty	specialty	NOUN
aiua-13642	34	66	hospital	hospital	NOUN
aiua-13642	34	67	,	,	PUNCT
aiua-13642	34	68	jordan	jordan	PROPN
aiua-13642	34	69	;	;	PUNCT
aiua-13642	34	70	3	3	NUM
aiua-13642	34	71	urology	urology	NOUN
aiua-13642	34	72	,	,	PUNCT
aiua-13642	34	73	department	department	NOUN
aiua-13642	34	74	of	of	ADP
aiua-13642	34	75	special	special	ADJ
aiua-13642	34	76	surgery	surgery	NOUN
aiua-13642	34	77	,	,	PUNCT
aiua-13642	34	78	ministry	ministry	NOUN
aiua-13642	34	79	of	of	ADP
aiua-13642	34	80	health	health	PROPN
aiua-13642	34	81	,	,	PUNCT
aiua-13642	34	82	saudi	saudi	PROPN
aiua-13642	34	83	arabia	arabia	PROPN
aiua-13642	34	84	;	;	PUNCT
aiua-13642	34	85	4	4	NUM
aiua-13642	34	86	urology	urology	NOUN
aiua-13642	34	87	and	and	CCONJ
aiua-13642	34	88	andrology	andrology	NOUN
aiua-13642	34	89	,	,	PUNCT
aiua-13642	34	90	department	department	NOUN
aiua-13642	34	91	of	of	ADP
aiua-13642	34	92	special	special	ADJ
aiua-13642	34	93	surgery	surgery	NOUN
aiua-13642	34	94	,	,	PUNCT
aiua-13642	34	95	ministry	ministry	NOUN
aiua-13642	34	96	of	of	ADP
aiua-13642	34	97	health	health	PROPN
aiua-13642	34	98	,	,	PUNCT
aiua-13642	34	99	sultanate	sultanate	NOUN
aiua-13642	34	100	of	of	ADP
aiua-13642	34	101	oman	oman	NOUN
aiua-13642	34	102	;	;	PUNCT
aiua-13642	34	103	5	5	NUM
aiua-13642	34	104	urology	urology	NOUN
aiua-13642	34	105	department	department	NOUN
aiua-13642	34	106	,	,	PUNCT
aiua-13642	34	107	al	al	PROPN
aiua-13642	34	108	nadeem	nadeem	PROPN
aiua-13642	34	109	hospital	hospital	PROPN
aiua-13642	34	110	,	,	PUNCT
aiua-13642	34	111	ministry	ministry	PROPN
aiua-13642	34	112	of	of	ADP
aiua-13642	34	113	health	health	PROPN
aiua-13642	34	114	,	,	PUNCT
aiua-13642	34	115	jordan	jordan	PROPN
aiua-13642	34	116	;	;	PUNCT
aiua-13642	34	117	6	6	NUM
aiua-13642	34	118	internship	internship	NOUN
aiua-13642	34	119	at	at	ADP
aiua-13642	34	120	al	al	PROPN
aiua-13642	34	121	nadeem	nadeem	PROPN
aiua-13642	34	122	hospital	hospital	PROPN
aiua-13642	34	123	,	,	PUNCT
aiua-13642	34	124	madaba	madaba	PROPN
aiua-13642	34	125	,	,	PUNCT
aiua-13642	34	126	jordan	jordan	PROPN
aiua-13642	34	127	.	.	PUNCT
aiua-13642	35	1	doi	doi	PROPN
aiua-13642	35	2	:	:	PUNCT
aiua-13642	35	3	10.4081	10.4081	NUM
aiua-13642	35	4	/	/	SYM
aiua-13642	35	5	aiua.2025.13642	aiua.2025.13642	PROPN
aiua-13642	35	6	summary	summary	NOUN
aiua-13642	35	7	archivio	archivio	NOUN
aiua-13642	35	8	italiano	italiano	X
aiua-13642	35	9	di	di	X
aiua-13642	35	10	urologia	urologia	PROPN
aiua-13642	35	11	e	e	PROPN
aiua-13642	35	12	andrologia	andrologia	NOUN
aiua-13642	35	13	2025	2025	NUM
aiua-13642	35	14	;	;	PUNCT
aiua-13642	35	15	97(2):13642	97(2):13642	NUM
aiua-13642	35	16	m.	m.	NOUN
aiua-13642	35	17	alsaid	alsaid	PROPN
aiua-13642	35	18	saad	saad	PROPN
aiua-13642	35	19	abdalaziz	abdalaziz	PROPN
aiua-13642	35	20	,	,	PUNCT
aiua-13642	35	21	y.	y.	PROPN
aiua-13642	35	22	ahmad	ahmad	PROPN
aiua-13642	35	23	hanafi	hanafi	PROPN
aiua-13642	35	24	,	,	PUNCT
aiua-13642	35	25	b.	b.	PROPN
aiua-13642	35	26	mohamed	mohamed	PROPN
aiua-13642	35	27	hamed	hamed	PROPN
aiua-13642	35	28	,	,	PUNCT
aiua-13642	35	29	et	et	PROPN
aiua-13642	35	30	al	al	PROPN
aiua-13642	35	31	.	.	PROPN
aiua-13642	35	32	2	2	NUM
aiua-13642	35	33	materials	material	NOUN
aiua-13642	35	34	and	and	CCONJ
aiua-13642	35	35	methods	method	NOUN
aiua-13642	35	36	we	we	PRON
aiua-13642	35	37	adhered	adhere	VERB
aiua-13642	35	38	to	to	ADP
aiua-13642	35	39	the	the	DET
aiua-13642	35	40	preferred	preferred	ADJ
aiua-13642	35	41	reporting	reporting	NOUN
aiua-13642	35	42	items	item	NOUN
aiua-13642	35	43	for	for	ADP
aiua-13642	35	44	systematic	systematic	ADJ
aiua-13642	35	45	reviews	review	NOUN
aiua-13642	35	46	and	and	CCONJ
aiua-13642	35	47	meta	meta	NOUN
aiua-13642	35	48	-	-	PUNCT
aiua-13642	35	49	analyses	analysis	NOUN
aiua-13642	35	50	(	(	PUNCT
aiua-13642	35	51	prisma	prisma	NOUN
aiua-13642	35	52	statement	statement	NOUN
aiua-13642	35	53	)	)	PUNCT
aiua-13642	35	54	(	(	PUNCT
aiua-13642	35	55	12	12	NUM
aiua-13642	35	56	)	)	PUNCT
aiua-13642	35	57	.	.	PUNCT
aiua-13642	36	1	all	all	DET
aiua-13642	36	2	steps	step	NOUN
aiua-13642	36	3	were	be	AUX
aiua-13642	36	4	completed	complete	VERB
aiua-13642	36	5	per	per	ADP
aiua-13642	36	6	the	the	DET
aiua-13642	36	7	cochrane	cochrane	PROPN
aiua-13642	36	8	handbook	handbook	NOUN
aiua-13642	36	9	of	of	ADP
aiua-13642	36	10	systematic	systematic	ADJ
aiua-13642	36	11	reviews	review	NOUN
aiua-13642	36	12	and	and	CCONJ
aiua-13642	36	13	meta	meta	NOUN
aiua-13642	36	14	-	-	PUNCT
aiua-13642	36	15	analysis	analysis	NOUN
aiua-13642	36	16	(	(	PUNCT
aiua-13642	36	17	13	13	NUM
aiua-13642	36	18	)	)	PUNCT
aiua-13642	36	19	.	.	PUNCT
aiua-13642	37	1	this	this	DET
aiua-13642	37	2	study	study	NOUN
aiua-13642	37	3	was	be	AUX
aiua-13642	37	4	prospectively	prospectively	ADV
aiua-13642	37	5	registered	register	VERB
aiua-13642	37	6	on	on	ADP
aiua-13642	37	7	prospero	prospero	NOUN
aiua-13642	37	8	with	with	ADP
aiua-13642	37	9	the	the	DET
aiua-13642	37	10	study	study	NOUN
aiua-13642	37	11	i	i	PROPN
aiua-13642	37	12	d	d	PROPN
aiua-13642	37	13	(	(	PUNCT
aiua-13642	37	14	crd42024597302	crd42024597302	PROPN
aiua-13642	37	15	)	)	PUNCT
aiua-13642	37	16	.	.	PUNCT
aiua-13642	38	1	search	search	NOUN
aiua-13642	38	2	strategy	strategy	NOUN
aiua-13642	38	3	and	and	CCONJ
aiua-13642	38	4	data	datum	NOUN
aiua-13642	38	5	collection	collection	NOUN
aiua-13642	38	6	a	a	DET
aiua-13642	38	7	search	search	NOUN
aiua-13642	38	8	of	of	ADP
aiua-13642	38	9	electronic	electronic	ADJ
aiua-13642	38	10	databases	database	NOUN
aiua-13642	38	11	including	include	VERB
aiua-13642	38	12	pubmed	pubmed	PROPN
aiua-13642	38	13	,	,	PUNCT
aiua-13642	38	14	scopus	scopus	PROPN
aiua-13642	38	15	,	,	PUNCT
aiua-13642	38	16	cochrane	cochrane	NOUN
aiua-13642	38	17	,	,	PUNCT
aiua-13642	38	18	science	science	NOUN
aiua-13642	38	19	direct	direct	ADJ
aiua-13642	38	20	,	,	PUNCT
aiua-13642	38	21	embase	embase	NOUN
aiua-13642	38	22	,	,	PUNCT
aiua-13642	38	23	web	web	NOUN
aiua-13642	38	24	of	of	ADP
aiua-13642	38	25	science	science	NOUN
aiua-13642	38	26	,	,	PUNCT
aiua-13642	38	27	ebsco	ebsco	PROPN
aiua-13642	38	28	and	and	CCONJ
aiua-13642	38	29	google	google	PROPN
aiua-13642	38	30	scholar	scholar	NOUN
aiua-13642	38	31	has	have	AUX
aiua-13642	38	32	been	be	AUX
aiua-13642	38	33	performed	perform	VERB
aiua-13642	38	34	until	until	ADP
aiua-13642	38	35	01/10/2024	01/10/2024	NOUN
aiua-13642	38	36	using	use	VERB
aiua-13642	38	37	the	the	DET
aiua-13642	38	38	following	follow	VERB
aiua-13642	38	39	keywords	keyword	NOUN
aiua-13642	38	40	(	(	PUNCT
aiua-13642	38	41	“	"	PUNCT
aiua-13642	38	42	silodosin	silodosin	VERB
aiua-13642	38	43	”	"	PUNCT
aiua-13642	38	44	or	or	CCONJ
aiua-13642	38	45	“	"	PUNCT
aiua-13642	38	46	alpha	alpha	NOUN
aiua-13642	38	47	blocker	blocker	NOUN
aiua-13642	38	48	”	"	PUNCT
aiua-13642	38	49	or	or	CCONJ
aiua-13642	38	50	“	"	PUNCT
aiua-13642	38	51	adrenergic	adrenergic	ADJ
aiua-13642	38	52	alpha	alpha	NOUN
aiua-13642	38	53	antagonists	antagonist	NOUN
aiua-13642	38	54	”	"	PUNCT
aiua-13642	38	55	or	or	CCONJ
aiua-13642	38	56	"	"	PUNCT
aiua-13642	38	57	adrenergic	adrenergic	ADJ
aiua-13642	38	58	alphaantagonists	alphaantagonist	NOUN
aiua-13642	38	59	"	"	PUNCT
aiua-13642	39	1	[	[	X
aiua-13642	39	2	mesh	mesh	NOUN
aiua-13642	39	3	]	]	PUNCT
aiua-13642	39	4	or	or	CCONJ
aiua-13642	39	5	“	"	PUNCT
aiua-13642	39	6	antihypertensive	antihypertensive	ADJ
aiua-13642	39	7	”	"	PUNCT
aiua-13642	39	8	)	)	PUNCT
aiua-13642	39	9	and	and	CCONJ
aiua-13642	39	10	(	(	PUNCT
aiua-13642	39	11	“	"	PUNCT
aiua-13642	39	12	tadalafil	tadalafil	PROPN
aiua-13642	39	13	”	"	PUNCT
aiua-13642	39	14	or	or	CCONJ
aiua-13642	39	15	“	"	PUNCT
aiua-13642	39	16	phosphodiesterase	phosphodiesterase	NOUN
aiua-13642	39	17	5	5	NUM
aiua-13642	39	18	inhibitor	inhibitor	NOUN
aiua-13642	39	19	”	"	PUNCT
aiua-13642	39	20	or	or	CCONJ
aiua-13642	39	21	“	"	PUNCT
aiua-13642	39	22	pde5	pde5	NOUN
aiua-13642	39	23	inhibitors	inhibitor	NOUN
aiua-13642	39	24	”	"	PUNCT
aiua-13642	39	25	)	)	PUNCT
aiua-13642	39	26	and	and	CCONJ
aiua-13642	39	27	(	(	PUNCT
aiua-13642	39	28	“	"	PUNCT
aiua-13642	39	29	ureteric	ureteric	ADJ
aiua-13642	39	30	stones	stone	NOUN
aiua-13642	39	31	”	"	PUNCT
aiua-13642	39	32	or	or	CCONJ
aiua-13642	39	33	“	"	PUNCT
aiua-13642	39	34	distal	distal	ADJ
aiua-13642	39	35	ureter	ureter	ADJ
aiua-13642	39	36	stones	stone	NOUN
aiua-13642	39	37	”	"	PUNCT
aiua-13642	39	38	or	or	CCONJ
aiua-13642	39	39	"	"	PUNCT
aiua-13642	39	40	lower	low	ADJ
aiua-13642	39	41	ureter	ureter	ADJ
aiua-13642	39	42	stones	stone	NOUN
aiua-13642	39	43	"	"	PUNCT
aiua-13642	40	1	[	[	X
aiua-13642	40	2	mesh	mesh	NOUN
aiua-13642	40	3	]	]	X
aiua-13642	40	4	)	)	PUNCT
aiua-13642	40	5	.	.	PUNCT
aiua-13642	41	1	selection	selection	NOUN
aiua-13642	41	2	criteria	criterion	NOUN
aiua-13642	41	3	to	to	PART
aiua-13642	41	4	screen	screen	VERB
aiua-13642	41	5	the	the	DET
aiua-13642	41	6	results	result	NOUN
aiua-13642	41	7	of	of	ADP
aiua-13642	41	8	the	the	DET
aiua-13642	41	9	literature	literature	NOUN
aiua-13642	41	10	search	search	NOUN
aiua-13642	41	11	,	,	PUNCT
aiua-13642	41	12	we	we	PRON
aiua-13642	41	13	used	use	VERB
aiua-13642	41	14	rayyan	rayyan	ADJ
aiua-13642	41	15	software	software	NOUN
aiua-13642	41	16	(	(	PUNCT
aiua-13642	41	17	14	14	NUM
aiua-13642	41	18	)	)	PUNCT
aiua-13642	41	19	.	.	PUNCT
aiua-13642	42	1	two	two	NUM
aiua-13642	42	2	stages	stage	NOUN
aiua-13642	42	3	of	of	ADP
aiua-13642	42	4	screening	screening	NOUN
aiua-13642	42	5	were	be	AUX
aiua-13642	42	6	used	use	VERB
aiua-13642	42	7	for	for	ADP
aiua-13642	42	8	studies	study	NOUN
aiua-13642	42	9	.	.	PUNCT
aiua-13642	43	1	title	title	NOUN
aiua-13642	43	2	and	and	CCONJ
aiua-13642	43	3	abstract	abstract	ADJ
aiua-13642	43	4	screening	screening	NOUN
aiua-13642	43	5	was	be	AUX
aiua-13642	43	6	the	the	DET
aiua-13642	43	7	initial	initial	ADJ
aiua-13642	43	8	stage	stage	NOUN
aiua-13642	43	9	.	.	PUNCT
aiua-13642	44	1	the	the	DET
aiua-13642	44	2	second	second	ADJ
aiua-13642	44	3	stage	stage	NOUN
aiua-13642	44	4	involved	involve	VERB
aiua-13642	44	5	screening	screen	VERB
aiua-13642	44	6	the	the	DET
aiua-13642	44	7	chosen	choose	VERB
aiua-13642	44	8	abstracts	abstract	NOUN
aiua-13642	44	9	for	for	ADP
aiua-13642	44	10	full	full	ADJ
aiua-13642	44	11	-	-	PUNCT
aiua-13642	44	12	text	text	NOUN
aiua-13642	44	13	articles	article	NOUN
aiua-13642	44	14	and	and	CCONJ
aiua-13642	44	15	resolving	resolve	VERB
aiua-13642	44	16	discrepancies	discrepancy	NOUN
aiua-13642	44	17	through	through	ADP
aiua-13642	44	18	discussion	discussion	NOUN
aiua-13642	44	19	.	.	PUNCT
aiua-13642	45	1	cohort	cohort	NOUN
aiua-13642	45	2	studies	study	NOUN
aiua-13642	45	3	and	and	CCONJ
aiua-13642	45	4	rcts	rct	NOUN
aiua-13642	45	5	that	that	PRON
aiua-13642	45	6	were	be	AUX
aiua-13642	45	7	reported	report	VERB
aiua-13642	45	8	on	on	ADP
aiua-13642	45	9	our	our	PRON
aiua-13642	45	10	pico	pico	NOUN
aiua-13642	45	11	model	model	NOUN
aiua-13642	45	12	as	as	SCONJ
aiua-13642	45	13	follows	follow	VERB
aiua-13642	45	14	.	.	PUNCT
aiua-13642	46	1	p	p	X
aiua-13642	46	2	(	(	PUNCT
aiua-13642	46	3	patient	patient	NOUN
aiua-13642	46	4	/	/	SYM
aiua-13642	46	5	problem	problem	NOUN
aiua-13642	46	6	):	):	PUNCT
aiua-13642	46	7	patients	patient	NOUN
aiua-13642	46	8	with	with	ADP
aiua-13642	46	9	lower	low	ADJ
aiua-13642	46	10	ureteric	ureteric	ADJ
aiua-13642	46	11	stones	stone	NOUN
aiua-13642	46	12	5	5	NUM
aiua-13642	46	13	to	to	PART
aiua-13642	46	14	10	10	NUM
aiua-13642	46	15	mm	mm	NOUN
aiua-13642	46	16	in	in	ADP
aiua-13642	46	17	size	size	NOUN
aiua-13642	46	18	;	;	PUNCT
aiua-13642	46	19	i	i	PRON
aiua-13642	46	20	(	(	PUNCT
aiua-13642	46	21	intervention	intervention	NOUN
aiua-13642	46	22	):	):	PUNCT
aiua-13642	46	23	studies	study	NOUN
aiua-13642	46	24	where	where	SCONJ
aiua-13642	46	25	tadalafil	tadalafil	PROPN
aiua-13642	46	26	was	be	AUX
aiua-13642	46	27	administered	administer	VERB
aiua-13642	46	28	;	;	PUNCT
aiua-13642	46	29	c	c	X
aiua-13642	46	30	(	(	PUNCT
aiua-13642	46	31	comparator	comparator	NOUN
aiua-13642	46	32	):	):	PUNCT
aiua-13642	46	33	studies	study	NOUN
aiua-13642	46	34	where	where	SCONJ
aiua-13642	46	35	silodosin	silodosin	NOUN
aiua-13642	46	36	was	be	AUX
aiua-13642	46	37	administered	administer	VERB
aiua-13642	46	38	;	;	PUNCT
aiua-13642	46	39	o	o	X
aiua-13642	46	40	(	(	PUNCT
aiua-13642	46	41	outcome	outcome	NOUN
aiua-13642	46	42	):	):	PUNCT
aiua-13642	46	43	stone	stone	NOUN
aiua-13642	46	44	size	size	NOUN
aiua-13642	46	45	,	,	PUNCT
aiua-13642	46	46	stone	stone	NOUN
aiua-13642	46	47	expulsion	expulsion	NOUN
aiua-13642	46	48	time	time	NOUN
aiua-13642	46	49	(	(	PUNCT
aiua-13642	46	50	set	set	NOUN
aiua-13642	46	51	)	)	PUNCT
aiua-13642	46	52	,	,	PUNCT
aiua-13642	46	53	stone	stone	NOUN
aiua-13642	46	54	expulsion	expulsion	NOUN
aiua-13642	46	55	rate	rate	NOUN
aiua-13642	46	56	(	(	PUNCT
aiua-13642	46	57	ser	ser	NOUN
aiua-13642	46	58	)	)	PUNCT
aiua-13642	46	59	,	,	PUNCT
aiua-13642	46	60	pain	pain	NOUN
aiua-13642	46	61	episodes	episode	NOUN
aiua-13642	46	62	,	,	PUNCT
aiua-13642	46	63	and	and	CCONJ
aiua-13642	46	64	side	side	NOUN
aiua-13642	46	65	effects	effect	NOUN
aiua-13642	46	66	;	;	PUNCT
aiua-13642	46	67	s	s	VERB
aiua-13642	46	68	(	(	PUNCT
aiua-13642	46	69	study	study	NOUN
aiua-13642	46	70	design	design	NOUN
aiua-13642	46	71	):	):	PUNCT
aiua-13642	46	72	randomized	randomize	VERB
aiua-13642	46	73	control	control	NOUN
aiua-13642	46	74	clinical	clinical	ADJ
aiua-13642	46	75	trials	trial	NOUN
aiua-13642	46	76	(	(	PUNCT
aiua-13642	46	77	rcts	rct	NOUN
aiua-13642	46	78	)	)	PUNCT
aiua-13642	46	79	and	and	CCONJ
aiua-13642	46	80	cohort	cohort	NOUN
aiua-13642	46	81	studies	study	NOUN
aiua-13642	46	82	.	.	PUNCT
aiua-13642	47	1	studies	study	NOUN
aiua-13642	47	2	with	with	ADP
aiua-13642	47	3	inadequate	inadequate	ADJ
aiua-13642	47	4	or	or	CCONJ
aiua-13642	47	5	deficient	deficient	ADJ
aiua-13642	47	6	data	datum	NOUN
aiua-13642	47	7	for	for	ADP
aiua-13642	47	8	extraction	extraction	NOUN
aiua-13642	47	9	were	be	AUX
aiua-13642	47	10	not	not	PART
aiua-13642	47	11	included	include	VERB
aiua-13642	47	12	.	.	PUNCT
aiua-13642	48	1	studies	study	NOUN
aiua-13642	48	2	with	with	ADP
aiua-13642	48	3	overlapping	overlap	VERB
aiua-13642	48	4	datasets	dataset	NOUN
aiua-13642	48	5	,	,	PUNCT
aiua-13642	48	6	case	case	NOUN
aiua-13642	48	7	-	-	PUNCT
aiua-13642	48	8	control	control	NOUN
aiua-13642	48	9	studies	study	NOUN
aiua-13642	48	10	,	,	PUNCT
aiua-13642	48	11	non	non	ADJ
aiua-13642	48	12	-	-	ADJ
aiua-13642	48	13	clinical	clinical	ADJ
aiua-13642	48	14	studies	study	NOUN
aiua-13642	48	15	,	,	PUNCT
aiua-13642	48	16	reviews	review	NOUN
aiua-13642	48	17	,	,	PUNCT
aiua-13642	48	18	book	book	NOUN
aiua-13642	48	19	chapters	chapter	NOUN
aiua-13642	48	20	,	,	PUNCT
aiua-13642	48	21	case	case	NOUN
aiua-13642	48	22	reports	report	NOUN
aiua-13642	48	23	,	,	PUNCT
aiua-13642	48	24	case	case	NOUN
aiua-13642	48	25	series	series	NOUN
aiua-13642	48	26	,	,	PUNCT
aiua-13642	48	27	theses	thesis	NOUN
aiua-13642	48	28	,	,	PUNCT
aiua-13642	48	29	editorials	editorial	NOUN
aiua-13642	48	30	,	,	PUNCT
aiua-13642	48	31	letters	letter	NOUN
aiua-13642	48	32	,	,	PUNCT
aiua-13642	48	33	conference	conference	NOUN
aiua-13642	48	34	papers	paper	NOUN
aiua-13642	48	35	,	,	PUNCT
aiua-13642	48	36	and	and	CCONJ
aiua-13642	48	37	non	non	ADJ
aiua-13642	48	38	-	-	ADJ
aiua-13642	48	39	english	english	ADJ
aiua-13642	48	40	studies	study	NOUN
aiua-13642	48	41	were	be	AUX
aiua-13642	48	42	excluded	exclude	VERB
aiua-13642	48	43	.	.	PUNCT
aiua-13642	49	1	additionally	additionally	ADV
aiua-13642	49	2	,	,	PUNCT
aiua-13642	49	3	non	non	ADJ
aiua-13642	49	4	-	-	ADJ
aiua-13642	49	5	randomized	randomized	ADJ
aiua-13642	49	6	controlled	control	VERB
aiua-13642	49	7	trials	trial	NOUN
aiua-13642	49	8	were	be	AUX
aiua-13642	49	9	not	not	PART
aiua-13642	49	10	included	include	VERB
aiua-13642	49	11	.	.	PUNCT
aiua-13642	50	1	data	datum	NOUN
aiua-13642	50	2	extraction	extraction	NOUN
aiua-13642	50	3	we	we	PRON
aiua-13642	50	4	used	use	VERB
aiua-13642	50	5	google	google	PROPN
aiua-13642	50	6	spreadsheets	spreadsheet	NOUN
aiua-13642	50	7	for	for	ADP
aiua-13642	50	8	data	data	NOUN
aiua-13642	50	9	extraction	extraction	NOUN
aiua-13642	50	10	.	.	PUNCT
aiua-13642	51	1	the	the	DET
aiua-13642	51	2	spreadsheet	spreadsheet	NOUN
aiua-13642	51	3	file	file	NOUN
aiua-13642	51	4	was	be	AUX
aiua-13642	51	5	accessible	accessible	ADJ
aiua-13642	51	6	to	to	ADP
aiua-13642	51	7	all	all	DET
aiua-13642	51	8	authors	author	NOUN
aiua-13642	51	9	.	.	PUNCT
aiua-13642	52	1	all	all	DET
aiua-13642	52	2	authors	author	NOUN
aiua-13642	52	3	took	take	VERB
aiua-13642	52	4	part	part	NOUN
aiua-13642	52	5	in	in	ADP
aiua-13642	52	6	data	data	NOUN
aiua-13642	52	7	extraction	extraction	NOUN
aiua-13642	52	8	.	.	PUNCT
aiua-13642	53	1	extracted	extract	VERB
aiua-13642	53	2	data	datum	NOUN
aiua-13642	53	3	were	be	AUX
aiua-13642	53	4	mainly	mainly	ADV
aiua-13642	53	5	divided	divide	VERB
aiua-13642	53	6	into	into	ADP
aiua-13642	53	7	four	four	NUM
aiua-13642	53	8	domains	domain	NOUN
aiua-13642	53	9	:	:	PUNCT
aiua-13642	53	10	1	1	NUM
aiua-13642	53	11	)	)	PUNCT
aiua-13642	53	12	study	study	NOUN
aiua-13642	53	13	characteristics	characteristic	NOUN
aiua-13642	53	14	,	,	PUNCT
aiua-13642	53	15	2	2	X
aiua-13642	53	16	)	)	PUNCT
aiua-13642	53	17	characteristics	characteristic	NOUN
aiua-13642	53	18	of	of	ADP
aiua-13642	53	19	the	the	DET
aiua-13642	53	20	included	include	VERB
aiua-13642	53	21	studies	study	NOUN
aiua-13642	53	22	'	'	PART
aiua-13642	53	23	population	population	NOUN
aiua-13642	53	24	,	,	PUNCT
aiua-13642	53	25	3	3	X
aiua-13642	53	26	)	)	PUNCT
aiua-13642	53	27	risk	risk	NOUN
aiua-13642	53	28	of	of	ADP
aiua-13642	53	29	bias	bias	NOUN
aiua-13642	53	30	domains	domain	NOUN
aiua-13642	53	31	,	,	PUNCT
aiua-13642	53	32	and	and	CCONJ
aiua-13642	53	33	4	4	X
aiua-13642	53	34	)	)	PUNCT
aiua-13642	53	35	study	study	NOUN
aiua-13642	53	36	outcomes	outcome	NOUN
aiua-13642	53	37	.	.	PUNCT
aiua-13642	54	1	summary	summary	NOUN
aiua-13642	54	2	:	:	PUNCT
aiua-13642	54	3	study	study	VERB
aiua-13642	54	4	i	i	PROPN
aiua-13642	54	5	d	d	PROPN
aiua-13642	54	6	(	(	PUNCT
aiua-13642	54	7	first	first	ADJ
aiua-13642	54	8	author	author	NOUN
aiua-13642	54	9	-	-	PUNCT
aiua-13642	54	10	publication	publication	NOUN
aiua-13642	54	11	year	year	NOUN
aiua-13642	54	12	)	)	PUNCT
aiua-13642	54	13	,	,	PUNCT
aiua-13642	54	14	study	study	NOUN
aiua-13642	54	15	design	design	NOUN
aiua-13642	54	16	,	,	PUNCT
aiua-13642	54	17	location	location	NOUN
aiua-13642	54	18	,	,	PUNCT
aiua-13642	54	19	year	year	NOUN
aiua-13642	54	20	,	,	PUNCT
aiua-13642	54	21	population	population	NOUN
aiua-13642	54	22	,	,	PUNCT
aiua-13642	54	23	intervention	intervention	NOUN
aiua-13642	54	24	,	,	PUNCT
aiua-13642	54	25	comparator	comparator	NOUN
aiua-13642	54	26	,	,	PUNCT
aiua-13642	54	27	outcome	outcome	NOUN
aiua-13642	54	28	,	,	PUNCT
aiua-13642	54	29	key	key	ADJ
aiua-13642	54	30	findings	finding	NOUN
aiua-13642	54	31	baseline	baseline	NOUN
aiua-13642	54	32	:	:	PUNCT
aiua-13642	54	33	study	study	NOUN
aiua-13642	54	34	arms	arm	NOUN
aiua-13642	54	35	,	,	PUNCT
aiua-13642	54	36	age	age	NOUN
aiua-13642	54	37	(	(	PUNCT
aiua-13642	54	38	years	year	NOUN
aiua-13642	54	39	)	)	PUNCT
aiua-13642	54	40	,	,	PUNCT
aiua-13642	54	41	stone	stone	NOUN
aiua-13642	54	42	size	size	NOUN
aiua-13642	54	43	(	(	PUNCT
aiua-13642	54	44	mm	mm	NOUN
aiua-13642	54	45	)	)	PUNCT
aiua-13642	54	46	,	,	PUNCT
aiua-13642	54	47	body	body	NOUN
aiua-13642	54	48	mass	mass	NOUN
aiua-13642	54	49	index	index	NOUN
aiua-13642	54	50	(	(	PUNCT
aiua-13642	54	51	kg	kg	NOUN
aiua-13642	54	52	/	/	SYM
aiua-13642	54	53	m²	m²	PROPN
aiua-13642	54	54	)	)	PUNCT
aiua-13642	54	55	,	,	PUNCT
aiua-13642	54	56	side	side	NOUN
aiua-13642	54	57	(	(	PUNCT
aiua-13642	54	58	n	n	CCONJ
aiua-13642	54	59	(	(	PUNCT
aiua-13642	54	60	%	%	NOUN
aiua-13642	54	61	)	)	PUNCT
aiua-13642	54	62	,	,	PUNCT
aiua-13642	54	63	stone	stone	NOUN
aiua-13642	54	64	expulsion	expulsion	NOUN
aiua-13642	54	65	time	time	NOUN
aiua-13642	54	66	(	(	PUNCT
aiua-13642	54	67	days	day	NOUN
aiua-13642	54	68	)	)	PUNCT
aiua-13642	54	69	,	,	PUNCT
aiua-13642	54	70	stone	stone	NOUN
aiua-13642	54	71	expulsion	expulsion	NOUN
aiua-13642	54	72	rate	rate	NOUN
aiua-13642	54	73	(	(	PUNCT
aiua-13642	54	74	%	%	INTJ
aiua-13642	54	75	)	)	PUNCT
aiua-13642	54	76	,	,	PUNCT
aiua-13642	54	77	analgesic	analgesic	ADJ
aiua-13642	54	78	dose	dose	NOUN
aiua-13642	54	79	(	(	PUNCT
aiua-13642	54	80	mb	mb	NOUN
aiua-13642	54	81	)	)	PUNCT
aiua-13642	54	82	.	.	PUNCT
aiua-13642	55	1	outcomes	outcome	NOUN
aiua-13642	55	2	:	:	PUNCT
aiua-13642	55	3	set	set	NOUN
aiua-13642	55	4	,	,	PUNCT
aiua-13642	55	5	ser	ser	NOUN
aiua-13642	55	6	,	,	PUNCT
aiua-13642	55	7	headache	headache	NOUN
aiua-13642	55	8	,	,	PUNCT
aiua-13642	55	9	backache	backache	NOUN
aiua-13642	55	10	,	,	PUNCT
aiua-13642	55	11	dizziness	dizziness	NOUN
aiua-13642	55	12	,	,	PUNCT
aiua-13642	55	13	orthostatic	orthostatic	ADJ
aiua-13642	55	14	hypotension	hypotension	NOUN
aiua-13642	55	15	,	,	PUNCT
aiua-13642	55	16	abnormal	abnormal	ADJ
aiua-13642	55	17	ejaculation	ejaculation	NOUN
aiua-13642	55	18	,	,	PUNCT
aiua-13642	55	19	pain	pain	NOUN
aiua-13642	55	20	episodes	episode	NOUN
aiua-13642	55	21	.	.	PUNCT
aiua-13642	56	1	quality	quality	NOUN
aiua-13642	56	2	assessment	assessment	NOUN
aiua-13642	56	3	the	the	DET
aiua-13642	56	4	cochrane	cochrane	NOUN
aiua-13642	56	5	risk	risk	NOUN
aiua-13642	56	6	of	of	ADP
aiua-13642	56	7	bias	bias	NOUN
aiua-13642	56	8	(	(	PUNCT
aiua-13642	56	9	rob	rob	PROPN
aiua-13642	56	10	2	2	NUM
aiua-13642	56	11	)	)	PUNCT
aiua-13642	56	12	tool	tool	NOUN
aiua-13642	56	13	was	be	AUX
aiua-13642	56	14	used	use	VERB
aiua-13642	56	15	to	to	PART
aiua-13642	56	16	assess	assess	VERB
aiua-13642	56	17	the	the	DET
aiua-13642	56	18	quality	quality	NOUN
aiua-13642	56	19	of	of	ADP
aiua-13642	56	20	the	the	DET
aiua-13642	56	21	studies	study	NOUN
aiua-13642	56	22	that	that	PRON
aiua-13642	56	23	were	be	AUX
aiua-13642	56	24	part	part	NOUN
aiua-13642	56	25	of	of	ADP
aiua-13642	56	26	this	this	DET
aiua-13642	56	27	systematic	systematic	ADJ
aiua-13642	56	28	review	review	NOUN
aiua-13642	56	29	(	(	PUNCT
aiua-13642	56	30	15	15	NUM
aiua-13642	56	31	)	)	PUNCT
aiua-13642	56	32	.	.	PUNCT
aiua-13642	57	1	there	there	PRON
aiua-13642	57	2	are	be	VERB
aiua-13642	57	3	seven	seven	NUM
aiua-13642	57	4	study	study	NOUN
aiua-13642	57	5	domains	domain	NOUN
aiua-13642	57	6	in	in	ADP
aiua-13642	57	7	the	the	DET
aiua-13642	57	8	cochrane	cochrane	PROPN
aiua-13642	57	9	rob	rob	PROPN
aiua-13642	57	10	:	:	PUNCT
aiua-13642	57	11	1	1	X
aiua-13642	57	12	)	)	PUNCT
aiua-13642	57	13	random	random	ADJ
aiua-13642	57	14	sequence	sequence	NOUN
aiua-13642	57	15	generation	generation	NOUN
aiua-13642	57	16	,	,	PUNCT
aiua-13642	57	17	2	2	NUM
aiua-13642	57	18	)	)	PUNCT
aiua-13642	57	19	allocation	allocation	NOUN
aiua-13642	57	20	concealment	concealment	NOUN
aiua-13642	57	21	,	,	PUNCT
aiua-13642	57	22	3	3	X
aiua-13642	57	23	)	)	PUNCT
aiua-13642	57	24	blinding	blinding	NOUN
aiua-13642	57	25	of	of	ADP
aiua-13642	57	26	the	the	DET
aiua-13642	57	27	investigators	investigator	NOUN
aiua-13642	57	28	and	and	CCONJ
aiua-13642	57	29	patients	patient	NOUN
aiua-13642	57	30	,	,	PUNCT
aiua-13642	57	31	4	4	X
aiua-13642	57	32	)	)	PUNCT
aiua-13642	57	33	blinding	blinding	NOUN
aiua-13642	57	34	of	of	ADP
aiua-13642	57	35	the	the	DET
aiua-13642	57	36	outcome	outcome	NOUN
aiua-13642	57	37	assessors	assessor	NOUN
aiua-13642	57	38	,	,	PUNCT
aiua-13642	57	39	5	5	NUM
aiua-13642	57	40	)	)	PUNCT
aiua-13642	57	41	incomplete	incomplete	ADJ
aiua-13642	57	42	outcome	outcome	NOUN
aiua-13642	57	43	data	datum	NOUN
aiua-13642	57	44	,	,	PUNCT
aiua-13642	57	45	6	6	NUM
aiua-13642	57	46	)	)	PUNCT
aiua-13642	57	47	selective	selective	ADJ
aiua-13642	57	48	outcome	outcome	NOUN
aiua-13642	57	49	reporting	reporting	NOUN
aiua-13642	57	50	,	,	PUNCT
aiua-13642	57	51	and	and	CCONJ
aiua-13642	57	52	7	7	X
aiua-13642	57	53	)	)	PUNCT
aiua-13642	57	54	other	other	ADJ
aiua-13642	57	55	sources	source	NOUN
aiua-13642	57	56	of	of	ADP
aiua-13642	57	57	bias	bias	NOUN
aiua-13642	57	58	.	.	PUNCT
aiua-13642	58	1	the	the	DET
aiua-13642	58	2	study	study	NOUN
aiua-13642	58	3	was	be	AUX
aiua-13642	58	4	classified	classify	VERB
aiua-13642	58	5	as	as	ADP
aiua-13642	58	6	"	"	PUNCT
aiua-13642	58	7	low	low	ADJ
aiua-13642	58	8	risk	risk	NOUN
aiua-13642	58	9	,	,	PUNCT
aiua-13642	58	10	"	"	PUNCT
aiua-13642	58	11	"	"	PUNCT
aiua-13642	58	12	high	high	ADJ
aiua-13642	58	13	risk	risk	NOUN
aiua-13642	58	14	,	,	PUNCT
aiua-13642	58	15	"	"	PUNCT
aiua-13642	58	16	or	or	CCONJ
aiua-13642	58	17	"	"	PUNCT
aiua-13642	58	18	unclear	unclear	ADJ
aiua-13642	58	19	"	"	PUNCT
aiua-13642	58	20	in	in	ADP
aiua-13642	58	21	each	each	DET
aiua-13642	58	22	domain	domain	NOUN
aiua-13642	58	23	;	;	PUNCT
aiua-13642	58	24	disagreements	disagreement	NOUN
aiua-13642	58	25	were	be	AUX
aiua-13642	58	26	settled	settle	VERB
aiua-13642	58	27	through	through	ADP
aiua-13642	58	28	discussion	discussion	NOUN
aiua-13642	58	29	.	.	PUNCT
aiua-13642	59	1	newcastle	newcastle	PROPN
aiua-13642	59	2	-	-	PUNCT
aiua-13642	59	3	ottawa	ottawa	PROPN
aiua-13642	59	4	scale	scale	NOUN
aiua-13642	59	5	(	(	PUNCT
aiua-13642	59	6	nos	nos	X
aiua-13642	59	7	)	)	PUNCT
aiua-13642	59	8	was	be	AUX
aiua-13642	59	9	used	use	VERB
aiua-13642	59	10	for	for	ADP
aiua-13642	59	11	observational	observational	ADJ
aiua-13642	59	12	cohort	cohort	NOUN
aiua-13642	59	13	studies	study	NOUN
aiua-13642	59	14	.	.	PUNCT
aiua-13642	60	1	statistical	statistical	ADJ
aiua-13642	60	2	analysis	analysis	NOUN
aiua-13642	60	3	we	we	PRON
aiua-13642	60	4	carried	carry	VERB
aiua-13642	60	5	out	out	ADP
aiua-13642	60	6	statistical	statistical	ADJ
aiua-13642	60	7	analysis	analysis	NOUN
aiua-13642	60	8	of	of	ADP
aiua-13642	60	9	the	the	DET
aiua-13642	60	10	included	include	VERB
aiua-13642	60	11	studies	study	NOUN
aiua-13642	60	12	using	use	VERB
aiua-13642	60	13	an	an	DET
aiua-13642	60	14	online	online	ADJ
aiua-13642	60	15	website	website	NOUN
aiua-13642	60	16	called	call	VERB
aiua-13642	60	17	“	"	PUNCT
aiua-13642	60	18	metaanalysisonline	metaanalysisonline	NOUN
aiua-13642	60	19	”	"	PUNCT
aiua-13642	60	20	with	with	ADP
aiua-13642	60	21	random	random	ADJ
aiua-13642	60	22	effect	effect	NOUN
aiua-13642	60	23	model	model	NOUN
aiua-13642	60	24	for	for	ADP
aiua-13642	60	25	the	the	DET
aiua-13642	60	26	heterogeneity	heterogeneity	NOUN
aiua-13642	60	27	results	result	NOUN
aiua-13642	60	28	and	and	CCONJ
aiua-13642	60	29	a	a	DET
aiua-13642	60	30	fixed	fix	VERB
aiua-13642	60	31	effect	effect	NOUN
aiua-13642	60	32	for	for	ADP
aiua-13642	60	33	non	non	ADJ
aiua-13642	60	34	-	-	ADJ
aiua-13642	60	35	heterogeneity	heterogeneity	ADJ
aiua-13642	60	36	results	result	NOUN
aiua-13642	60	37	.	.	PUNCT
aiua-13642	61	1	continuous	continuous	ADJ
aiua-13642	61	2	data	datum	NOUN
aiua-13642	61	3	were	be	AUX
aiua-13642	61	4	exhibited	exhibit	VERB
aiua-13642	61	5	as	as	ADP
aiua-13642	61	6	mean	mean	ADJ
aiua-13642	61	7	difference	difference	NOUN
aiua-13642	61	8	(	(	PUNCT
aiua-13642	61	9	md	md	PROPN
aiua-13642	61	10	)	)	PUNCT
aiua-13642	61	11	and	and	CCONJ
aiua-13642	61	12	95	95	NUM
aiua-13642	61	13	%	%	NOUN
aiua-13642	61	14	confidence	confidence	NOUN
aiua-13642	61	15	interval	interval	NOUN
aiua-13642	61	16	(	(	PUNCT
aiua-13642	61	17	ci	ci	NOUN
aiua-13642	61	18	)	)	PUNCT
aiua-13642	61	19	,	,	PUNCT
aiua-13642	61	20	while	while	SCONJ
aiua-13642	61	21	dichotomous	dichotomous	ADJ
aiua-13642	61	22	data	datum	NOUN
aiua-13642	61	23	was	be	AUX
aiua-13642	61	24	exhibited	exhibit	VERB
aiua-13642	61	25	as	as	ADP
aiua-13642	61	26	risk	risk	NOUN
aiua-13642	61	27	ratio	ratio	NOUN
aiua-13642	61	28	(	(	PUNCT
aiua-13642	61	29	rr	rr	NOUN
aiua-13642	61	30	)	)	PUNCT
aiua-13642	61	31	and	and	CCONJ
aiua-13642	61	32	95	95	NUM
aiua-13642	61	33	%	%	NOUN
aiua-13642	61	34	ci	ci	NOUN
aiua-13642	61	35	.	.	PROPN
aiua-13642	61	36	heterogeneity	heterogeneity	PROPN
aiua-13642	61	37	evaluated	evaluate	VERB
aiua-13642	61	38	using	use	VERB
aiua-13642	61	39	i	i	PRON
aiua-13642	61	40	-	-	PUNCT
aiua-13642	61	41	squared	square	VERB
aiua-13642	61	42	(	(	PUNCT
aiua-13642	61	43	i2	i2	NOUN
aiua-13642	61	44	)	)	PUNCT
aiua-13642	61	45	and	and	CCONJ
aiua-13642	61	46	chi	chi	ADJ
aiua-13642	61	47	-	-	PUNCT
aiua-13642	61	48	square	square	ADJ
aiua-13642	61	49	(	(	PUNCT
aiua-13642	61	50	chi2	chi2	NOUN
aiua-13642	61	51	)	)	PUNCT
aiua-13642	61	52	tests	test	NOUN
aiua-13642	61	53	(	(	PUNCT
aiua-13642	61	54	16	16	NUM
aiua-13642	61	55	)	)	PUNCT
aiua-13642	61	56	.	.	PUNCT
aiua-13642	62	1	we	we	PRON
aiua-13642	62	2	considered	consider	VERB
aiua-13642	62	3	heterogeneity	heterogeneity	NOUN
aiua-13642	62	4	significant	significant	ADJ
aiua-13642	62	5	if	if	SCONJ
aiua-13642	62	6	i2	i2	PROPN
aiua-13642	62	7	was	be	AUX
aiua-13642	62	8	more	more	ADJ
aiua-13642	62	9	than	than	ADP
aiua-13642	62	10	(	(	PUNCT
aiua-13642	62	11	45	45	NUM
aiua-13642	62	12	)	)	PUNCT
aiua-13642	62	13	%	%	NOUN
aiua-13642	62	14	and	and	CCONJ
aiua-13642	62	15	the	the	DET
aiua-13642	62	16	p	p	NOUN
aiua-13642	62	17	-	-	PUNCT
aiua-13642	62	18	value	value	NOUN
aiua-13642	62	19	of	of	ADP
aiua-13642	62	20	chi2	chi2	NOUN
aiua-13642	62	21	was	be	AUX
aiua-13642	62	22	less	less	ADJ
aiua-13642	62	23	than	than	ADP
aiua-13642	62	24	0.1	0.1	NUM
aiua-13642	62	25	.	.	PUNCT
aiua-13642	63	1	the	the	DET
aiua-13642	63	2	random	random	ADJ
aiua-13642	63	3	-	-	PUNCT
aiua-13642	63	4	effect	effect	NOUN
aiua-13642	63	5	model	model	NOUN
aiua-13642	63	6	and	and	CCONJ
aiua-13642	63	7	sensitivity	sensitivity	NOUN
aiua-13642	63	8	analysis	analysis	NOUN
aiua-13642	63	9	were	be	AUX
aiua-13642	63	10	used	use	VERB
aiua-13642	63	11	for	for	ADP
aiua-13642	63	12	significant	significant	ADJ
aiua-13642	63	13	heterogeneity	heterogeneity	NOUN
aiua-13642	63	14	.	.	PUNCT
aiua-13642	64	1	results	result	VERB
aiua-13642	64	2	literature	literature	NOUN
aiua-13642	64	3	search	search	NOUN
aiua-13642	64	4	results	result	NOUN
aiua-13642	64	5	and	and	CCONJ
aiua-13642	64	6	characteristics	characteristic	NOUN
aiua-13642	64	7	of	of	ADP
aiua-13642	64	8	the	the	DET
aiua-13642	64	9	included	include	VERB
aiua-13642	64	10	studies	study	NOUN
aiua-13642	64	11	we	we	PRON
aiua-13642	64	12	identified	identify	VERB
aiua-13642	64	13	176	176	NUM
aiua-13642	64	14	studies	study	NOUN
aiua-13642	64	15	through	through	ADP
aiua-13642	64	16	a	a	DET
aiua-13642	64	17	database	database	NOUN
aiua-13642	64	18	search	search	NOUN
aiua-13642	64	19	.	.	PUNCT
aiua-13642	65	1	following	follow	VERB
aiua-13642	65	2	the	the	DET
aiua-13642	65	3	removal	removal	NOUN
aiua-13642	65	4	of	of	ADP
aiua-13642	65	5	duplicates	duplicate	NOUN
aiua-13642	65	6	,	,	PUNCT
aiua-13642	65	7	96	96	NUM
aiua-13642	65	8	articles	article	NOUN
aiua-13642	65	9	proceeded	proceed	VERB
aiua-13642	65	10	to	to	ADP
aiua-13642	65	11	the	the	DET
aiua-13642	65	12	next	next	ADJ
aiua-13642	65	13	review	review	NOUN
aiua-13642	65	14	stage	stage	NOUN
aiua-13642	65	15	.	.	PUNCT
aiua-13642	66	1	our	our	PRON
aiua-13642	66	2	meta	meta	ADJ
aiua-13642	66	3	-	-	PUNCT
aiua-13642	66	4	analysis	analysis	NOUN
aiua-13642	66	5	included	include	VERB
aiua-13642	66	6	8	8	NUM
aiua-13642	66	7	studies	study	NOUN
aiua-13642	66	8	after	after	ADP
aiua-13642	66	9	screening	screen	VERB
aiua-13642	66	10	abstracts	abstract	NOUN
aiua-13642	66	11	and	and	CCONJ
aiua-13642	66	12	full	full	ADJ
aiua-13642	66	13	texts	text	NOUN
aiua-13642	66	14	;	;	PUNCT
aiua-13642	66	15	this	this	DET
aiua-13642	66	16	process	process	NOUN
aiua-13642	66	17	is	be	AUX
aiua-13642	66	18	depicted	depict	VERB
aiua-13642	66	19	in	in	ADP
aiua-13642	66	20	the	the	DET
aiua-13642	66	21	prisma	prisma	NOUN
aiua-13642	66	22	flow	flow	NOUN
aiua-13642	66	23	diagram	diagram	NOUN
aiua-13642	66	24	figure	figure	NOUN
aiua-13642	66	25	1	1	NUM
aiua-13642	66	26	.	.	PUNCT
aiua-13642	67	1	three	three	NUM
aiua-13642	67	2	observational	observational	ADJ
aiua-13642	67	3	studies	study	NOUN
aiua-13642	67	4	and	and	CCONJ
aiua-13642	67	5	five	five	NUM
aiua-13642	67	6	randomized	randomized	ADJ
aiua-13642	67	7	controlled	control	VERB
aiua-13642	67	8	trials	trial	NOUN
aiua-13642	67	9	(	(	PUNCT
aiua-13642	67	10	rcts	rct	NOUN
aiua-13642	67	11	)	)	PUNCT
aiua-13642	67	12	formed	form	VERB
aiua-13642	67	13	the	the	DET
aiua-13642	67	14	basis	basis	NOUN
aiua-13642	67	15	of	of	ADP
aiua-13642	67	16	our	our	PRON
aiua-13642	67	17	meta	meta	ADJ
aiua-13642	67	18	-	-	PUNCT
aiua-13642	67	19	analysis	analysis	NOUN
aiua-13642	67	20	.	.	PUNCT
aiua-13642	68	1	these	these	DET
aiua-13642	68	2	studies	study	NOUN
aiua-13642	68	3	compared	compare	VERB
aiua-13642	68	4	tadalafil	tadalafil	PROPN
aiua-13642	68	5	and	and	CCONJ
aiua-13642	68	6	silodosin	silodosin	VERB
aiua-13642	68	7	to	to	PART
aiua-13642	68	8	determine	determine	VERB
aiua-13642	68	9	how	how	SCONJ
aiua-13642	68	10	they	they	PRON
aiua-13642	68	11	affected	affect	VERB
aiua-13642	68	12	the	the	DET
aiua-13642	68	13	rate	rate	NOUN
aiua-13642	68	14	and	and	CCONJ
aiua-13642	68	15	time	time	NOUN
aiua-13642	68	16	of	of	ADP
aiua-13642	68	17	stone	stone	NOUN
aiua-13642	68	18	expulsion	expulsion	NOUN
aiua-13642	68	19	.	.	PUNCT
aiua-13642	69	1	table	table	NOUN
aiua-13642	69	2	1	1	NUM
aiua-13642	69	3	(	(	PUNCT
aiua-13642	69	4	see	see	VERB
aiua-13642	69	5	supplementary	supplementary	ADJ
aiua-13642	69	6	material	material	NOUN
aiua-13642	69	7	)	)	PUNCT
aiua-13642	69	8	provides	provide	VERB
aiua-13642	69	9	details	detail	NOUN
aiua-13642	69	10	on	on	ADP
aiua-13642	69	11	the	the	DET
aiua-13642	69	12	studies	study	NOUN
aiua-13642	69	13	included	include	VERB
aiua-13642	69	14	in	in	ADP
aiua-13642	69	15	this	this	DET
aiua-13642	69	16	analysis	analysis	NOUN
aiua-13642	69	17	,	,	PUNCT
aiua-13642	69	18	which	which	PRON
aiua-13642	69	19	were	be	AUX
aiua-13642	69	20	carried	carry	VERB
aiua-13642	69	21	out	out	ADP
aiua-13642	69	22	between	between	ADP
aiua-13642	69	23	2014	2014	NUM
aiua-13642	69	24	and	and	CCONJ
aiua-13642	69	25	2024	2024	NUM
aiua-13642	69	26	across	across	ADP
aiua-13642	69	27	egypt	egypt	PROPN
aiua-13642	69	28	,	,	PUNCT
aiua-13642	69	29	india	india	PROPN
aiua-13642	69	30	,	,	PUNCT
aiua-13642	69	31	tunisia	tunisia	PROPN
aiua-13642	69	32	,	,	PUNCT
aiua-13642	69	33	and	and	CCONJ
aiua-13642	69	34	turkey	turkey	NOUN
aiua-13642	69	35	.	.	PUNCT
aiua-13642	70	1	a	a	DET
aiua-13642	70	2	total	total	NOUN
aiua-13642	70	3	of	of	ADP
aiua-13642	70	4	797	797	NUM
aiua-13642	70	5	patients	patient	NOUN
aiua-13642	70	6	with	with	ADP
aiua-13642	70	7	lower	low	ADJ
aiua-13642	70	8	ureteric	ureteric	ADJ
aiua-13642	70	9	stones	stone	NOUN
aiua-13642	70	10	was	be	AUX
aiua-13642	70	11	included	include	VERB
aiua-13642	70	12	in	in	ADP
aiua-13642	70	13	these	these	DET
aiua-13642	70	14	eight	eight	NUM
aiua-13642	70	15	studies	study	NOUN
aiua-13642	70	16	.	.	PUNCT
aiua-13642	71	1	the	the	DET
aiua-13642	71	2	mean	mean	ADJ
aiua-13642	71	3	age	age	NOUN
aiua-13642	71	4	of	of	ADP
aiua-13642	71	5	participants	participant	NOUN
aiua-13642	71	6	was	be	AUX
aiua-13642	71	7	40.20	40.20	NUM
aiua-13642	71	8	years	year	NOUN
aiua-13642	71	9	for	for	ADP
aiua-13642	71	10	the	the	DET
aiua-13642	71	11	tadalafil	tadalafil	ADJ
aiua-13642	71	12	groups	group	NOUN
aiua-13642	71	13	and	and	CCONJ
aiua-13642	71	14	39.6	39.6	NUM
aiua-13642	71	15	years	year	NOUN
aiua-13642	71	16	for	for	ADP
aiua-13642	71	17	the	the	DET
aiua-13642	71	18	silodosin	silodosin	NOUN
aiua-13642	71	19	groups	group	NOUN
aiua-13642	71	20	,	,	PUNCT
aiua-13642	71	21	with	with	ADP
aiua-13642	71	22	a	a	DET
aiua-13642	71	23	mean	mean	ADJ
aiua-13642	71	24	stone	stone	NOUN
aiua-13642	71	25	size	size	NOUN
aiua-13642	71	26	of	of	ADP
aiua-13642	71	27	6.7	6.7	NUM
aiua-13642	71	28	mm	mm	NOUN
aiua-13642	71	29	.	.	PUNCT
aiua-13642	72	1	the	the	DET
aiua-13642	72	2	intervention	intervention	NOUN
aiua-13642	72	3	lasted	last	VERB
aiua-13642	72	4	between	between	ADP
aiua-13642	72	5	three	three	NUM
aiua-13642	72	6	and	and	CCONJ
aiua-13642	72	7	six	six	NUM
aiua-13642	72	8	weeks	week	NOUN
aiua-13642	72	9	.	.	PUNCT
aiua-13642	73	1	table	table	NOUN
aiua-13642	73	2	2	2	NUM
aiua-13642	73	3	(	(	PUNCT
aiua-13642	73	4	see	see	VERB
aiua-13642	73	5	supplementary	supplementary	ADJ
aiua-13642	73	6	material	material	NOUN
aiua-13642	73	7	)	)	PUNCT
aiua-13642	73	8	presents	present	VERB
aiua-13642	73	9	the	the	DET
aiua-13642	73	10	characteristics	characteristic	NOUN
aiua-13642	73	11	of	of	ADP
aiua-13642	73	12	the	the	DET
aiua-13642	73	13	study	study	NOUN
aiua-13642	73	14	populations	population	NOUN
aiua-13642	73	15	.	.	PUNCT
aiua-13642	74	1	table	table	NOUN
aiua-13642	74	2	3	3	NUM
aiua-13642	74	3	(	(	PUNCT
aiua-13642	74	4	see	see	VERB
aiua-13642	74	5	supplementary	supplementary	ADJ
aiua-13642	74	6	material	material	NOUN
aiua-13642	74	7	)	)	PUNCT
aiua-13642	74	8	summarizes	summarize	NOUN
aiua-13642	74	9	characteristics	characteristic	NOUN
aiua-13642	74	10	of	of	ADP
aiua-13642	74	11	adverse	adverse	ADJ
aiua-13642	74	12	events	event	NOUN
aiua-13642	74	13	.	.	PUNCT
aiua-13642	75	1	risk	risk	NOUN
aiua-13642	75	2	of	of	ADP
aiua-13642	75	3	bias	bias	NOUN
aiua-13642	75	4	in	in	ADP
aiua-13642	75	5	the	the	DET
aiua-13642	75	6	included	include	VERB
aiua-13642	75	7	studies	study	NOUN
aiua-13642	75	8	the	the	DET
aiua-13642	75	9	assessment	assessment	NOUN
aiua-13642	75	10	of	of	ADP
aiua-13642	75	11	the	the	DET
aiua-13642	75	12	quality	quality	NOUN
aiua-13642	75	13	of	of	ADP
aiua-13642	75	14	the	the	DET
aiua-13642	75	15	included	include	VERB
aiua-13642	75	16	studies	study	NOUN
aiua-13642	75	17	is	be	AUX
aiua-13642	75	18	demonstrated	demonstrate	VERB
aiua-13642	75	19	in	in	ADP
aiua-13642	75	20	figure	figure	NOUN
aiua-13642	75	21	2	2	NUM
aiua-13642	75	22	.	.	PUNCT
aiua-13642	76	1	we	we	PRON
aiua-13642	76	2	utilized	utilize	VERB
aiua-13642	76	3	the	the	DET
aiua-13642	76	4	cochrane	cochrane	NOUN
aiua-13642	76	5	risk	risk	NOUN
aiua-13642	76	6	of	of	ADP
aiua-13642	76	7	bias	bias	NOUN
aiua-13642	76	8	2	2	NUM
aiua-13642	76	9	(	(	PUNCT
aiua-13642	76	10	rob2	rob2	NOUN
aiua-13642	76	11	)	)	PUNCT
aiua-13642	76	12	tool	tool	NOUN
aiua-13642	76	13	for	for	ADP
aiua-13642	76	14	randomized	randomized	ADJ
aiua-13642	76	15	trials	trial	NOUN
aiua-13642	76	16	and	and	CCONJ
aiua-13642	76	17	the	the	DET
aiua-13642	76	18	newcastle	newcastle	PROPN
aiua-13642	76	19	-	-	PUNCT
aiua-13642	76	20	ottawa	ottawa	PROPN
aiua-13642	76	21	scale	scale	NOUN
aiua-13642	76	22	(	(	PUNCT
aiua-13642	76	23	nos	nos	NOUN
aiua-13642	76	24	)	)	PUNCT
aiua-13642	76	25	for	for	ADP
aiua-13642	76	26	observational	observational	ADJ
aiua-13642	76	27	cohort	cohort	NOUN
aiua-13642	76	28	studies	study	NOUN
aiua-13642	76	29	.	.	PUNCT
aiua-13642	77	1	our	our	PRON
aiua-13642	77	2	assessment	assessment	NOUN
aiua-13642	77	3	revealed	reveal	VERB
aiua-13642	77	4	that	that	SCONJ
aiua-13642	77	5	two	two	NUM
aiua-13642	77	6	rcts	rct	NOUN
aiua-13642	77	7	had	have	VERB
aiua-13642	77	8	a	a	DET
aiua-13642	77	9	low	low	ADJ
aiua-13642	77	10	risk	risk	NOUN
aiua-13642	77	11	of	of	ADP
aiua-13642	77	12	bias	bias	NOUN
aiua-13642	77	13	,	,	PUNCT
aiua-13642	77	14	while	while	SCONJ
aiua-13642	77	15	three	three	NUM
aiua-13642	77	16	studies	study	NOUN
aiua-13642	77	17	showed	show	VERB
aiua-13642	77	18	some	some	DET
aiua-13642	77	19	concerns	concern	NOUN
aiua-13642	77	20	.	.	PUNCT
aiua-13642	78	1	the	the	DET
aiua-13642	78	2	three	three	NUM
aiua-13642	78	3	observational	observational	ADJ
aiua-13642	78	4	cohort	cohort	NOUN
aiua-13642	78	5	studies	study	NOUN
aiua-13642	78	6	were	be	AUX
aiua-13642	78	7	rated	rate	VERB
aiua-13642	78	8	7	7	NUM
aiua-13642	78	9	points	point	NOUN
aiua-13642	78	10	,	,	PUNCT
aiua-13642	78	11	and	and	CCONJ
aiua-13642	78	12	one	one	NUM
aiua-13642	78	13	was	be	AUX
aiua-13642	78	14	rated	rate	VERB
aiua-13642	78	15	8	8	NUM
aiua-13642	78	16	points	point	NOUN
aiua-13642	78	17	indicating	indicate	VERB
aiua-13642	78	18	a	a	DET
aiua-13642	78	19	low	low	ADJ
aiua-13642	78	20	risk	risk	NOUN
aiua-13642	78	21	of	of	ADP
aiua-13642	78	22	bias	bias	NOUN
aiua-13642	78	23	(	(	PUNCT
aiua-13642	78	24	table	table	NOUN
aiua-13642	78	25	4	4	NUM
aiua-13642	78	26	,	,	PUNCT
aiua-13642	78	27	see	see	VERB
aiua-13642	78	28	supplementary	supplementary	ADJ
aiua-13642	78	29	material	material	NOUN
aiua-13642	78	30	)	)	PUNCT
aiua-13642	78	31	.	.	PUNCT
aiua-13642	79	1	archivio	archivio	NOUN
aiua-13642	79	2	italiano	italiano	PROPN
aiua-13642	79	3	di	di	PROPN
aiua-13642	79	4	urologia	urologia	PROPN
aiua-13642	79	5	e	e	PROPN
aiua-13642	79	6	andrologia	andrologia	NOUN
aiua-13642	79	7	2025	2025	NUM
aiua-13642	79	8	;	;	PUNCT
aiua-13642	79	9	97(2):13642	97(2):13642	NUM
aiua-13642	79	10	3	3	NUM
aiua-13642	79	11	tadalafil	tadalafil	ADJ
aiua-13642	79	12	and	and	CCONJ
aiua-13642	79	13	silodosin	silodosin	VERB
aiua-13642	79	14	in	in	ADP
aiua-13642	79	15	ureter	ureter	ADJ
aiua-13642	79	16	stones	stone	NOUN
aiua-13642	79	17	figure	figure	NOUN
aiua-13642	79	18	1	1	NUM
aiua-13642	79	19	.	.	PUNCT
aiua-13642	80	1	prisma	prisma	PROPN
aiua-13642	80	2	flow	flow	PROPN
aiua-13642	80	3	diagram	diagram	PROPN
aiua-13642	80	4	.	.	PUNCT
aiua-13642	81	1	figure	figure	NOUN
aiua-13642	81	2	2	2	NUM
aiua-13642	81	3	.	.	PUNCT
aiua-13642	81	4	risk	risk	NOUN
aiua-13642	81	5	of	of	ADP
aiua-13642	81	6	bias	bias	NOUN
aiua-13642	81	7	assessment	assessment	NOUN
aiua-13642	81	8	.	.	PUNCT
aiua-13642	82	1	archivio	archivio	NOUN
aiua-13642	82	2	italiano	italiano	PROPN
aiua-13642	82	3	di	di	PROPN
aiua-13642	82	4	urologia	urologia	PROPN
aiua-13642	82	5	e	e	PROPN
aiua-13642	82	6	andrologia	andrologia	NOUN
aiua-13642	82	7	2025	2025	NUM
aiua-13642	82	8	;	;	PUNCT
aiua-13642	82	9	97(2):13642	97(2):13642	NUM
aiua-13642	82	10	m.	m.	NOUN
aiua-13642	82	11	alsaid	alsaid	PROPN
aiua-13642	82	12	saad	saad	PROPN
aiua-13642	82	13	abdalaziz	abdalaziz	PROPN
aiua-13642	82	14	,	,	PUNCT
aiua-13642	82	15	y.	y.	PROPN
aiua-13642	82	16	ahmad	ahmad	PROPN
aiua-13642	82	17	hanafi	hanafi	PROPN
aiua-13642	82	18	,	,	PUNCT
aiua-13642	82	19	b.	b.	PROPN
aiua-13642	82	20	mohamed	mohamed	PROPN
aiua-13642	82	21	hamed	hamed	PROPN
aiua-13642	82	22	,	,	PUNCT
aiua-13642	82	23	et	et	PROPN
aiua-13642	82	24	al	al	PROPN
aiua-13642	82	25	.	.	PROPN
aiua-13642	82	26	4	4	NUM
aiua-13642	82	27	set	set	VERB
aiua-13642	82	28	eight	eight	NUM
aiua-13642	82	29	studies	study	NOUN
aiua-13642	82	30	reported	report	VERB
aiua-13642	82	31	on	on	ADP
aiua-13642	82	32	set	set	NOUN
aiua-13642	82	33	comparing	compare	VERB
aiua-13642	82	34	tadalafil	tadalafil	NOUN
aiua-13642	82	35	to	to	PART
aiua-13642	82	36	silodosin	silodosin	VERB
aiua-13642	82	37	,	,	PUNCT
aiua-13642	82	38	as	as	SCONJ
aiua-13642	82	39	shown	show	VERB
aiua-13642	82	40	in	in	ADP
aiua-13642	82	41	figure	figure	NOUN
aiua-13642	82	42	3	3	NUM
aiua-13642	82	43	.	.	PUNCT
aiua-13642	83	1	the	the	DET
aiua-13642	83	2	pooled	pooled	ADJ
aiua-13642	83	3	analysis	analysis	NOUN
aiua-13642	83	4	of	of	ADP
aiua-13642	83	5	these	these	DET
aiua-13642	83	6	studies	study	NOUN
aiua-13642	83	7	showed	show	VERB
aiua-13642	83	8	no	no	DET
aiua-13642	83	9	statistically	statistically	ADV
aiua-13642	83	10	significant	significant	ADJ
aiua-13642	83	11	difference	difference	NOUN
aiua-13642	83	12	,	,	PUNCT
aiua-13642	83	13	with	with	ADP
aiua-13642	83	14	the	the	DET
aiua-13642	83	15	overall	overall	ADJ
aiua-13642	83	16	mean	mean	ADJ
aiua-13642	83	17	difference	difference	NOUN
aiua-13642	83	18	(	(	PUNCT
aiua-13642	83	19	md	md	PROPN
aiua-13642	83	20	)	)	PUNCT
aiua-13642	83	21	=	=	PUNCT
aiua-13642	84	1	0.15	0.15	NUM
aiua-13642	84	2	(	(	PUNCT
aiua-13642	84	3	95	95	NUM
aiua-13642	84	4	%	%	NOUN
aiua-13642	84	5	ci	ci	NOUN
aiua-13642	85	1	[	[	X
aiua-13642	85	2	-0.28	-0.28	NUM
aiua-13642	85	3	,	,	PUNCT
aiua-13642	85	4	0.57	0.57	NUM
aiua-13642	85	5	]	]	PUNCT
aiua-13642	85	6	,	,	PUNCT
aiua-13642	85	7	p	p	X
aiua-13642	85	8	=	=	NOUN
aiua-13642	85	9	0.50	0.50	NUM
aiua-13642	85	10	)	)	PUNCT
aiua-13642	85	11	.	.	PUNCT
aiua-13642	86	1	a	a	DET
aiua-13642	86	2	random	random	ADJ
aiua-13642	86	3	-	-	PUNCT
aiua-13642	86	4	effects	effect	NOUN
aiua-13642	86	5	model	model	NOUN
aiua-13642	86	6	was	be	AUX
aiua-13642	86	7	applied	apply	VERB
aiua-13642	86	8	due	due	ADP
aiua-13642	86	9	to	to	ADP
aiua-13642	86	10	significant	significant	ADJ
aiua-13642	86	11	heterogeneity	heterogeneity	NOUN
aiua-13642	86	12	(	(	PUNCT
aiua-13642	86	13	chi	chi	ADJ
aiua-13642	86	14	-	-	PUNCT
aiua-13642	86	15	square	square	NOUN
aiua-13642	86	16	p	p	X
aiua-13642	86	17	<	<	X
aiua-13642	86	18	0.01	0.01	NUM
aiua-13642	86	19	,	,	PUNCT
aiua-13642	86	20	i²	i²	NOUN
aiua-13642	86	21	=	=	PUNCT
aiua-13642	86	22	87	87	NUM
aiua-13642	86	23	%	%	NOUN
aiua-13642	86	24	)	)	PUNCT
aiua-13642	86	25	.	.	PUNCT
aiua-13642	87	1	we	we	PRON
aiua-13642	87	2	used	use	VERB
aiua-13642	87	3	sensitivity	sensitivity	NOUN
aiua-13642	87	4	analyses	analysis	NOUN
aiua-13642	87	5	but	but	CCONJ
aiua-13642	87	6	did	do	AUX
aiua-13642	87	7	not	not	PART
aiua-13642	87	8	identify	identify	VERB
aiua-13642	87	9	any	any	DET
aiua-13642	87	10	study	study	NOUN
aiua-13642	87	11	that	that	PRON
aiua-13642	87	12	significantly	significantly	ADV
aiua-13642	87	13	affected	affect	VERB
aiua-13642	87	14	the	the	DET
aiua-13642	87	15	pooled	pooled	ADJ
aiua-13642	87	16	estimate	estimate	NOUN
aiua-13642	87	17	,	,	PUNCT
aiua-13642	87	18	and	and	CCONJ
aiua-13642	87	19	we	we	PRON
aiua-13642	87	20	could	could	AUX
aiua-13642	87	21	not	not	PART
aiua-13642	87	22	resolve	resolve	VERB
aiua-13642	87	23	the	the	DET
aiua-13642	87	24	heterogeneity	heterogeneity	NOUN
aiua-13642	87	25	.	.	PUNCT
aiua-13642	88	1	ser	ser	NOUN
aiua-13642	88	2	eight	eight	NUM
aiua-13642	88	3	studies	study	NOUN
aiua-13642	88	4	reported	report	VERB
aiua-13642	88	5	on	on	ADP
aiua-13642	88	6	stone	stone	NOUN
aiua-13642	88	7	expulsion	expulsion	NOUN
aiua-13642	88	8	rate	rate	NOUN
aiua-13642	88	9	(	(	PUNCT
aiua-13642	88	10	ser	ser	NOUN
aiua-13642	88	11	)	)	PUNCT
aiua-13642	88	12	comparing	compare	VERB
aiua-13642	88	13	tadalafil	tadalafil	NOUN
aiua-13642	88	14	to	to	PART
aiua-13642	88	15	silodosin	silodosin	VERB
aiua-13642	88	16	(	(	PUNCT
aiua-13642	88	17	17	17	NUM
aiua-13642	88	18	-	-	SYM
aiua-13642	88	19	24	24	NUM
aiua-13642	88	20	)	)	PUNCT
aiua-13642	88	21	.	.	PUNCT
aiua-13642	89	1	the	the	DET
aiua-13642	89	2	pooled	pool	VERB
aiua-13642	89	3	analysis	analysis	NOUN
aiua-13642	89	4	showed	show	VERB
aiua-13642	89	5	no	no	DET
aiua-13642	89	6	significant	significant	ADJ
aiua-13642	89	7	difference	difference	NOUN
aiua-13642	89	8	between	between	ADP
aiua-13642	89	9	tadalafil	tadalafil	PROPN
aiua-13642	89	10	and	and	CCONJ
aiua-13642	89	11	silodosin	silodosin	VERB
aiua-13642	89	12	in	in	ADP
aiua-13642	89	13	the	the	DET
aiua-13642	89	14	incidence	incidence	NOUN
aiua-13642	89	15	of	of	ADP
aiua-13642	89	16	stone	stone	NOUN
aiua-13642	89	17	expulsion	expulsion	NOUN
aiua-13642	89	18	rate	rate	NOUN
aiua-13642	89	19	(	(	PUNCT
aiua-13642	89	20	rr	rr	NOUN
aiua-13642	89	21	=	=	NUM
aiua-13642	89	22	0.92	0.92	NUM
aiua-13642	89	23	,	,	PUNCT
aiua-13642	89	24	95	95	NUM
aiua-13642	89	25	%	%	NOUN
aiua-13642	89	26	ci	ci	NOUN
aiua-13642	90	1	[	[	X
aiua-13642	90	2	0.80	0.80	NUM
aiua-13642	90	3	to	to	ADP
aiua-13642	90	4	1.05	1.05	NUM
aiua-13642	90	5	]	]	PUNCT
aiua-13642	90	6	,	,	PUNCT
aiua-13642	90	7	p	p	NOUN
aiua-13642	90	8	=	=	NOUN
aiua-13642	90	9	0.22	0.22	NUM
aiua-13642	90	10	)	)	PUNCT
aiua-13642	90	11	,	,	PUNCT
aiua-13642	90	12	with	with	ADP
aiua-13642	90	13	heterogeneity	heterogeneity	NOUN
aiua-13642	90	14	(	(	PUNCT
aiua-13642	90	15	p	p	X
aiua-13642	90	16	=	=	NOUN
aiua-13642	90	17	0.01	0.01	NUM
aiua-13642	90	18	)	)	PUNCT
aiua-13642	90	19	.	.	PUNCT
aiua-13642	91	1	to	to	PART
aiua-13642	91	2	resolve	resolve	VERB
aiua-13642	91	3	the	the	DET
aiua-13642	91	4	heterogeneity	heterogeneity	NOUN
aiua-13642	91	5	,	,	PUNCT
aiua-13642	91	6	we	we	PRON
aiua-13642	91	7	conducted	conduct	VERB
aiua-13642	91	8	a	a	DET
aiua-13642	91	9	sensitivity	sensitivity	NOUN
aiua-13642	91	10	analysis	analysis	NOUN
aiua-13642	91	11	in	in	ADP
aiua-13642	91	12	multiple	multiple	ADJ
aiua-13642	91	13	scenarios	scenario	NOUN
aiua-13642	91	14	,	,	PUNCT
aiua-13642	91	15	excluding	exclude	VERB
aiua-13642	91	16	one	one	NUM
aiua-13642	91	17	study	study	NOUN
aiua-13642	91	18	in	in	ADP
aiua-13642	91	19	each	each	DET
aiua-13642	91	20	scenario	scenario	NOUN
aiua-13642	91	21	.	.	PUNCT
aiua-13642	92	1	heterogeneity	heterogeneity	NOUN
aiua-13642	92	2	was	be	AUX
aiua-13642	92	3	best	well	ADV
aiua-13642	92	4	resolved	resolve	VERB
aiua-13642	92	5	by	by	ADP
aiua-13642	92	6	excluding	exclude	VERB
aiua-13642	92	7	the	the	DET
aiua-13642	92	8	study	study	NOUN
aiua-13642	92	9	of	of	ADP
aiua-13642	92	10	abdelaal	abdelaal	PROPN
aiua-13642	92	11	et	et	PROPN
aiua-13642	92	12	al	al	PROPN
aiua-13642	92	13	.	.	PROPN
aiua-13642	93	1	(	(	PUNCT
aiua-13642	93	2	20	20	NUM
aiua-13642	93	3	)	)	PUNCT
aiua-13642	93	4	(	(	PUNCT
aiua-13642	93	5	p	p	X
aiua-13642	93	6	=	=	NOUN
aiua-13642	93	7	0.14	0.14	NUM
aiua-13642	93	8	,	,	PUNCT
aiua-13642	93	9	isquare	isquare	NOUN
aiua-13642	93	10	=	=	PROPN
aiua-13642	93	11	38	38	NUM
aiua-13642	93	12	%	%	NOUN
aiua-13642	93	13	)	)	PUNCT
aiua-13642	93	14	.	.	PUNCT
aiua-13642	94	1	after	after	ADP
aiua-13642	94	2	removing	remove	VERB
aiua-13642	94	3	abdelaal	abdelaal	NOUN
aiua-13642	94	4	et	et	PROPN
aiua-13642	94	5	al	al	PROPN
aiua-13642	94	6	.	.	PROPN
aiua-13642	94	7	from	from	ADP
aiua-13642	94	8	the	the	DET
aiua-13642	94	9	meta	meta	ADJ
aiua-13642	94	10	-	-	PUNCT
aiua-13642	94	11	analysis	analysis	NOUN
aiua-13642	94	12	model	model	NOUN
aiua-13642	94	13	,	,	PUNCT
aiua-13642	94	14	the	the	DET
aiua-13642	94	15	overall	overall	ADJ
aiua-13642	94	16	rr	rr	PROPN
aiua-13642	94	17	favored	favor	VERB
aiua-13642	94	18	silodosin	silodosin	NOUN
aiua-13642	94	19	over	over	ADP
aiua-13642	94	20	tadalafil	tadalafil	PROPN
aiua-13642	94	21	(	(	PUNCT
aiua-13642	94	22	rr	rr	NOUN
aiua-13642	94	23	0.88	0.88	NUM
aiua-13642	94	24	,	,	PUNCT
aiua-13642	94	25	95	95	NUM
aiua-13642	94	26	%	%	NOUN
aiua-13642	94	27	ci	ci	NOUN
aiua-13642	95	1	[	[	X
aiua-13642	95	2	0.79	0.79	NUM
aiua-13642	95	3	to	to	ADP
aiua-13642	95	4	0.98	0.98	NUM
aiua-13642	95	5	]	]	PUNCT
aiua-13642	95	6	,	,	PUNCT
aiua-13642	95	7	p	p	X
aiua-13642	95	8	=	=	NOUN
aiua-13642	95	9	0.02	0.02	NUM
aiua-13642	95	10	)	)	PUNCT
aiua-13642	95	11	,	,	PUNCT
aiua-13642	95	12	as	as	SCONJ
aiua-13642	95	13	shown	show	VERB
aiua-13642	95	14	in	in	ADP
aiua-13642	95	15	figure	figure	NOUN
aiua-13642	95	16	3	3	NUM
aiua-13642	95	17	.	.	PUNCT
aiua-13642	95	18	headache	headache	NOUN
aiua-13642	95	19	six	six	NUM
aiua-13642	95	20	studies	study	NOUN
aiua-13642	95	21	reported	report	VERB
aiua-13642	95	22	headache	headache	NOUN
aiua-13642	95	23	as	as	ADP
aiua-13642	95	24	a	a	DET
aiua-13642	95	25	side	side	NOUN
aiua-13642	95	26	effect	effect	NOUN
aiua-13642	95	27	,	,	PUNCT
aiua-13642	95	28	as	as	SCONJ
aiua-13642	95	29	shown	show	VERB
aiua-13642	95	30	in	in	ADP
aiua-13642	95	31	figure	figure	NOUN
aiua-13642	95	32	4a	4a	NOUN
aiua-13642	95	33	.	.	PUNCT
aiua-13642	96	1	the	the	DET
aiua-13642	96	2	pooled	pooled	ADJ
aiua-13642	96	3	analysis	analysis	NOUN
aiua-13642	96	4	showed	show	VERB
aiua-13642	96	5	no	no	DET
aiua-13642	96	6	significant	significant	ADJ
aiua-13642	96	7	diffigure	diffigure	NOUN
aiua-13642	96	8	3	3	NUM
aiua-13642	96	9	.	.	PUNCT
aiua-13642	96	10	a	a	DET
aiua-13642	96	11	:	:	PUNCT
aiua-13642	96	12	stone	stone	NOUN
aiua-13642	96	13	expulsion	expulsion	NOUN
aiua-13642	96	14	time	time	NOUN
aiua-13642	96	15	.	.	PUNCT
aiua-13642	97	1	b	b	X
aiua-13642	97	2	:	:	PUNCT
aiua-13642	97	3	stone	stone	NOUN
aiua-13642	97	4	expulsion	expulsion	NOUN
aiua-13642	97	5	rate	rate	NOUN
aiua-13642	97	6	.	.	PUNCT
aiua-13642	98	1	archivio	archivio	NOUN
aiua-13642	98	2	italiano	italiano	PROPN
aiua-13642	98	3	di	di	PROPN
aiua-13642	98	4	urologia	urologia	PROPN
aiua-13642	98	5	e	e	PROPN
aiua-13642	98	6	andrologia	andrologia	NOUN
aiua-13642	98	7	2025	2025	NUM
aiua-13642	98	8	;	;	PUNCT
aiua-13642	98	9	97(2):13642	97(2):13642	NUM
aiua-13642	98	10	5	5	NUM
aiua-13642	98	11	tadalafil	tadalafil	ADJ
aiua-13642	98	12	and	and	CCONJ
aiua-13642	98	13	silodosin	silodosin	VERB
aiua-13642	98	14	in	in	ADP
aiua-13642	98	15	ureter	ureter	ADJ
aiua-13642	98	16	stones	stone	NOUN
aiua-13642	98	17	ference	ference	NOUN
aiua-13642	98	18	between	between	ADP
aiua-13642	98	19	tadalafil	tadalafil	PROPN
aiua-13642	98	20	and	and	CCONJ
aiua-13642	98	21	silodosin	silodosin	VERB
aiua-13642	98	22	in	in	ADP
aiua-13642	98	23	the	the	DET
aiua-13642	98	24	incidence	incidence	NOUN
aiua-13642	98	25	of	of	ADP
aiua-13642	98	26	headache	headache	NOUN
aiua-13642	98	27	(	(	PUNCT
aiua-13642	98	28	rr	rr	NOUN
aiua-13642	98	29	=	=	SYM
aiua-13642	98	30	1.16	1.16	NUM
aiua-13642	98	31	,	,	PUNCT
aiua-13642	98	32	95	95	NUM
aiua-13642	98	33	%	%	NOUN
aiua-13642	98	34	ci	ci	NOUN
aiua-13642	99	1	[	[	X
aiua-13642	99	2	0.77	0.77	NUM
aiua-13642	99	3	to	to	ADP
aiua-13642	99	4	1.73	1.73	NUM
aiua-13642	99	5	]	]	PUNCT
aiua-13642	99	6	,	,	PUNCT
aiua-13642	99	7	p	p	X
aiua-13642	99	8	=	=	NOUN
aiua-13642	99	9	0.48	0.48	NUM
aiua-13642	99	10	)	)	PUNCT
aiua-13642	99	11	,	,	PUNCT
aiua-13642	99	12	with	with	ADP
aiua-13642	99	13	no	no	DET
aiua-13642	99	14	heterogeneity	heterogeneity	NOUN
aiua-13642	99	15	.	.	PUNCT
aiua-13642	100	1	backache	backache	NOUN
aiua-13642	100	2	five	five	NUM
aiua-13642	100	3	studies	study	NOUN
aiua-13642	100	4	reported	report	VERB
aiua-13642	100	5	backache	backache	NOUN
aiua-13642	100	6	as	as	ADP
aiua-13642	100	7	a	a	DET
aiua-13642	100	8	side	side	NOUN
aiua-13642	100	9	effect	effect	NOUN
aiua-13642	100	10	,	,	PUNCT
aiua-13642	100	11	as	as	SCONJ
aiua-13642	100	12	shown	show	VERB
aiua-13642	100	13	in	in	ADP
aiua-13642	100	14	figure	figure	NOUN
aiua-13642	100	15	4b	4b	PROPN
aiua-13642	100	16	.	.	PUNCT
aiua-13642	101	1	the	the	DET
aiua-13642	101	2	pooled	pooled	PROPN
aiua-13642	101	3	rr	rr	PROPN
aiua-13642	101	4	was	be	AUX
aiua-13642	101	5	1.36	1.36	NUM
aiua-13642	101	6	(	(	PUNCT
aiua-13642	101	7	95	95	NUM
aiua-13642	101	8	%	%	NOUN
aiua-13642	101	9	ci	ci	NOUN
aiua-13642	102	1	[	[	X
aiua-13642	102	2	0.84	0.84	NUM
aiua-13642	102	3	to	to	ADP
aiua-13642	102	4	2.20	2.20	NUM
aiua-13642	102	5	]	]	PUNCT
aiua-13642	102	6	,	,	PUNCT
aiua-13642	102	7	p	p	X
aiua-13642	102	8	=	=	NOUN
aiua-13642	102	9	0.21	0.21	NUM
aiua-13642	102	10	)	)	PUNCT
aiua-13642	102	11	,	,	PUNCT
aiua-13642	102	12	with	with	ADP
aiua-13642	102	13	no	no	DET
aiua-13642	102	14	significant	significant	ADJ
aiua-13642	102	15	difference	difference	NOUN
aiua-13642	102	16	between	between	ADP
aiua-13642	102	17	the	the	DET
aiua-13642	102	18	two	two	NUM
aiua-13642	102	19	groups	group	NOUN
aiua-13642	102	20	and	and	CCONJ
aiua-13642	102	21	no	no	DET
aiua-13642	102	22	heterogeneity	heterogeneity	NOUN
aiua-13642	102	23	.	.	PUNCT
aiua-13642	103	1	dizziness	dizziness	NOUN
aiua-13642	103	2	five	five	NUM
aiua-13642	103	3	studies	study	NOUN
aiua-13642	103	4	reported	report	VERB
aiua-13642	103	5	dizziness	dizziness	NOUN
aiua-13642	103	6	as	as	ADP
aiua-13642	103	7	a	a	DET
aiua-13642	103	8	side	side	NOUN
aiua-13642	103	9	effect	effect	NOUN
aiua-13642	103	10	,	,	PUNCT
aiua-13642	103	11	as	as	SCONJ
aiua-13642	103	12	shown	show	VERB
aiua-13642	103	13	in	in	ADP
aiua-13642	103	14	figure	figure	NOUN
aiua-13642	103	15	4c	4c	NOUN
aiua-13642	103	16	.	.	PUNCT
aiua-13642	104	1	the	the	DET
aiua-13642	104	2	pooled	pooled	ADJ
aiua-13642	104	3	analysis	analysis	NOUN
aiua-13642	104	4	indicated	indicate	VERB
aiua-13642	104	5	no	no	DET
aiua-13642	104	6	significant	significant	ADJ
aiua-13642	104	7	difference	difference	NOUN
aiua-13642	104	8	in	in	ADP
aiua-13642	104	9	dizziness	dizziness	NOUN
aiua-13642	104	10	rates	rate	NOUN
aiua-13642	104	11	between	between	ADP
aiua-13642	104	12	tadalafil	tadalafil	PROPN
aiua-13642	104	13	and	and	CCONJ
aiua-13642	104	14	figure	figure	VERB
aiua-13642	104	15	4	4	NUM
aiua-13642	104	16	.	.	PUNCT
aiua-13642	104	17	adverse	adverse	ADJ
aiua-13642	104	18	effects	effect	NOUN
aiua-13642	104	19	.	.	PUNCT
aiua-13642	105	1	aheadache	aheadache	PROPN
aiua-13642	105	2	.	.	PUNCT
aiua-13642	106	1	b	b	X
aiua-13642	106	2	:	:	PUNCT
aiua-13642	106	3	backache	backache	NOUN
aiua-13642	106	4	.	.	PUNCT
aiua-13642	107	1	c	c	X
aiua-13642	107	2	:	:	PUNCT
aiua-13642	107	3	dizziness	dizziness	NOUN
aiua-13642	107	4	.	.	PUNCT
aiua-13642	108	1	d	d	X
aiua-13642	108	2	:	:	PUNCT
aiua-13642	108	3	orthostatic	orthostatic	ADJ
aiua-13642	108	4	hypotension	hypotension	NOUN
aiua-13642	108	5	.	.	PUNCT
aiua-13642	109	1	e	e	NOUN
aiua-13642	109	2	:	:	PUNCT
aiua-13642	109	3	abnormal	abnormal	ADJ
aiua-13642	109	4	ejaculation	ejaculation	NOUN
aiua-13642	109	5	.	.	PUNCT
aiua-13642	110	1	archivio	archivio	NOUN
aiua-13642	110	2	italiano	italiano	PROPN
aiua-13642	110	3	di	di	PROPN
aiua-13642	110	4	urologia	urologia	PROPN
aiua-13642	110	5	e	e	PROPN
aiua-13642	110	6	andrologia	andrologia	NOUN
aiua-13642	110	7	2025	2025	NUM
aiua-13642	110	8	;	;	PUNCT
aiua-13642	110	9	97(2):13642	97(2):13642	NUM
aiua-13642	110	10	m.	m.	NOUN
aiua-13642	110	11	alsaid	alsaid	PROPN
aiua-13642	110	12	saad	saad	PROPN
aiua-13642	110	13	abdalaziz	abdalaziz	PROPN
aiua-13642	110	14	,	,	PUNCT
aiua-13642	110	15	y.	y.	PROPN
aiua-13642	110	16	ahmad	ahmad	PROPN
aiua-13642	110	17	hanafi	hanafi	PROPN
aiua-13642	110	18	,	,	PUNCT
aiua-13642	110	19	b.	b.	PROPN
aiua-13642	110	20	mohamed	mohamed	PROPN
aiua-13642	110	21	hamed	hamed	PROPN
aiua-13642	110	22	,	,	PUNCT
aiua-13642	110	23	et	et	PROPN
aiua-13642	110	24	al	al	PROPN
aiua-13642	110	25	.	.	PROPN
aiua-13642	110	26	6	6	NUM
aiua-13642	110	27	silodosin	silodosin	NOUN
aiua-13642	110	28	(	(	PUNCT
aiua-13642	110	29	rr	rr	NOUN
aiua-13642	110	30	=	=	SYM
aiua-13642	110	31	0.99	0.99	NUM
aiua-13642	110	32	,	,	PUNCT
aiua-13642	110	33	95	95	NUM
aiua-13642	110	34	%	%	NOUN
aiua-13642	110	35	ci	ci	NOUN
aiua-13642	111	1	[	[	X
aiua-13642	111	2	0.59	0.59	NUM
aiua-13642	111	3	to	to	ADP
aiua-13642	111	4	1.64	1.64	NUM
aiua-13642	111	5	]	]	PUNCT
aiua-13642	111	6	,	,	PUNCT
aiua-13642	111	7	p	p	X
aiua-13642	111	8	=	=	NOUN
aiua-13642	111	9	0.96	0.96	NUM
aiua-13642	111	10	)	)	PUNCT
aiua-13642	111	11	,	,	PUNCT
aiua-13642	111	12	with	with	SCONJ
aiua-13642	111	13	no	no	DET
aiua-13642	111	14	heterogeneity	heterogeneity	NOUN
aiua-13642	111	15	observed	observe	VERB
aiua-13642	111	16	.	.	PUNCT
aiua-13642	112	1	orthostatic	orthostatic	ADJ
aiua-13642	112	2	hypotension	hypotension	NOUN
aiua-13642	112	3	six	six	NUM
aiua-13642	112	4	studies	study	NOUN
aiua-13642	112	5	reported	report	VERB
aiua-13642	112	6	on	on	ADP
aiua-13642	112	7	orthostatic	orthostatic	ADJ
aiua-13642	112	8	hypotension	hypotension	NOUN
aiua-13642	112	9	comparing	compare	VERB
aiua-13642	112	10	tadalafil	tadalafil	NOUN
aiua-13642	112	11	to	to	PART
aiua-13642	112	12	silodosin	silodosin	VERB
aiua-13642	112	13	.	.	PUNCT
aiua-13642	113	1	the	the	DET
aiua-13642	113	2	pooled	pooled	ADJ
aiua-13642	113	3	analysis	analysis	NOUN
aiua-13642	113	4	showed	show	VERB
aiua-13642	113	5	no	no	DET
aiua-13642	113	6	significant	significant	ADJ
aiua-13642	113	7	difference	difference	NOUN
aiua-13642	113	8	between	between	ADP
aiua-13642	113	9	tadalafil	tadalafil	PROPN
aiua-13642	113	10	and	and	CCONJ
aiua-13642	113	11	silodosin	silodosin	VERB
aiua-13642	113	12	in	in	ADP
aiua-13642	113	13	the	the	DET
aiua-13642	113	14	incidence	incidence	NOUN
aiua-13642	113	15	of	of	ADP
aiua-13642	113	16	orthostatic	orthostatic	ADJ
aiua-13642	113	17	hypotension	hypotension	NOUN
aiua-13642	113	18	(	(	PUNCT
aiua-13642	113	19	rr	rr	NOUN
aiua-13642	113	20	=	=	SYM
aiua-13642	113	21	0.69	0.69	NUM
aiua-13642	113	22	,	,	PUNCT
aiua-13642	113	23	95	95	NUM
aiua-13642	113	24	%	%	NOUN
aiua-13642	113	25	ci	ci	NOUN
aiua-13642	114	1	[	[	X
aiua-13642	114	2	0.29	0.29	NUM
aiua-13642	114	3	to	to	PART
aiua-13642	114	4	1.68	1.68	NUM
aiua-13642	114	5	]	]	PUNCT
aiua-13642	114	6	,	,	PUNCT
aiua-13642	114	7	p	p	X
aiua-13642	114	8	=	=	NOUN
aiua-13642	114	9	0.42	0.42	NUM
aiua-13642	114	10	)	)	PUNCT
aiua-13642	114	11	,	,	PUNCT
aiua-13642	114	12	with	with	ADP
aiua-13642	114	13	heterogeneity	heterogeneity	NOUN
aiua-13642	114	14	(	(	PUNCT
aiua-13642	114	15	p	p	NOUN
aiua-13642	114	16	=	=	NOUN
aiua-13642	114	17	0.09	0.09	NUM
aiua-13642	114	18	)	)	PUNCT
aiua-13642	114	19	.	.	PUNCT
aiua-13642	115	1	to	to	PART
aiua-13642	115	2	resolve	resolve	VERB
aiua-13642	115	3	the	the	DET
aiua-13642	115	4	heterogeneity	heterogeneity	NOUN
aiua-13642	115	5	,	,	PUNCT
aiua-13642	115	6	we	we	PRON
aiua-13642	115	7	conducted	conduct	VERB
aiua-13642	115	8	a	a	DET
aiua-13642	115	9	sensitivity	sensitivity	NOUN
aiua-13642	115	10	analysis	analysis	NOUN
aiua-13642	115	11	in	in	ADP
aiua-13642	115	12	multiple	multiple	ADJ
aiua-13642	115	13	scenarios	scenario	NOUN
aiua-13642	115	14	,	,	PUNCT
aiua-13642	115	15	excluding	exclude	VERB
aiua-13642	115	16	one	one	NUM
aiua-13642	115	17	study	study	NOUN
aiua-13642	115	18	in	in	ADP
aiua-13642	115	19	each	each	DET
aiua-13642	115	20	scenario	scenario	NOUN
aiua-13642	115	21	.	.	PUNCT
aiua-13642	116	1	heterogeneity	heterogeneity	NOUN
aiua-13642	116	2	was	be	AUX
aiua-13642	116	3	best	well	ADV
aiua-13642	116	4	resolved	resolve	VERB
aiua-13642	116	5	by	by	ADP
aiua-13642	116	6	excluding	exclude	VERB
aiua-13642	116	7	the	the	DET
aiua-13642	116	8	study	study	NOUN
aiua-13642	116	9	of	of	ADP
aiua-13642	116	10	kumar	kumar	PROPN
aiua-13642	116	11	et	et	PROPN
aiua-13642	116	12	al	al	PROPN
aiua-13642	116	13	.	.	PROPN
aiua-13642	117	1	(	(	PUNCT
aiua-13642	117	2	24	24	NUM
aiua-13642	117	3	)	)	PUNCT
aiua-13642	117	4	(	(	PUNCT
aiua-13642	117	5	p	p	X
aiua-13642	117	6	=	=	NOUN
aiua-13642	117	7	0.54	0.54	NUM
aiua-13642	117	8	,	,	PUNCT
aiua-13642	117	9	i	i	NOUN
aiua-13642	117	10	-	-	PUNCT
aiua-13642	117	11	square	square	ADJ
aiua-13642	117	12	=	=	SYM
aiua-13642	117	13	0	0	NUM
aiua-13642	117	14	%	%	NOUN
aiua-13642	117	15	)	)	PUNCT
aiua-13642	117	16	.	.	PUNCT
aiua-13642	118	1	after	after	ADP
aiua-13642	118	2	removing	remove	VERB
aiua-13642	118	3	kumar	kumar	PROPN
aiua-13642	118	4	et	et	PROPN
aiua-13642	118	5	al	al	PROPN
aiua-13642	118	6	.	.	PROPN
aiua-13642	118	7	from	from	ADP
aiua-13642	118	8	the	the	DET
aiua-13642	118	9	meta	meta	ADJ
aiua-13642	118	10	-	-	PUNCT
aiua-13642	118	11	analysis	analysis	NOUN
aiua-13642	118	12	model	model	NOUN
aiua-13642	118	13	,	,	PUNCT
aiua-13642	118	14	the	the	DET
aiua-13642	118	15	overall	overall	ADJ
aiua-13642	118	16	rr	rr	NOUN
aiua-13642	118	17	depicts	depict	NOUN
aiua-13642	118	18	that	that	PRON
aiua-13642	118	19	silodosin	silodosin	NOUN
aiua-13642	118	20	causes	cause	VERB
aiua-13642	118	21	more	more	ADJ
aiua-13642	118	22	orthostatic	orthostatic	ADJ
aiua-13642	118	23	hypotension	hypotension	NOUN
aiua-13642	118	24	than	than	ADP
aiua-13642	118	25	tadalafil	tadalafil	PROPN
aiua-13642	118	26	(	(	PUNCT
aiua-13642	118	27	rr	rr	NOUN
aiua-13642	118	28	0.45	0.45	NUM
aiua-13642	118	29	,	,	PUNCT
aiua-13642	118	30	95	95	NUM
aiua-13642	118	31	%	%	NOUN
aiua-13642	118	32	ci	ci	NOUN
aiua-13642	119	1	[	[	X
aiua-13642	119	2	0.22	0.22	NUM
aiua-13642	119	3	to	to	ADP
aiua-13642	119	4	0.91	0.91	NUM
aiua-13642	119	5	]	]	PUNCT
aiua-13642	119	6	,	,	PUNCT
aiua-13642	119	7	p	p	X
aiua-13642	119	8	=	=	NOUN
aiua-13642	119	9	0.03	0.03	NUM
aiua-13642	119	10	)	)	PUNCT
aiua-13642	119	11	,	,	PUNCT
aiua-13642	119	12	as	as	SCONJ
aiua-13642	119	13	shown	show	VERB
aiua-13642	119	14	in	in	ADP
aiua-13642	119	15	figure	figure	NOUN
aiua-13642	119	16	4d	4d	NUM
aiua-13642	119	17	.	.	PUNCT
aiua-13642	120	1	abnormal	abnormal	ADJ
aiua-13642	120	2	ejaculation	ejaculation	NOUN
aiua-13642	120	3	six	six	NUM
aiua-13642	120	4	studies	study	NOUN
aiua-13642	120	5	reported	report	VERB
aiua-13642	120	6	abnormal	abnormal	ADJ
aiua-13642	120	7	ejaculation	ejaculation	NOUN
aiua-13642	120	8	as	as	ADP
aiua-13642	120	9	a	a	DET
aiua-13642	120	10	side	side	ADJ
aiua-13642	120	11	effect	effect	NOUN
aiua-13642	120	12	of	of	ADP
aiua-13642	120	13	treatment	treatment	NOUN
aiua-13642	120	14	.	.	PUNCT
aiua-13642	121	1	as	as	SCONJ
aiua-13642	121	2	shown	show	VERB
aiua-13642	121	3	in	in	ADP
aiua-13642	121	4	figure	figure	NOUN
aiua-13642	121	5	4e	4e	NOUN
aiua-13642	121	6	the	the	DET
aiua-13642	121	7	pooled	pooled	ADJ
aiua-13642	121	8	analysis	analysis	NOUN
aiua-13642	121	9	showed	show	VERB
aiua-13642	121	10	a	a	DET
aiua-13642	121	11	significant	significant	ADJ
aiua-13642	121	12	difference	difference	NOUN
aiua-13642	121	13	between	between	ADP
aiua-13642	121	14	tadalafil	tadalafil	PROPN
aiua-13642	121	15	and	and	CCONJ
aiua-13642	121	16	silodosin	silodosin	NOUN
aiua-13642	121	17	(	(	PUNCT
aiua-13642	121	18	rr	rr	PROPN
aiua-13642	121	19	=	=	SYM
aiua-13642	121	20	0.16	0.16	NUM
aiua-13642	121	21	,	,	PUNCT
aiua-13642	121	22	95	95	NUM
aiua-13642	121	23	%	%	NOUN
aiua-13642	121	24	ci	ci	NOUN
aiua-13642	122	1	[	[	X
aiua-13642	122	2	0.09	0.09	NUM
aiua-13642	122	3	to	to	PART
aiua-13642	122	4	0.29	0.29	NUM
aiua-13642	122	5	]	]	PUNCT
aiua-13642	122	6	,	,	PUNCT
aiua-13642	122	7	p	p	X
aiua-13642	122	8	=	=	NOUN
aiua-13642	122	9	0.01	0.01	NUM
aiua-13642	122	10	)	)	PUNCT
aiua-13642	122	11	,	,	PUNCT
aiua-13642	122	12	favoring	favor	VERB
aiua-13642	122	13	silodosin	silodosin	NOUN
aiua-13642	122	14	,	,	PUNCT
aiua-13642	122	15	with	with	ADP
aiua-13642	122	16	no	no	DET
aiua-13642	122	17	heterogeneity	heterogeneity	NOUN
aiua-13642	122	18	.	.	PUNCT
aiua-13642	123	1	archivio	archivio	NOUN
aiua-13642	123	2	italiano	italiano	PROPN
aiua-13642	123	3	di	di	PROPN
aiua-13642	123	4	urologia	urologia	PROPN
aiua-13642	123	5	e	e	PROPN
aiua-13642	123	6	andrologia	andrologia	NOUN
aiua-13642	123	7	2025	2025	NUM
aiua-13642	123	8	;	;	PUNCT
aiua-13642	123	9	97(2):13642	97(2):13642	NUM
aiua-13642	123	10	7	7	NUM
aiua-13642	123	11	tadalafil	tadalafil	NOUN
aiua-13642	123	12	and	and	CCONJ
aiua-13642	123	13	silodosin	silodosin	VERB
aiua-13642	123	14	in	in	ADP
aiua-13642	123	15	ureter	ureter	ADJ
aiua-13642	123	16	stones	stone	NOUN
aiua-13642	123	17	discussion	discussion	NOUN
aiua-13642	123	18	in	in	ADP
aiua-13642	123	19	2006	2006	NUM
aiua-13642	123	20	,	,	PUNCT
aiua-13642	123	21	silodosin	silodosin	NOUN
aiua-13642	123	22	was	be	AUX
aiua-13642	123	23	first	first	ADV
aiua-13642	123	24	released	release	VERB
aiua-13642	123	25	in	in	ADP
aiua-13642	123	26	the	the	DET
aiua-13642	123	27	japanese	japanese	ADJ
aiua-13642	123	28	market	market	NOUN
aiua-13642	123	29	as	as	ADP
aiua-13642	123	30	the	the	DET
aiua-13642	123	31	newest	new	ADJ
aiua-13642	123	32	generation	generation	NOUN
aiua-13642	123	33	of	of	ADP
aiua-13642	123	34	alpha	alpha	ADJ
aiua-13642	123	35	blockers	blocker	NOUN
aiua-13642	123	36	as	as	ADP
aiua-13642	123	37	a	a	DET
aiua-13642	123	38	promising	promising	ADJ
aiua-13642	123	39	treatment	treatment	NOUN
aiua-13642	123	40	in	in	ADP
aiua-13642	123	41	voiding	void	VERB
aiua-13642	123	42	dysfunction	dysfunction	NOUN
aiua-13642	123	43	(	(	PUNCT
aiua-13642	123	44	25	25	NUM
aiua-13642	123	45	)	)	PUNCT
aiua-13642	123	46	.	.	PUNCT
aiua-13642	124	1	since	since	SCONJ
aiua-13642	124	2	2010	2010	NUM
aiua-13642	124	3	,	,	PUNCT
aiua-13642	124	4	there	there	PRON
aiua-13642	124	5	has	have	AUX
aiua-13642	124	6	been	be	AUX
aiua-13642	124	7	a	a	DET
aiua-13642	124	8	new	new	ADJ
aiua-13642	124	9	emerging	emerge	VERB
aiua-13642	124	10	debate	debate	NOUN
aiua-13642	124	11	about	about	ADP
aiua-13642	124	12	using	use	VERB
aiua-13642	124	13	tadalafil	tadalafil	PROPN
aiua-13642	124	14	and	and	CCONJ
aiua-13642	124	15	silodosin	silodosin	VERB
aiua-13642	124	16	as	as	ADP
aiua-13642	124	17	a	a	DET
aiua-13642	124	18	met	meet	VERB
aiua-13642	124	19	in	in	ADP
aiua-13642	124	20	lower	low	ADJ
aiua-13642	124	21	ureter	ureter	ADJ
aiua-13642	124	22	stones	stone	NOUN
aiua-13642	124	23	.	.	PUNCT
aiua-13642	125	1	kumar	kumar	PROPN
aiua-13642	125	2	et	et	PROPN
aiua-13642	125	3	al	al	PROPN
aiua-13642	125	4	.	.	PROPN
aiua-13642	126	1	(	(	PUNCT
aiua-13642	126	2	24	24	NUM
aiua-13642	126	3	)	)	PUNCT
aiua-13642	126	4	was	be	AUX
aiua-13642	126	5	the	the	DET
aiua-13642	126	6	first	first	ADJ
aiua-13642	126	7	to	to	PART
aiua-13642	126	8	put	put	VERB
aiua-13642	126	9	both	both	DET
aiua-13642	126	10	drugs	drug	NOUN
aiua-13642	126	11	in	in	ADP
aiua-13642	126	12	direct	direct	ADJ
aiua-13642	126	13	comparison	comparison	NOUN
aiua-13642	126	14	with	with	ADP
aiua-13642	126	15	each	each	DET
aiua-13642	126	16	other	other	ADJ
aiua-13642	126	17	for	for	ADP
aiua-13642	126	18	met	meet	VERB
aiua-13642	126	19	of	of	ADP
aiua-13642	126	20	lower	low	ADJ
aiua-13642	126	21	ureter	ureter	ADJ
aiua-13642	126	22	stones	stone	NOUN
aiua-13642	126	23	through	through	ADP
aiua-13642	126	24	a	a	DET
aiua-13642	126	25	double	double	ADJ
aiua-13642	126	26	blind	blind	ADJ
aiua-13642	126	27	randomized	randomized	ADJ
aiua-13642	126	28	control	control	NOUN
aiua-13642	126	29	trial	trial	NOUN
aiua-13642	126	30	,	,	PUNCT
aiua-13642	126	31	showing	show	VERB
aiua-13642	126	32	that	that	SCONJ
aiua-13642	126	33	both	both	DET
aiua-13642	126	34	drugs	drug	NOUN
aiua-13642	126	35	are	be	AUX
aiua-13642	126	36	effective	effective	ADJ
aiua-13642	126	37	with	with	ADP
aiua-13642	126	38	few	few	ADJ
aiua-13642	126	39	and	and	CCONJ
aiua-13642	126	40	tolerable	tolerable	ADJ
aiua-13642	126	41	adverse	adverse	ADJ
aiua-13642	126	42	effects	effect	NOUN
aiua-13642	126	43	.	.	PUNCT
aiua-13642	127	1	this	this	PRON
aiua-13642	127	2	led	lead	VERB
aiua-13642	127	3	to	to	ADP
aiua-13642	127	4	further	further	ADJ
aiua-13642	127	5	studies	study	NOUN
aiua-13642	127	6	and	and	CCONJ
aiua-13642	127	7	clinical	clinical	ADJ
aiua-13642	127	8	trials	trial	NOUN
aiua-13642	127	9	which	which	PRON
aiua-13642	127	10	demonstrated	demonstrate	VERB
aiua-13642	127	11	that	that	SCONJ
aiua-13642	127	12	they	they	PRON
aiua-13642	127	13	were	be	AUX
aiua-13642	127	14	comparable	comparable	ADJ
aiua-13642	127	15	to	to	ADP
aiua-13642	127	16	other	other	ADJ
aiua-13642	127	17	drugs	drug	NOUN
aiua-13642	127	18	used	use	VERB
aiua-13642	127	19	for	for	ADP
aiua-13642	127	20	met	meet	VERB
aiua-13642	127	21	(	(	PUNCT
aiua-13642	127	22	5	5	NUM
aiua-13642	127	23	)	)	PUNCT
aiua-13642	127	24	.	.	PUNCT
aiua-13642	128	1	the	the	DET
aiua-13642	128	2	first	first	ADJ
aiua-13642	128	3	and	and	CCONJ
aiua-13642	128	4	only	only	ADV
aiua-13642	128	5	meta	meta	ADJ
aiua-13642	128	6	-	-	PUNCT
aiua-13642	128	7	analysis	analysis	NOUN
aiua-13642	128	8	comparing	compare	VERB
aiua-13642	128	9	tadalafil	tadalafil	NOUN
aiua-13642	128	10	and	and	CCONJ
aiua-13642	128	11	silodosin	silodosin	NOUN
aiua-13642	128	12	was	be	AUX
aiua-13642	128	13	delivered	deliver	VERB
aiua-13642	128	14	by	by	ADP
aiua-13642	128	15	ebrahimpour	ebrahimpour	PROPN
aiua-13642	128	16	et	et	PROPN
aiua-13642	128	17	al	al	PROPN
aiua-13642	128	18	.	.	PROPN
aiua-13642	129	1	(	(	PUNCT
aiua-13642	129	2	7	7	NUM
aiua-13642	129	3	)	)	PUNCT
aiua-13642	129	4	,	,	PUNCT
aiua-13642	129	5	with	with	ADP
aiua-13642	129	6	a	a	DET
aiua-13642	129	7	total	total	NOUN
aiua-13642	129	8	of	of	ADP
aiua-13642	129	9	five	five	NUM
aiua-13642	129	10	studies	study	NOUN
aiua-13642	129	11	included	include	VERB
aiua-13642	129	12	in	in	ADP
aiua-13642	129	13	the	the	DET
aiua-13642	129	14	meta	meta	ADJ
aiua-13642	129	15	analysis	analysis	NOUN
aiua-13642	129	16	.	.	PUNCT
aiua-13642	130	1	since	since	SCONJ
aiua-13642	130	2	then	then	ADV
aiua-13642	130	3	several	several	ADJ
aiua-13642	130	4	high	high	ADJ
aiua-13642	130	5	-	-	PUNCT
aiua-13642	130	6	quality	quality	NOUN
aiua-13642	130	7	studies	study	NOUN
aiua-13642	130	8	were	be	AUX
aiua-13642	130	9	published	publish	VERB
aiua-13642	130	10	,	,	PUNCT
aiua-13642	130	11	allowing	allow	VERB
aiua-13642	130	12	for	for	ADP
aiua-13642	130	13	a	a	DET
aiua-13642	130	14	more	more	ADV
aiua-13642	130	15	robust	robust	ADJ
aiua-13642	130	16	evidence	evidence	NOUN
aiua-13642	130	17	synthesis	synthesis	NOUN
aiua-13642	130	18	.	.	PUNCT
aiua-13642	131	1	our	our	PRON
aiua-13642	131	2	metaanalysis	metaanalysis	NOUN
aiua-13642	131	3	adds	add	VERB
aiua-13642	131	4	evaluation	evaluation	NOUN
aiua-13642	131	5	of	of	ADP
aiua-13642	131	6	adverse	adverse	ADJ
aiua-13642	131	7	events	event	NOUN
aiua-13642	131	8	and	and	CCONJ
aiua-13642	131	9	solving	solving	NOUN
aiua-13642	131	10	of	of	ADP
aiua-13642	131	11	the	the	DET
aiua-13642	131	12	heterogeneity	heterogeneity	NOUN
aiua-13642	131	13	which	which	PRON
aiua-13642	131	14	was	be	AUX
aiua-13642	131	15	n’t	not	PART
aiua-13642	131	16	taken	take	VERB
aiua-13642	131	17	care	care	NOUN
aiua-13642	131	18	of	of	ADP
aiua-13642	131	19	in	in	ADP
aiua-13642	131	20	the	the	DET
aiua-13642	131	21	previous	previous	ADJ
aiua-13642	131	22	meta	meta	ADJ
aiua-13642	131	23	-	-	PUNCT
aiua-13642	131	24	analysis	analysis	NOUN
aiua-13642	131	25	.	.	PUNCT
aiua-13642	132	1	this	this	DET
aiua-13642	132	2	broader	broad	ADJ
aiua-13642	132	3	approach	approach	NOUN
aiua-13642	132	4	provides	provide	VERB
aiua-13642	132	5	a	a	DET
aiua-13642	132	6	more	more	ADV
aiua-13642	132	7	comprehensive	comprehensive	ADJ
aiua-13642	132	8	view	view	NOUN
aiua-13642	132	9	of	of	ADP
aiua-13642	132	10	treatment	treatment	NOUN
aiua-13642	132	11	effects	effect	NOUN
aiua-13642	132	12	beyond	beyond	ADP
aiua-13642	132	13	the	the	DET
aiua-13642	132	14	scope	scope	NOUN
aiua-13642	132	15	of	of	ADP
aiua-13642	132	16	the	the	DET
aiua-13642	132	17	previous	previous	ADJ
aiua-13642	132	18	analysis	analysis	NOUN
aiua-13642	132	19	,	,	PUNCT
aiua-13642	132	20	enabling	enable	VERB
aiua-13642	132	21	a	a	DET
aiua-13642	132	22	more	more	ADV
aiua-13642	132	23	detailed	detailed	ADJ
aiua-13642	132	24	comparison	comparison	NOUN
aiua-13642	132	25	of	of	ADP
aiua-13642	132	26	treatment	treatment	NOUN
aiua-13642	132	27	efficacy	efficacy	NOUN
aiua-13642	132	28	and	and	CCONJ
aiua-13642	132	29	adverse	adverse	ADJ
aiua-13642	132	30	events	event	NOUN
aiua-13642	132	31	.	.	PUNCT
aiua-13642	133	1	to	to	ADP
aiua-13642	133	2	our	our	PRON
aiua-13642	133	3	knowledge	knowledge	NOUN
aiua-13642	133	4	,	,	PUNCT
aiua-13642	133	5	this	this	PRON
aiua-13642	133	6	is	be	AUX
aiua-13642	133	7	the	the	DET
aiua-13642	133	8	most	most	ADV
aiua-13642	133	9	comprehensive	comprehensive	ADJ
aiua-13642	133	10	systematic	systematic	ADJ
aiua-13642	133	11	review	review	NOUN
aiua-13642	133	12	and	and	CCONJ
aiua-13642	133	13	meta	meta	ADJ
aiua-13642	133	14	-	-	PUNCT
aiua-13642	133	15	analysis	analysis	NOUN
aiua-13642	133	16	comparing	compare	VERB
aiua-13642	133	17	tadalafil	tadalafil	NOUN
aiua-13642	133	18	and	and	CCONJ
aiua-13642	133	19	silodosin	silodosin	NOUN
aiua-13642	133	20	.	.	PUNCT
aiua-13642	134	1	pooled	pool	VERB
aiua-13642	134	2	results	result	NOUN
aiua-13642	134	3	of	of	ADP
aiua-13642	134	4	our	our	PRON
aiua-13642	134	5	study	study	NOUN
aiua-13642	134	6	showed	show	VERB
aiua-13642	134	7	that	that	SCONJ
aiua-13642	134	8	silodosin	silodosin	NOUN
aiua-13642	134	9	and	and	CCONJ
aiua-13642	134	10	tadalafil	tadalafil	PROPN
aiua-13642	134	11	had	have	VERB
aiua-13642	134	12	no	no	DET
aiua-13642	134	13	significant	significant	ADJ
aiua-13642	134	14	difference	difference	NOUN
aiua-13642	134	15	on	on	ADP
aiua-13642	134	16	stone	stone	NOUN
aiua-13642	134	17	expulsion	expulsion	NOUN
aiua-13642	134	18	rate	rate	NOUN
aiua-13642	134	19	,	,	PUNCT
aiua-13642	134	20	however	however	ADV
aiua-13642	134	21	after	after	ADP
aiua-13642	134	22	solving	solve	VERB
aiua-13642	134	23	high	high	ADJ
aiua-13642	134	24	heterogeneity	heterogeneity	NOUN
aiua-13642	134	25	by	by	ADP
aiua-13642	134	26	deleting	delete	VERB
aiua-13642	134	27	the	the	DET
aiua-13642	134	28	study	study	NOUN
aiua-13642	134	29	of	of	ADP
aiua-13642	134	30	abdelaal	abdelaal	PROPN
aiua-13642	134	31	et	et	PROPN
aiua-13642	134	32	al	al	PROPN
aiua-13642	134	33	.	.	PUNCT
aiua-13642	135	1	(	(	PUNCT
aiua-13642	135	2	20	20	NUM
aiua-13642	135	3	)	)	PUNCT
aiua-13642	135	4	it	it	PRON
aiua-13642	135	5	was	be	AUX
aiua-13642	135	6	shown	show	VERB
aiua-13642	135	7	a	a	DET
aiua-13642	135	8	statistically	statistically	ADV
aiua-13642	135	9	significant	significant	ADJ
aiua-13642	135	10	difference	difference	NOUN
aiua-13642	135	11	between	between	ADP
aiua-13642	135	12	silodosin	silodosin	NOUN
aiua-13642	135	13	and	and	CCONJ
aiua-13642	135	14	tadalafil	tadalafil	NOUN
aiua-13642	135	15	favoring	favor	VERB
aiua-13642	135	16	silodosin	silodosin	NOUN
aiua-13642	135	17	.	.	PUNCT
aiua-13642	136	1	we	we	PRON
aiua-13642	136	2	believe	believe	VERB
aiua-13642	136	3	that	that	SCONJ
aiua-13642	136	4	abdelaal	abdelaal	PROPN
aiua-13642	136	5	et	et	PROPN
aiua-13642	136	6	al	al	PROPN
aiua-13642	136	7	.	.	PROPN
aiua-13642	136	8	study	study	PROPN
aiua-13642	136	9	(	(	PUNCT
aiua-13642	136	10	20	20	NUM
aiua-13642	136	11	)	)	PUNCT
aiua-13642	136	12	was	be	AUX
aiua-13642	136	13	a	a	DET
aiua-13642	136	14	poorly	poorly	ADV
aiua-13642	136	15	controlled	control	VERB
aiua-13642	136	16	clinical	clinical	ADJ
aiua-13642	136	17	trial	trial	NOUN
aiua-13642	136	18	,	,	PUNCT
aiua-13642	136	19	with	with	ADP
aiua-13642	136	20	relatively	relatively	ADV
aiua-13642	136	21	high	high	ADJ
aiua-13642	136	22	risk	risk	NOUN
aiua-13642	136	23	of	of	ADP
aiua-13642	136	24	bias	bias	NOUN
aiua-13642	136	25	.	.	PUNCT
aiua-13642	137	1	the	the	DET
aiua-13642	137	2	study	study	NOUN
aiua-13642	137	3	did	do	AUX
aiua-13642	137	4	n’t	not	AUX
aiua-13642	137	5	mention	mention	VERB
aiua-13642	137	6	the	the	DET
aiua-13642	137	7	type	type	NOUN
aiua-13642	137	8	of	of	ADP
aiua-13642	137	9	randomization	randomization	NOUN
aiua-13642	137	10	and	and	CCONJ
aiua-13642	137	11	modality	modality	NOUN
aiua-13642	137	12	of	of	ADP
aiua-13642	137	13	allocation	allocation	NOUN
aiua-13642	137	14	,	,	PUNCT
aiua-13642	137	15	and	and	CCONJ
aiua-13642	137	16	the	the	DET
aiua-13642	137	17	materials	material	NOUN
aiua-13642	137	18	and	and	CCONJ
aiua-13642	137	19	method	method	NOUN
aiua-13642	137	20	section	section	NOUN
aiua-13642	137	21	was	be	AUX
aiua-13642	137	22	brief	brief	ADJ
aiua-13642	137	23	,	,	PUNCT
aiua-13642	137	24	blurry	blurry	ADJ
aiua-13642	137	25	,	,	PUNCT
aiua-13642	137	26	with	with	ADP
aiua-13642	137	27	weak	weak	ADJ
aiua-13642	137	28	writing	writing	NOUN
aiua-13642	137	29	skills	skill	NOUN
aiua-13642	137	30	.	.	PUNCT
aiua-13642	138	1	abdelaal	abdelaal	PROPN
aiua-13642	138	2	et	et	PROPN
aiua-13642	138	3	al	al	PROPN
aiua-13642	138	4	.	.	PROPN
aiua-13642	138	5	was	be	AUX
aiua-13642	138	6	the	the	DET
aiua-13642	138	7	only	only	ADJ
aiua-13642	138	8	study	study	NOUN
aiua-13642	138	9	among	among	ADP
aiua-13642	138	10	all	all	DET
aiua-13642	138	11	the	the	DET
aiua-13642	138	12	eight	eight	NUM
aiua-13642	138	13	studies	study	NOUN
aiua-13642	138	14	that	that	PRON
aiua-13642	138	15	pointed	point	VERB
aiua-13642	138	16	towards	towards	ADP
aiua-13642	138	17	the	the	DET
aiua-13642	138	18	use	use	NOUN
aiua-13642	138	19	of	of	ADP
aiua-13642	138	20	tadalafil	tadalafil	PROPN
aiua-13642	138	21	(	(	PUNCT
aiua-13642	138	22	5	5	NUM
aiua-13642	138	23	mg	mg	NOUN
aiua-13642	138	24	)	)	PUNCT
aiua-13642	138	25	as	as	ADP
aiua-13642	138	26	a	a	DET
aiua-13642	138	27	met	meet	VERB
aiua-13642	138	28	with	with	ADP
aiua-13642	138	29	a	a	DET
aiua-13642	138	30	high	high	ADJ
aiua-13642	138	31	significant	significant	ADJ
aiua-13642	138	32	difference	difference	NOUN
aiua-13642	138	33	between	between	ADP
aiua-13642	138	34	it	it	PRON
aiua-13642	138	35	and	and	CCONJ
aiua-13642	138	36	the	the	DET
aiua-13642	138	37	silodosin	silodosin	NOUN
aiua-13642	138	38	,	,	PUNCT
aiua-13642	138	39	which	which	PRON
aiua-13642	138	40	raised	raise	VERB
aiua-13642	138	41	a	a	DET
aiua-13642	138	42	lot	lot	NOUN
aiua-13642	138	43	of	of	ADP
aiua-13642	138	44	concern	concern	NOUN
aiua-13642	138	45	about	about	ADP
aiua-13642	138	46	the	the	DET
aiua-13642	138	47	methodology	methodology	NOUN
aiua-13642	138	48	of	of	ADP
aiua-13642	138	49	the	the	DET
aiua-13642	138	50	study	study	NOUN
aiua-13642	138	51	.	.	PUNCT
aiua-13642	139	1	although	although	SCONJ
aiua-13642	139	2	silodosin	silodosin	NOUN
aiua-13642	139	3	and	and	CCONJ
aiua-13642	139	4	tadalafil	tadalafil	PROPN
aiua-13642	139	5	had	have	VERB
aiua-13642	139	6	no	no	DET
aiua-13642	139	7	significant	significant	ADJ
aiua-13642	139	8	difference	difference	NOUN
aiua-13642	139	9	in	in	ADP
aiua-13642	139	10	terms	term	NOUN
aiua-13642	139	11	of	of	ADP
aiua-13642	139	12	set	set	NOUN
aiua-13642	139	13	,	,	PUNCT
aiua-13642	139	14	silodosin	silodosin	PROPN
aiua-13642	139	15	showed	show	VERB
aiua-13642	139	16	positive	positive	ADJ
aiua-13642	139	17	trends	trend	NOUN
aiua-13642	139	18	towards	towards	ADP
aiua-13642	139	19	set	set	VERB
aiua-13642	139	20	without	without	ADP
aiua-13642	139	21	reaching	reach	VERB
aiua-13642	139	22	significance	significance	NOUN
aiua-13642	139	23	level	level	NOUN
aiua-13642	139	24	.	.	PUNCT
aiua-13642	140	1	results	result	NOUN
aiua-13642	140	2	of	of	ADP
aiua-13642	140	3	the	the	DET
aiua-13642	140	4	adverse	adverse	ADJ
aiua-13642	140	5	effects	effect	NOUN
aiua-13642	140	6	showed	show	VERB
aiua-13642	140	7	that	that	SCONJ
aiua-13642	140	8	patients	patient	NOUN
aiua-13642	140	9	on	on	ADP
aiua-13642	140	10	silodosin	silodosin	NOUN
aiua-13642	140	11	had	have	VERB
aiua-13642	140	12	a	a	DET
aiua-13642	140	13	relatively	relatively	ADV
aiua-13642	140	14	higher	high	ADJ
aiua-13642	140	15	chance	chance	NOUN
aiua-13642	140	16	for	for	ADP
aiua-13642	140	17	orthostatic	orthostatic	ADJ
aiua-13642	140	18	hypotension	hypotension	NOUN
aiua-13642	140	19	and	and	CCONJ
aiua-13642	140	20	abnormal	abnormal	ADJ
aiua-13642	140	21	ejaculation	ejaculation	NOUN
aiua-13642	140	22	(	(	PUNCT
aiua-13642	140	23	e.g.	e.g.	ADV
aiua-13642	140	24	loss	loss	NOUN
aiua-13642	140	25	of	of	ADP
aiua-13642	140	26	seminal	seminal	ADJ
aiua-13642	140	27	emission	emission	NOUN
aiua-13642	140	28	)	)	PUNCT
aiua-13642	140	29	than	than	ADP
aiua-13642	140	30	patients	patient	NOUN
aiua-13642	140	31	on	on	ADP
aiua-13642	140	32	tadalafil	tadalafil	PROPN
aiua-13642	140	33	as	as	SCONJ
aiua-13642	140	34	shown	show	VERB
aiua-13642	140	35	by	by	ADP
aiua-13642	140	36	the	the	DET
aiua-13642	140	37	significant	significant	ADJ
aiua-13642	140	38	difference	difference	NOUN
aiua-13642	140	39	between	between	ADP
aiua-13642	140	40	the	the	DET
aiua-13642	140	41	two	two	NUM
aiua-13642	140	42	drugs	drug	NOUN
aiua-13642	140	43	.	.	PUNCT
aiua-13642	141	1	the	the	DET
aiua-13642	141	2	mechanism	mechanism	NOUN
aiua-13642	141	3	of	of	ADP
aiua-13642	141	4	orthostatic	orthostatic	ADJ
aiua-13642	141	5	hypotension	hypotension	NOUN
aiua-13642	141	6	is	be	AUX
aiua-13642	141	7	due	due	ADJ
aiua-13642	141	8	to	to	ADP
aiua-13642	141	9	the	the	DET
aiua-13642	141	10	natural	natural	ADJ
aiua-13642	141	11	effect	effect	NOUN
aiua-13642	141	12	of	of	ADP
aiua-13642	141	13	silodosin	silodosin	NOUN
aiua-13642	141	14	on	on	ADP
aiua-13642	141	15	alpha	alpha	NOUN
aiua-13642	141	16	receptors	receptor	NOUN
aiua-13642	141	17	which	which	PRON
aiua-13642	141	18	are	be	AUX
aiua-13642	141	19	extensively	extensively	ADV
aiua-13642	141	20	located	locate	VERB
aiua-13642	141	21	on	on	ADP
aiua-13642	141	22	blood	blood	NOUN
aiua-13642	141	23	vessels	vessel	NOUN
aiua-13642	141	24	(	(	PUNCT
aiua-13642	141	25	particularly	particularly	ADV
aiua-13642	141	26	alpha-1	alpha-1	NUM
aiua-13642	141	27	receptors	receptor	NOUN
aiua-13642	141	28	)	)	PUNCT
aiua-13642	141	29	(	(	PUNCT
aiua-13642	141	30	26	26	NUM
aiua-13642	141	31	)	)	PUNCT
aiua-13642	141	32	.	.	PUNCT
aiua-13642	142	1	abnormal	abnormal	ADJ
aiua-13642	142	2	ejaculation	ejaculation	NOUN
aiua-13642	142	3	caused	cause	VERB
aiua-13642	142	4	by	by	ADP
aiua-13642	142	5	silodosin	silodosin	NOUN
aiua-13642	142	6	is	be	AUX
aiua-13642	142	7	related	relate	VERB
aiua-13642	142	8	to	to	PART
aiua-13642	142	9	decreased	decrease	VERB
aiua-13642	142	10	number	number	NOUN
aiua-13642	142	11	of	of	ADP
aiua-13642	142	12	bulbocavernous	bulbocavernous	ADJ
aiua-13642	142	13	floor	floor	NOUN
aiua-13642	142	14	muscle	muscle	NOUN
aiua-13642	142	15	contractions	contraction	NOUN
aiua-13642	142	16	,	,	PUNCT
aiua-13642	142	17	thus	thus	ADV
aiua-13642	142	18	decreasing	decrease	VERB
aiua-13642	142	19	semen	semen	NOUN
aiua-13642	142	20	discharge	discharge	NOUN
aiua-13642	142	21	(	(	PUNCT
aiua-13642	142	22	27	27	NUM
aiua-13642	142	23	)	)	PUNCT
aiua-13642	142	24	.	.	PUNCT
aiua-13642	143	1	kumar	kumar	PROPN
aiua-13642	143	2	et	et	PROPN
aiua-13642	143	3	al	al	PROPN
aiua-13642	143	4	.	.	PROPN
aiua-13642	144	1	(	(	PUNCT
aiua-13642	144	2	24	24	NUM
aiua-13642	144	3	)	)	PUNCT
aiua-13642	144	4	and	and	CCONJ
aiua-13642	144	5	sharma	sharma	PROPN
aiua-13642	144	6	et	et	PROPN
aiua-13642	144	7	al	al	PROPN
aiua-13642	144	8	.	.	PROPN
aiua-13642	145	1	(	(	PUNCT
aiua-13642	145	2	19	19	NUM
aiua-13642	145	3	)	)	PUNCT
aiua-13642	145	4	were	be	AUX
aiua-13642	145	5	the	the	DET
aiua-13642	145	6	only	only	ADJ
aiua-13642	145	7	two	two	NUM
aiua-13642	145	8	studies	study	NOUN
aiua-13642	145	9	that	that	PRON
aiua-13642	145	10	used	use	VERB
aiua-13642	145	11	oral	oral	ADJ
aiua-13642	145	12	tablets	tablet	NOUN
aiua-13642	145	13	with	with	ADP
aiua-13642	145	14	10	10	NUM
aiua-13642	145	15	mg	mg	PROPN
aiua-13642	145	16	tadalafil	tadalafil	PROPN
aiua-13642	145	17	,	,	PUNCT
aiua-13642	145	18	unlike	unlike	ADP
aiua-13642	145	19	the	the	DET
aiua-13642	145	20	rest	rest	NOUN
aiua-13642	145	21	of	of	ADP
aiua-13642	145	22	the	the	DET
aiua-13642	145	23	studies	study	NOUN
aiua-13642	145	24	,	,	PUNCT
aiua-13642	145	25	however	however	ADV
aiua-13642	145	26	no	no	DET
aiua-13642	145	27	statistical	statistical	ADJ
aiua-13642	145	28	difference	difference	NOUN
aiua-13642	145	29	was	be	AUX
aiua-13642	145	30	observed	observe	VERB
aiua-13642	145	31	even	even	ADV
aiua-13642	145	32	after	after	ADP
aiua-13642	145	33	the	the	DET
aiua-13642	145	34	administration	administration	NOUN
aiua-13642	145	35	of	of	ADP
aiua-13642	145	36	10	10	NUM
aiua-13642	145	37	mg	mg	PROPN
aiua-13642	145	38	tadalafil	tadalafil	PROPN
aiua-13642	145	39	.	.	PUNCT
aiua-13642	146	1	furthermore	furthermore	ADV
aiua-13642	146	2	tadalafil	tadalafil	PROPN
aiua-13642	146	3	group	group	NOUN
aiua-13642	146	4	in	in	ADP
aiua-13642	146	5	kumar	kumar	PROPN
aiua-13642	146	6	et	et	PROPN
aiua-13642	146	7	al	al	PROPN
aiua-13642	146	8	.	.	PROPN
aiua-13642	147	1	(	(	PUNCT
aiua-13642	147	2	24	24	NUM
aiua-13642	147	3	)	)	PUNCT
aiua-13642	147	4	was	be	AUX
aiua-13642	147	5	associated	associate	VERB
aiua-13642	147	6	with	with	ADP
aiua-13642	147	7	a	a	DET
aiua-13642	147	8	higher	high	ADJ
aiua-13642	147	9	incidence	incidence	NOUN
aiua-13642	147	10	of	of	ADP
aiua-13642	147	11	adverse	adverse	ADJ
aiua-13642	147	12	events	event	NOUN
aiua-13642	147	13	including	include	VERB
aiua-13642	147	14	hypotension	hypotension	NOUN
aiua-13642	147	15	and	and	CCONJ
aiua-13642	147	16	abnormal	abnormal	ADJ
aiua-13642	147	17	ejaculation	ejaculation	NOUN
aiua-13642	147	18	witch	witch	NOUN
aiua-13642	147	19	raise	raise	VERB
aiua-13642	147	20	concerns	concern	NOUN
aiua-13642	147	21	and	and	CCONJ
aiua-13642	147	22	question	question	NOUN
aiua-13642	147	23	about	about	ADP
aiua-13642	147	24	dose	dose	VERB
aiua-13642	147	25	related	relate	VERB
aiua-13642	147	26	adverse	adverse	ADJ
aiua-13642	147	27	effects	effect	NOUN
aiua-13642	147	28	of	of	ADP
aiua-13642	147	29	tadalafil	tadalafil	PROPN
aiua-13642	147	30	as	as	ADP
aiua-13642	147	31	a	a	DET
aiua-13642	147	32	met	met	NOUN
aiua-13642	147	33	.	.	PUNCT
aiua-13642	148	1	huang	huang	PROPN
aiua-13642	148	2	et	et	PROPN
aiua-13642	148	3	al	al	PROPN
aiua-13642	148	4	.	.	PROPN
aiua-13642	149	1	(	(	PUNCT
aiua-13642	149	2	28	28	NUM
aiua-13642	149	3	)	)	PUNCT
aiua-13642	149	4	demonstrated	demonstrate	VERB
aiua-13642	149	5	that	that	SCONJ
aiua-13642	149	6	patients	patient	NOUN
aiua-13642	149	7	with	with	ADP
aiua-13642	149	8	distal	distal	ADJ
aiua-13642	149	9	ureteric	ureteric	ADJ
aiua-13642	149	10	stones	stone	NOUN
aiua-13642	149	11	who	who	PRON
aiua-13642	149	12	were	be	AUX
aiua-13642	149	13	treated	treat	VERB
aiua-13642	149	14	with	with	ADP
aiua-13642	149	15	silodosin	silodosin	NOUN
aiua-13642	149	16	had	have	VERB
aiua-13642	149	17	an	an	DET
aiua-13642	149	18	expulsion	expulsion	NOUN
aiua-13642	149	19	rate	rate	NOUN
aiua-13642	149	20	of	of	ADP
aiua-13642	149	21	83.5	83.5	NUM
aiua-13642	149	22	%	%	NOUN
aiua-13642	149	23	and	and	CCONJ
aiua-13642	149	24	a	a	DET
aiua-13642	149	25	mean	mean	ADJ
aiua-13642	149	26	expulsion	expulsion	NOUN
aiua-13642	149	27	time	time	NOUN
aiua-13642	149	28	of	of	ADP
aiua-13642	149	29	11	11	NUM
aiua-13642	149	30	days	day	NOUN
aiua-13642	149	31	.	.	PUNCT
aiua-13642	150	1	this	this	PRON
aiua-13642	150	2	was	be	AUX
aiua-13642	150	3	significantly	significantly	ADV
aiua-13642	150	4	better	well	ADJ
aiua-13642	150	5	than	than	ADP
aiua-13642	150	6	the	the	DET
aiua-13642	150	7	results	result	NOUN
aiua-13642	150	8	for	for	ADP
aiua-13642	150	9	tamsulosin	tamsulosin	NOUN
aiua-13642	150	10	,	,	PUNCT
aiua-13642	150	11	which	which	PRON
aiua-13642	150	12	had	have	VERB
aiua-13642	150	13	an	an	DET
aiua-13642	150	14	expulsion	expulsion	NOUN
aiua-13642	150	15	rate	rate	NOUN
aiua-13642	150	16	of	of	ADP
aiua-13642	150	17	66.9	66.9	NUM
aiua-13642	150	18	%	%	NOUN
aiua-13642	150	19	and	and	CCONJ
aiua-13642	150	20	a	a	DET
aiua-13642	150	21	mean	mean	ADJ
aiua-13642	150	22	expulsion	expulsion	NOUN
aiua-13642	150	23	time	time	NOUN
aiua-13642	150	24	of	of	ADP
aiua-13642	150	25	14	14	NUM
aiua-13642	150	26	days	day	NOUN
aiua-13642	150	27	,	,	PUNCT
aiua-13642	150	28	along	along	ADP
aiua-13642	150	29	with	with	ADP
aiua-13642	150	30	a	a	DET
aiua-13642	150	31	notable	notable	ADJ
aiua-13642	150	32	reduction	reduction	NOUN
aiua-13642	150	33	in	in	ADP
aiua-13642	150	34	pain	pain	NOUN
aiua-13642	150	35	episodes	episode	NOUN
aiua-13642	150	36	.	.	PUNCT
aiua-13642	151	1	combination	combination	NOUN
aiua-13642	151	2	of	of	ADP
aiua-13642	151	3	silodosin	silodosin	NOUN
aiua-13642	151	4	and	and	CCONJ
aiua-13642	151	5	tadalafil	tadalafil	PROPN
aiua-13642	151	6	have	have	AUX
aiua-13642	151	7	showed	show	VERB
aiua-13642	151	8	positive	positive	ADJ
aiua-13642	151	9	results	result	NOUN
aiua-13642	151	10	on	on	ADP
aiua-13642	151	11	set	set	NOUN
aiua-13642	151	12	and	and	CCONJ
aiua-13642	151	13	ser	ser	NOUN
aiua-13642	151	14	when	when	SCONJ
aiua-13642	151	15	used	use	VERB
aiua-13642	151	16	as	as	ADP
aiua-13642	151	17	a	a	DET
aiua-13642	151	18	medical	medical	ADJ
aiua-13642	151	19	expulsive	expulsive	NOUN
aiua-13642	151	20	therapy	therapy	NOUN
aiua-13642	151	21	,	,	PUNCT
aiua-13642	151	22	with	with	ADP
aiua-13642	151	23	variations	variation	NOUN
aiua-13642	151	24	between	between	ADP
aiua-13642	151	25	the	the	DET
aiua-13642	151	26	studies	study	NOUN
aiua-13642	151	27	about	about	ADP
aiua-13642	151	28	how	how	SCONJ
aiua-13642	151	29	tolerated	tolerate	VERB
aiua-13642	151	30	is	be	AUX
aiua-13642	151	31	the	the	DET
aiua-13642	151	32	combination	combination	NOUN
aiua-13642	151	33	by	by	ADP
aiua-13642	151	34	the	the	DET
aiua-13642	151	35	patients	patient	NOUN
aiua-13642	151	36	(	(	PUNCT
aiua-13642	151	37	29	29	NUM
aiua-13642	151	38	)	)	PUNCT
aiua-13642	151	39	.	.	PUNCT
aiua-13642	152	1	strength	strength	NOUN
aiua-13642	152	2	and	and	CCONJ
aiua-13642	152	3	limitations	limitation	NOUN
aiua-13642	152	4	a	a	DET
aiua-13642	152	5	major	major	ADJ
aiua-13642	152	6	strength	strength	NOUN
aiua-13642	152	7	of	of	ADP
aiua-13642	152	8	this	this	DET
aiua-13642	152	9	study	study	NOUN
aiua-13642	152	10	is	be	AUX
aiua-13642	152	11	the	the	DET
aiua-13642	152	12	exhaustive	exhaustive	ADJ
aiua-13642	152	13	inclusion	inclusion	NOUN
aiua-13642	152	14	of	of	ADP
aiua-13642	152	15	all	all	DET
aiua-13642	152	16	available	available	ADJ
aiua-13642	152	17	clinical	clinical	ADJ
aiua-13642	152	18	trials	trial	NOUN
aiua-13642	152	19	that	that	PRON
aiua-13642	152	20	directly	directly	ADV
aiua-13642	152	21	compare	compare	VERB
aiua-13642	152	22	tadalafil	tadalafil	PROPN
aiua-13642	152	23	and	and	CCONJ
aiua-13642	152	24	silodosin	silodosin	NOUN
aiua-13642	152	25	treatment	treatment	NOUN
aiua-13642	152	26	for	for	ADP
aiua-13642	152	27	distal	distal	ADJ
aiua-13642	152	28	ureter	ureter	ADJ
aiua-13642	152	29	stones	stone	NOUN
aiua-13642	152	30	below	below	ADP
aiua-13642	152	31	10	10	NUM
aiua-13642	152	32	mm	mm	NOUN
aiua-13642	152	33	.	.	PUNCT
aiua-13642	153	1	our	our	PRON
aiua-13642	153	2	team	team	NOUN
aiua-13642	153	3	conducted	conduct	VERB
aiua-13642	153	4	an	an	DET
aiua-13642	153	5	extensive	extensive	ADJ
aiua-13642	153	6	search	search	NOUN
aiua-13642	153	7	across	across	ADP
aiua-13642	153	8	all	all	DET
aiua-13642	153	9	major	major	ADJ
aiua-13642	153	10	databases	database	NOUN
aiua-13642	153	11	to	to	PART
aiua-13642	153	12	ensure	ensure	VERB
aiua-13642	153	13	a	a	DET
aiua-13642	153	14	comprehensive	comprehensive	ADJ
aiua-13642	153	15	dataset	dataset	NOUN
aiua-13642	153	16	;	;	PUNCT
aiua-13642	153	17	moreover	moreover	ADV
aiua-13642	153	18	,	,	PUNCT
aiua-13642	153	19	the	the	DET
aiua-13642	153	20	study	study	NOUN
aiua-13642	153	21	solved	solve	VERB
aiua-13642	153	22	the	the	DET
aiua-13642	153	23	heterogeneity	heterogeneity	NOUN
aiua-13642	153	24	that	that	PRON
aiua-13642	153	25	came	come	VERB
aiua-13642	153	26	across	across	ADP
aiua-13642	153	27	the	the	DET
aiua-13642	153	28	results	result	NOUN
aiua-13642	153	29	using	use	VERB
aiua-13642	153	30	random	random	ADJ
aiua-13642	153	31	effect	effect	NOUN
aiua-13642	153	32	model	model	NOUN
aiua-13642	153	33	and	and	CCONJ
aiua-13642	153	34	sensitivity	sensitivity	NOUN
aiua-13642	153	35	analysis	analysis	NOUN
aiua-13642	153	36	;	;	PUNCT
aiua-13642	153	37	finally	finally	ADV
aiua-13642	153	38	,	,	PUNCT
aiua-13642	153	39	an	an	DET
aiua-13642	153	40	extensive	extensive	ADJ
aiua-13642	153	41	analysis	analysis	NOUN
aiua-13642	153	42	of	of	ADP
aiua-13642	153	43	all	all	DET
aiua-13642	153	44	the	the	DET
aiua-13642	153	45	possible	possible	ADJ
aiua-13642	153	46	adverse	adverse	ADJ
aiua-13642	153	47	effects	effect	NOUN
aiua-13642	153	48	of	of	ADP
aiua-13642	153	49	both	both	DET
aiua-13642	153	50	drugs	drug	NOUN
aiua-13642	153	51	was	be	AUX
aiua-13642	153	52	done	do	VERB
aiua-13642	153	53	.	.	PUNCT
aiua-13642	154	1	despite	despite	SCONJ
aiua-13642	154	2	adhering	adhere	VERB
aiua-13642	154	3	to	to	PART
aiua-13642	154	4	prisma	prisma	VERB
aiua-13642	154	5	guidelines	guideline	NOUN
aiua-13642	154	6	,	,	PUNCT
aiua-13642	154	7	our	our	PRON
aiua-13642	154	8	study	study	NOUN
aiua-13642	154	9	has	have	VERB
aiua-13642	154	10	limitations	limitation	NOUN
aiua-13642	154	11	that	that	PRON
aiua-13642	154	12	must	must	AUX
aiua-13642	154	13	be	be	AUX
aiua-13642	154	14	acknowledged	acknowledge	VERB
aiua-13642	154	15	.	.	PUNCT
aiua-13642	155	1	first	first	ADV
aiua-13642	155	2	,	,	PUNCT
aiua-13642	155	3	the	the	DET
aiua-13642	155	4	heterogeneity	heterogeneity	NOUN
aiua-13642	155	5	found	find	VERB
aiua-13642	155	6	upon	upon	SCONJ
aiua-13642	155	7	analysis	analysis	NOUN
aiua-13642	155	8	of	of	ADP
aiua-13642	155	9	stone	stone	NOUN
aiua-13642	155	10	expulsion	expulsion	NOUN
aiua-13642	155	11	time	time	NOUN
aiua-13642	155	12	could	could	AUX
aiua-13642	155	13	n’t	not	PART
aiua-13642	155	14	be	be	AUX
aiua-13642	155	15	solved	solve	VERB
aiua-13642	155	16	by	by	ADP
aiua-13642	155	17	any	any	DET
aiua-13642	155	18	method	method	NOUN
aiua-13642	155	19	:	:	PUNCT
aiua-13642	155	20	random	random	ADJ
aiua-13642	155	21	effect	effect	NOUN
aiua-13642	155	22	model	model	NOUN
aiua-13642	155	23	;	;	PUNCT
aiua-13642	155	24	sensitivity	sensitivity	NOUN
aiua-13642	155	25	analysis	analysis	NOUN
aiua-13642	155	26	and	and	CCONJ
aiua-13642	155	27	selective	selective	ADJ
aiua-13642	155	28	regression	regression	NOUN
aiua-13642	155	29	were	be	AUX
aiua-13642	155	30	all	all	ADV
aiua-13642	155	31	useless	useless	ADJ
aiua-13642	155	32	.	.	PUNCT
aiua-13642	156	1	second	second	ADV
aiua-13642	156	2	,	,	PUNCT
aiua-13642	156	3	the	the	DET
aiua-13642	156	4	high	high	ADJ
aiua-13642	156	5	risk	risk	NOUN
aiua-13642	156	6	of	of	ADP
aiua-13642	156	7	bias	bias	NOUN
aiua-13642	156	8	in	in	ADP
aiua-13642	156	9	some	some	DET
aiua-13642	156	10	studies	study	NOUN
aiua-13642	156	11	should	should	AUX
aiua-13642	156	12	be	be	AUX
aiua-13642	156	13	taken	take	VERB
aiua-13642	156	14	into	into	ADP
aiua-13642	156	15	account	account	NOUN
aiua-13642	156	16	when	when	SCONJ
aiua-13642	156	17	interpreting	interpret	VERB
aiua-13642	156	18	their	their	PRON
aiua-13642	156	19	results	result	NOUN
aiua-13642	156	20	.	.	PUNCT
aiua-13642	157	1	further	further	ADJ
aiua-13642	157	2	high	high	ADJ
aiua-13642	157	3	-	-	PUNCT
aiua-13642	157	4	quality	quality	NOUN
aiua-13642	157	5	rcts	rct	NOUN
aiua-13642	157	6	with	with	ADP
aiua-13642	157	7	larger	large	ADJ
aiua-13642	157	8	sample	sample	NOUN
aiua-13642	157	9	sizes	size	NOUN
aiua-13642	157	10	and	and	CCONJ
aiua-13642	157	11	longer	long	ADV
aiua-13642	157	12	follow	follow	VERB
aiua-13642	157	13	-	-	PUNCT
aiua-13642	157	14	up	up	ADP
aiua-13642	157	15	periods	period	NOUN
aiua-13642	157	16	are	be	AUX
aiua-13642	157	17	needed	need	VERB
aiua-13642	157	18	to	to	PART
aiua-13642	157	19	further	far	ADV
aiua-13642	157	20	support	support	VERB
aiua-13642	157	21	our	our	PRON
aiua-13642	157	22	results	result	NOUN
aiua-13642	157	23	.	.	PUNCT
aiua-13642	158	1	conclusions	conclusion	NOUN
aiua-13642	158	2	silodosin	silodosin	PROPN
aiua-13642	158	3	has	have	AUX
aiua-13642	158	4	shown	show	VERB
aiua-13642	158	5	better	well	ADJ
aiua-13642	158	6	results	result	NOUN
aiua-13642	158	7	in	in	ADP
aiua-13642	158	8	terms	term	NOUN
aiua-13642	158	9	of	of	ADP
aiua-13642	158	10	stone	stone	NOUN
aiua-13642	158	11	expulsion	expulsion	NOUN
aiua-13642	158	12	rate	rate	NOUN
aiua-13642	158	13	,	,	PUNCT
aiua-13642	158	14	together	together	ADV
aiua-13642	158	15	with	with	ADP
aiua-13642	158	16	positive	positive	ADJ
aiua-13642	158	17	trends	trend	NOUN
aiua-13642	158	18	towards	towards	ADP
aiua-13642	158	19	stone	stone	NOUN
aiua-13642	158	20	expulsion	expulsion	NOUN
aiua-13642	158	21	time	time	NOUN
aiua-13642	158	22	making	make	VERB
aiua-13642	158	23	it	it	PRON
aiua-13642	158	24	a	a	DET
aiua-13642	158	25	valued	value	VERB
aiua-13642	158	26	drug	drug	NOUN
aiua-13642	158	27	than	than	ADP
aiua-13642	158	28	tadalafil	tadalafil	PROPN
aiua-13642	158	29	as	as	ADP
aiua-13642	158	30	a	a	DET
aiua-13642	158	31	met	meet	VERB
aiua-13642	158	32	despite	despite	SCONJ
aiua-13642	158	33	the	the	DET
aiua-13642	158	34	fact	fact	NOUN
aiua-13642	158	35	that	that	SCONJ
aiua-13642	158	36	no	no	DET
aiua-13642	158	37	significant	significant	ADJ
aiua-13642	158	38	differences	difference	NOUN
aiua-13642	158	39	were	be	AUX
aiua-13642	158	40	observed	observe	VERB
aiua-13642	158	41	.	.	PUNCT
aiua-13642	159	1	however	however	ADV
aiua-13642	159	2	,	,	PUNCT
aiua-13642	159	3	assessment	assessment	NOUN
aiua-13642	159	4	of	of	ADP
aiua-13642	159	5	adverse	adverse	ADJ
aiua-13642	159	6	effects	effect	NOUN
aiua-13642	159	7	while	while	SCONJ
aiua-13642	159	8	giving	give	VERB
aiua-13642	159	9	the	the	DET
aiua-13642	159	10	patients	patient	NOUN
aiua-13642	159	11	silodosin	silodosin	VERB
aiua-13642	159	12	should	should	AUX
aiua-13642	159	13	be	be	AUX
aiua-13642	159	14	taken	take	VERB
aiua-13642	159	15	in	in	ADP
aiua-13642	159	16	account	account	NOUN
aiua-13642	159	17	as	as	ADP
aiua-13642	159	18	,	,	PUNCT
aiua-13642	159	19	especially	especially	ADV
aiua-13642	159	20	,	,	PUNCT
aiua-13642	159	21	orthostatic	orthostatic	ADJ
aiua-13642	159	22	hypotension	hypotension	NOUN
aiua-13642	159	23	and	and	CCONJ
aiua-13642	159	24	abnormal	abnormal	ADJ
aiua-13642	159	25	ejaculation	ejaculation	NOUN
aiua-13642	159	26	.	.	PUNCT
aiua-13642	160	1	further	further	ADJ
aiua-13642	160	2	high	high	ADJ
aiua-13642	160	3	-	-	PUNCT
aiua-13642	160	4	quality	quality	NOUN
aiua-13642	160	5	rcts	rct	NOUN
aiua-13642	160	6	with	with	ADP
aiua-13642	160	7	larger	large	ADJ
aiua-13642	160	8	sample	sample	NOUN
aiua-13642	160	9	sizes	size	NOUN
aiua-13642	160	10	and	and	CCONJ
aiua-13642	160	11	longer	long	ADV
aiua-13642	160	12	follow	follow	VERB
aiua-13642	160	13	-	-	PUNCT
aiua-13642	160	14	up	up	ADP
aiua-13642	160	15	periods	period	NOUN
aiua-13642	160	16	are	be	AUX
aiua-13642	160	17	needed	need	VERB
aiua-13642	160	18	to	to	PART
aiua-13642	160	19	further	far	ADV
aiua-13642	160	20	support	support	VERB
aiua-13642	160	21	our	our	PRON
aiua-13642	160	22	results	result	NOUN
aiua-13642	160	23	.	.	PUNCT
aiua-13642	161	1	references	reference	NOUN
aiua-13642	161	2	1	1	NUM
aiua-13642	161	3	.	.	PUNCT
aiua-13642	162	1	qian	qian	PROPN
aiua-13642	162	2	x	x	PROPN
aiua-13642	162	3	,	,	PUNCT
aiua-13642	162	4	wan	wan	PROPN
aiua-13642	162	5	j	j	PROPN
aiua-13642	162	6	,	,	PUNCT
aiua-13642	162	7	xu	xu	PROPN
aiua-13642	162	8	j	j	PROPN
aiua-13642	162	9	,	,	PUNCT
aiua-13642	162	10	et	et	PROPN
aiua-13642	162	11	al	al	PROPN
aiua-13642	162	12	.	.	PROPN
aiua-13642	163	1	epidemiological	epidemiological	ADJ
aiua-13642	163	2	trends	trend	NOUN
aiua-13642	163	3	of	of	ADP
aiua-13642	163	4	urolithiasis	urolithiasis	NOUN
aiua-13642	163	5	at	at	ADP
aiua-13642	163	6	the	the	DET
aiua-13642	163	7	global	global	ADJ
aiua-13642	163	8	,	,	PUNCT
aiua-13642	163	9	regional	regional	ADJ
aiua-13642	163	10	,	,	PUNCT
aiua-13642	163	11	and	and	CCONJ
aiua-13642	163	12	national	national	ADJ
aiua-13642	163	13	levels	level	NOUN
aiua-13642	163	14	:	:	PUNCT
aiua-13642	163	15	a	a	DET
aiua-13642	163	16	population	population	NOUN
aiua-13642	163	17	-	-	PUNCT
aiua-13642	163	18	based	base	VERB
aiua-13642	163	19	study	study	NOUN
aiua-13642	163	20	.	.	PUNCT
aiua-13642	164	1	int	int	PROPN
aiua-13642	165	1	j	j	PROPN
aiua-13642	165	2	clin	clin	PROPN
aiua-13642	165	3	pract	pract	PROPN
aiua-13642	165	4	.	.	PUNCT
aiua-13642	166	1	2022	2022	NUM
aiua-13642	166	2	;	;	PUNCT
aiua-13642	166	3	2022:6807203	2022:6807203	NUM
aiua-13642	166	4	.	.	NOUN
aiua-13642	167	1	2	2	NUM
aiua-13642	167	2	.	.	X
aiua-13642	167	3	stamatelou	stamatelou	PROPN
aiua-13642	167	4	k	k	PROPN
aiua-13642	167	5	,	,	PUNCT
aiua-13642	167	6	goldfarb	goldfarb	PROPN
aiua-13642	167	7	ds	ds	PROPN
aiua-13642	167	8	.	.	PROPN
aiua-13642	167	9	epidemiology	epidemiology	NOUN
aiua-13642	167	10	of	of	ADP
aiua-13642	167	11	kidney	kidney	NOUN
aiua-13642	167	12	stones	stone	NOUN
aiua-13642	167	13	.	.	PUNCT
aiua-13642	168	1	healthcare	healthcare	PROPN
aiua-13642	168	2	2023	2023	NUM
aiua-13642	168	3	;	;	PUNCT
aiua-13642	168	4	11:424	11:424	NUM
aiua-13642	168	5	3	3	NUM
aiua-13642	168	6	.	.	PUNCT
aiua-13642	169	1	osther	osther	ADJ
aiua-13642	169	2	pjs	pjs	NOUN
aiua-13642	169	3	.	.	PUNCT
aiua-13642	170	1	epidemiology	epidemiology	NOUN
aiua-13642	170	2	of	of	ADP
aiua-13642	170	3	kidney	kidney	NOUN
aiua-13642	170	4	stones	stone	NOUN
aiua-13642	170	5	in	in	ADP
aiua-13642	170	6	the	the	DET
aiua-13642	170	7	european	european	PROPN
aiua-13642	170	8	union	union	PROPN
aiua-13642	170	9	.	.	PUNCT
aiua-13642	171	1	in	in	ADP
aiua-13642	171	2	:	:	PUNCT
aiua-13642	171	3	talati	talati	PROPN
aiua-13642	171	4	j.	j.	PROPN
aiua-13642	171	5	tiselius	tiselius	PROPN
aiua-13642	171	6	hg	hg	PROPN
aiua-13642	171	7	,	,	PUNCT
aiua-13642	171	8	albala	albala	PROPN
aiua-13642	171	9	d	d	NOUN
aiua-13642	171	10	,	,	PUNCT
aiua-13642	171	11	ye	ye	PROPN
aiua-13642	171	12	z.	z.	PROPN
aiua-13642	171	13	(	(	PUNCT
aiua-13642	171	14	eds	eds	PROPN
aiua-13642	171	15	)	)	PUNCT
aiua-13642	172	1	urolithiasis	urolithiasis	NOUN
aiua-13642	172	2	.	.	PUNCT
aiua-13642	173	1	springer	springer	PROPN
aiua-13642	173	2	,	,	PUNCT
aiua-13642	173	3	london	london	PROPN
aiua-13642	173	4	2012	2012	NUM
aiua-13642	173	5	.	.	PUNCT
aiua-13642	174	1	archivio	archivio	NOUN
aiua-13642	174	2	italiano	italiano	PROPN
aiua-13642	174	3	di	di	PROPN
aiua-13642	174	4	urologia	urologia	PROPN
aiua-13642	174	5	e	e	PROPN
aiua-13642	174	6	andrologia	andrologia	NOUN
aiua-13642	174	7	2025	2025	NUM
aiua-13642	174	8	;	;	PUNCT
aiua-13642	174	9	97(2):13642	97(2):13642	NUM
aiua-13642	174	10	m.	m.	NOUN
aiua-13642	174	11	alsaid	alsaid	PROPN
aiua-13642	174	12	saad	saad	PROPN
aiua-13642	174	13	abdalaziz	abdalaziz	PROPN
aiua-13642	174	14	,	,	PUNCT
aiua-13642	174	15	y.	y.	PROPN
aiua-13642	174	16	ahmad	ahmad	PROPN
aiua-13642	174	17	hanafi	hanafi	PROPN
aiua-13642	174	18	,	,	PUNCT
aiua-13642	174	19	b.	b.	PROPN
aiua-13642	174	20	mohamed	mohamed	PROPN
aiua-13642	174	21	hamed	hamed	PROPN
aiua-13642	174	22	,	,	PUNCT
aiua-13642	174	23	et	et	PROPN
aiua-13642	174	24	al	al	PROPN
aiua-13642	174	25	.	.	PROPN
aiua-13642	174	26	8	8	NUM
aiua-13642	174	27	4	4	NUM
aiua-13642	174	28	.	.	PUNCT
aiua-13642	174	29	thakore	thakore	PROPN
aiua-13642	174	30	p	p	X
aiua-13642	174	31	,	,	PUNCT
aiua-13642	174	32	liang	liang	PROPN
aiua-13642	174	33	th	th	PROPN
aiua-13642	174	34	.	.	PUNCT
aiua-13642	175	1	urolithiasis	urolithiasis	NOUN
aiua-13642	175	2	.	.	PUNCT
aiua-13642	176	1	[	[	X
aiua-13642	176	2	updated	update	VERB
aiua-13642	176	3	2023	2023	NUM
aiua-13642	176	4	jun	jun	PROPN
aiua-13642	176	5	5	5	NUM
aiua-13642	176	6	]	]	PUNCT
aiua-13642	176	7	.	.	PUNCT
aiua-13642	177	1	in	in	ADP
aiua-13642	177	2	:	:	PUNCT
aiua-13642	177	3	statpearls	statpearl	NOUN
aiua-13642	178	1	[	[	X
aiua-13642	178	2	internet	internet	NOUN
aiua-13642	178	3	]	]	PUNCT
aiua-13642	178	4	.	.	PUNCT
aiua-13642	179	1	treasure	treasure	NOUN
aiua-13642	179	2	island	island	NOUN
aiua-13642	179	3	(	(	PUNCT
aiua-13642	179	4	fl	fl	PROPN
aiua-13642	179	5	):	):	PUNCT
aiua-13642	179	6	statpearls	statpearl	NOUN
aiua-13642	179	7	publishing	publishing	NOUN
aiua-13642	179	8	;	;	PUNCT
aiua-13642	179	9	2025	2025	NUM
aiua-13642	179	10	jan-	jan-	NOUN
aiua-13642	179	11	.	.	PUNCT
aiua-13642	180	1	available	available	ADJ
aiua-13642	180	2	from	from	ADP
aiua-13642	180	3	:	:	PUNCT
aiua-13642	180	4	https://www.ncbi.nlm.nih.gov/books/nbk559101/	https://www.ncbi.nlm.nih.gov/books/nbk559101/	PROPN
aiua-13642	180	5	5	5	NUM
aiua-13642	180	6	.	.	PUNCT
aiua-13642	180	7	bos	bos	PROPN
aiua-13642	180	8	d	d	PROPN
aiua-13642	180	9	,	,	PUNCT
aiua-13642	180	10	kapoor	kapoor	PROPN
aiua-13642	180	11	a.	a.	NOUN
aiua-13642	180	12	update	update	NOUN
aiua-13642	180	13	on	on	ADP
aiua-13642	180	14	medical	medical	ADJ
aiua-13642	180	15	expulsive	expulsive	NOUN
aiua-13642	180	16	therapy	therapy	NOUN
aiua-13642	180	17	for	for	ADP
aiua-13642	180	18	distal	distal	ADJ
aiua-13642	180	19	ureteral	ureteral	ADJ
aiua-13642	180	20	stones	stone	NOUN
aiua-13642	180	21	:	:	PUNCT
aiua-13642	180	22	beyond	beyond	ADP
aiua-13642	180	23	alpha	alpha	NOUN
aiua-13642	180	24	-	-	PUNCT
aiua-13642	180	25	blockers	blocker	NOUN
aiua-13642	180	26	.	.	PUNCT
aiua-13642	181	1	can	can	AUX
aiua-13642	181	2	urol	urol	VERB
aiua-13642	181	3	assoc	assoc	PROPN
aiua-13642	181	4	j.	j.	PROPN
aiua-13642	181	5	2014	2014	NUM
aiua-13642	181	6	;	;	PUNCT
aiua-13642	181	7	8:442	8:442	NUM
aiua-13642	181	8	-	-	SYM
aiua-13642	181	9	5	5	NUM
aiua-13642	181	10	.	.	NOUN
aiua-13642	181	11	6	6	NUM
aiua-13642	181	12	.	.	X
aiua-13642	181	13	voznesensky	voznesensky	ADV
aiua-13642	182	1	i	i	PRON
aiua-13642	182	2	,	,	PUNCT
aiua-13642	182	3	shaw	shaw	PROPN
aiua-13642	182	4	e	e	PROPN
aiua-13642	182	5	,	,	PUNCT
aiua-13642	182	6	delay	delay	NOUN
aiua-13642	182	7	kj	kj	PROPN
aiua-13642	182	8	,	,	PUNCT
aiua-13642	182	9	et	et	PROPN
aiua-13642	182	10	al	al	PROPN
aiua-13642	182	11	.	.	PUNCT
aiua-13642	183	1	benign	benign	ADJ
aiua-13642	183	2	prostatic	prostatic	ADJ
aiua-13642	183	3	hyperplasia	hyperplasia	NOUN
aiua-13642	183	4	treatment	treatment	NOUN
aiua-13642	183	5	options	option	NOUN
aiua-13642	183	6	and	and	CCONJ
aiua-13642	183	7	their	their	PRON
aiua-13642	183	8	effects	effect	NOUN
aiua-13642	183	9	on	on	ADP
aiua-13642	183	10	sexual	sexual	ADJ
aiua-13642	183	11	function	function	NOUN
aiua-13642	183	12	.	.	PUNCT
aiua-13642	184	1	sexual	sexual	ADJ
aiua-13642	184	2	medicine	medicine	NOUN
aiua-13642	184	3	reviews	review	NOUN
aiua-13642	184	4	.	.	PUNCT
aiua-13642	185	1	2017	2017	NUM
aiua-13642	185	2	,	,	PUNCT
aiua-13642	185	3	5	5	NUM
aiua-13642	185	4	:	:	SYM
aiua-13642	185	5	87	87	NUM
aiua-13642	185	6	-	-	SYM
aiua-13642	185	7	102	102	NUM
aiua-13642	185	8	.	.	PUNCT
aiua-13642	186	1	7	7	X
aiua-13642	186	2	.	.	X
aiua-13642	187	1	ebrahimpour	ebrahimpour	PRON
aiua-13642	187	2	s	s	PROPN
aiua-13642	187	3	,	,	PUNCT
aiua-13642	187	4	kargar	kargar	NOUN
aiua-13642	187	5	m	m	PROPN
aiua-13642	187	6	,	,	PUNCT
aiua-13642	187	7	balvardi	balvardi	PROPN
aiua-13642	187	8	m	m	PROPN
aiua-13642	187	9	,	,	PUNCT
aiua-13642	187	10	et	et	PROPN
aiua-13642	187	11	al	al	PROPN
aiua-13642	187	12	.	.	PROPN
aiua-13642	188	1	comparing	compare	VERB
aiua-13642	188	2	the	the	DET
aiua-13642	188	3	efficacy	efficacy	NOUN
aiua-13642	188	4	and	and	CCONJ
aiua-13642	188	5	safety	safety	NOUN
aiua-13642	188	6	of	of	ADP
aiua-13642	188	7	monotherapy	monotherapy	NOUN
aiua-13642	188	8	and	and	CCONJ
aiua-13642	188	9	combination	combination	NOUN
aiua-13642	188	10	therapy	therapy	NOUN
aiua-13642	188	11	with	with	ADP
aiua-13642	188	12	tadalafil	tadalafil	PROPN
aiua-13642	188	13	,	,	PUNCT
aiua-13642	188	14	tamsulosin	tamsulosin	NOUN
aiua-13642	188	15	,	,	PUNCT
aiua-13642	188	16	and	and	CCONJ
aiua-13642	188	17	silodosin	silodosin	VERB
aiua-13642	188	18	for	for	ADP
aiua-13642	188	19	distal	distal	ADJ
aiua-13642	188	20	ureteral	ureteral	ADJ
aiua-13642	188	21	stones	stone	NOUN
aiua-13642	188	22	:	:	PUNCT
aiua-13642	188	23	a	a	DET
aiua-13642	188	24	systematic	systematic	ADJ
aiua-13642	188	25	review	review	NOUN
aiua-13642	188	26	and	and	CCONJ
aiua-13642	188	27	meta	meta	ADJ
aiua-13642	188	28	-	-	PUNCT
aiua-13642	188	29	analysis	analysis	NOUN
aiua-13642	188	30	,	,	PUNCT
aiua-13642	188	31	asian	asian	ADJ
aiua-13642	188	32	journal	journal	NOUN
aiua-13642	188	33	of	of	ADP
aiua-13642	188	34	urology	urology	NOUN
aiua-13642	188	35	2024	2024	NUM
aiua-13642	188	36	available	available	ADJ
aiua-13642	188	37	from	from	ADP
aiua-13642	188	38	https://doi.org/10.1016/j.ajur.2024.05.003	https://doi.org/10.1016/j.ajur.2024.05.003	PROPN
aiua-13642	188	39	.	.	PROPN
aiua-13642	188	40	8	8	NUM
aiua-13642	188	41	.	.	PUNCT
aiua-13642	189	1	fahmy	fahmy	PROPN
aiua-13642	189	2	g	g	PROPN
aiua-13642	189	3	,	,	PUNCT
aiua-13642	189	4	hess	hess	PROPN
aiua-13642	189	5	j.	j.	PROPN
aiua-13642	189	6	tadalafil	tadalafil	PROPN
aiua-13642	189	7	.	.	PUNCT
aiua-13642	190	1	[	[	X
aiua-13642	190	2	updated	update	VERB
aiua-13642	190	3	2024	2024	NUM
aiua-13642	190	4	mar	mar	PROPN
aiua-13642	190	5	20	20	NUM
aiua-13642	190	6	]	]	PUNCT
aiua-13642	190	7	.	.	PUNCT
aiua-13642	191	1	in	in	ADP
aiua-13642	191	2	:	:	PUNCT
aiua-13642	191	3	statpearls	statpearl	NOUN
aiua-13642	192	1	[	[	X
aiua-13642	192	2	internet	internet	NOUN
aiua-13642	192	3	]	]	PUNCT
aiua-13642	192	4	.	.	PUNCT
aiua-13642	193	1	treasure	treasure	NOUN
aiua-13642	193	2	island	island	NOUN
aiua-13642	193	3	(	(	PUNCT
aiua-13642	193	4	fl	fl	PROPN
aiua-13642	193	5	):	):	PUNCT
aiua-13642	193	6	statpearls	statpearl	NOUN
aiua-13642	193	7	publishing	publishing	NOUN
aiua-13642	193	8	;	;	PUNCT
aiua-13642	193	9	2025	2025	NUM
aiua-13642	193	10	jan-	jan-	NOUN
aiua-13642	193	11	.	.	PUNCT
aiua-13642	194	1	available	available	ADJ
aiua-13642	194	2	from	from	ADP
aiua-13642	194	3	:	:	PUNCT
aiua-13642	194	4	https://www.ncbi.nlm.nih.gov/books/	https://www.ncbi.nlm.nih.gov/books/	PROPN
aiua-13642	194	5	nbk603743/	nbk603743/	PROPN
aiua-13642	194	6	9	9	NUM
aiua-13642	194	7	.	.	PUNCT
aiua-13642	195	1	kc	kc	PROPN
aiua-13642	195	2	hb	hb	PROPN
aiua-13642	195	3	,	,	PUNCT
aiua-13642	195	4	shrestha	shrestha	PROPN
aiua-13642	195	5	a	a	X
aiua-13642	195	6	,	,	PUNCT
aiua-13642	195	7	acharya	acharya	NOUN
aiua-13642	195	8	gb	gb	PROPN
aiua-13642	195	9	,	,	PUNCT
aiua-13642	195	10	et	et	PROPN
aiua-13642	195	11	al	al	PROPN
aiua-13642	195	12	.	.	PROPN
aiua-13642	195	13	tamsulosin	tamsulosin	PROPN
aiua-13642	195	14	versus	versus	ADP
aiua-13642	195	15	tadalafil	tadalafil	NOUN
aiua-13642	195	16	as	as	ADP
aiua-13642	195	17	a	a	DET
aiua-13642	195	18	medical	medical	ADJ
aiua-13642	195	19	expulsive	expulsive	NOUN
aiua-13642	195	20	therapy	therapy	NOUN
aiua-13642	195	21	for	for	ADP
aiua-13642	195	22	distal	distal	ADJ
aiua-13642	195	23	ureteral	ureteral	ADJ
aiua-13642	195	24	stones	stone	NOUN
aiua-13642	195	25	:	:	PUNCT
aiua-13642	195	26	a	a	DET
aiua-13642	195	27	prospective	prospective	ADJ
aiua-13642	195	28	randomized	randomized	ADJ
aiua-13642	195	29	study	study	NOUN
aiua-13642	195	30	.	.	PUNCT
aiua-13642	196	1	investig	investig	PROPN
aiua-13642	196	2	clin	clin	PROPN
aiua-13642	196	3	urol	urol	PROPN
aiua-13642	196	4	.	.	PROPN
aiua-13642	196	5	2016	2016	NUM
aiua-13642	196	6	;	;	PUNCT
aiua-13642	196	7	57:351	57:351	NUM
aiua-13642	196	8	-	-	SYM
aiua-13642	196	9	6	6	NUM
aiua-13642	196	10	.	.	NOUN
aiua-13642	196	11	10	10	NUM
aiua-13642	196	12	.	.	PUNCT
aiua-13642	197	1	liu	liu	PROPN
aiua-13642	197	2	z	z	PROPN
aiua-13642	197	3	,	,	PUNCT
aiua-13642	197	4	su	su	PROPN
aiua-13642	197	5	j	j	PROPN
aiua-13642	197	6	,	,	PUNCT
aiua-13642	197	7	yuan	yuan	PROPN
aiua-13642	197	8	d	d	PROPN
aiua-13642	197	9	,	,	PUNCT
aiua-13642	197	10	et	et	PROPN
aiua-13642	197	11	al	al	PROPN
aiua-13642	197	12	.	.	PUNCT
aiua-13642	197	13	original	original	ADJ
aiua-13642	197	14	article	article	NOUN
aiua-13642	197	15	efficacy	efficacy	NOUN
aiua-13642	197	16	and	and	CCONJ
aiua-13642	197	17	safety	safety	NOUN
aiua-13642	197	18	of	of	ADP
aiua-13642	197	19	pde5	pde5	NOUN
aiua-13642	197	20	-	-	PUNCT
aiua-13642	197	21	is	be	AUX
aiua-13642	197	22	and	and	CCONJ
aiua-13642	197	23	α-1	α-1	NOUN
aiua-13642	197	24	blockers	blocker	NOUN
aiua-13642	197	25	for	for	ADP
aiua-13642	197	26	treating	treat	VERB
aiua-13642	197	27	distal	distal	ADJ
aiua-13642	197	28	ureteral	ureteral	ADJ
aiua-13642	197	29	calculi	calculi	NOUN
aiua-13642	197	30	:	:	PUNCT
aiua-13642	197	31	a	a	DET
aiua-13642	197	32	mixed	mixed	ADJ
aiua-13642	197	33	treatment	treatment	NOUN
aiua-13642	197	34	comparison	comparison	NOUN
aiua-13642	197	35	network	network	NOUN
aiua-13642	197	36	meta	meta	NOUN
aiua-13642	197	37	-	-	PUNCT
aiua-13642	197	38	analysis	analysis	NOUN
aiua-13642	197	39	of	of	ADP
aiua-13642	197	40	randomized	randomized	ADJ
aiua-13642	197	41	controlled	control	VERB
aiua-13642	197	42	clinical	clinical	ADJ
aiua-13642	197	43	trials	trial	NOUN
aiua-13642	198	1	[	[	X
aiua-13642	198	2	internet	internet	NOUN
aiua-13642	198	3	]	]	PUNCT
aiua-13642	198	4	.	.	PUNCT
aiua-13642	199	1	int	int	PROPN
aiua-13642	200	1	j	j	PROPN
aiua-13642	200	2	clin	clin	PROPN
aiua-13642	200	3	exp	exp	PROPN
aiua-13642	200	4	med	med	PROPN
aiua-13642	200	5	.	.	PROPN
aiua-13642	200	6	2019	2019	NUM
aiua-13642	200	7	;	;	PUNCT
aiua-13642	201	1	12	12	NUM
aiua-13642	201	2	available	available	ADJ
aiua-13642	201	3	from	from	ADP
aiua-13642	201	4	:	:	PUNCT
aiua-13642	201	5	www.ijcem.com/	www.ijcem.com/	NOUN
aiua-13642	201	6	11	11	NUM
aiua-13642	201	7	.	.	PUNCT
aiua-13642	202	1	sakhaee	sakhaee	VERB
aiua-13642	202	2	k	k	PROPN
aiua-13642	202	3	,	,	PUNCT
aiua-13642	202	4	maalouf	maalouf	PROPN
aiua-13642	202	5	nm	nm	VERB
aiua-13642	202	6	,	,	PUNCT
aiua-13642	202	7	sinnott	sinnott	PROPN
aiua-13642	202	8	b.	b.	PROPN
aiua-13642	202	9	kidney	kidney	PROPN
aiua-13642	202	10	stones	stone	NOUN
aiua-13642	202	11	2012	2012	NUM
aiua-13642	202	12	:	:	PUNCT
aiua-13642	202	13	pathogenesis	pathogenesis	NOUN
aiua-13642	202	14	,	,	PUNCT
aiua-13642	202	15	diagnosis	diagnosis	NOUN
aiua-13642	202	16	,	,	PUNCT
aiua-13642	202	17	and	and	CCONJ
aiua-13642	202	18	management	management	NOUN
aiua-13642	202	19	.	.	PUNCT
aiua-13642	203	1	j	j	PROPN
aiua-13642	203	2	clin	clin	PROPN
aiua-13642	203	3	endocrinol	endocrinol	PROPN
aiua-13642	203	4	metab	metab	NOUN
aiua-13642	203	5	.	.	PUNCT
aiua-13642	204	1	2012	2012	NUM
aiua-13642	204	2	;	;	PUNCT
aiua-13642	204	3	97:1847	97:1847	X
aiua-13642	204	4	-	-	SYM
aiua-13642	204	5	60	60	NUM
aiua-13642	204	6	.	.	PUNCT
aiua-13642	205	1	12	12	NUM
aiua-13642	205	2	.	.	PUNCT
aiua-13642	205	3	page	page	NOUN
aiua-13642	205	4	mj	mj	PROPN
aiua-13642	205	5	,	,	PUNCT
aiua-13642	205	6	mckenzie	mckenzie	PROPN
aiua-13642	205	7	je	je	PROPN
aiua-13642	205	8	,	,	PUNCT
aiua-13642	205	9	bossuyt	bossuyt	NOUN
aiua-13642	205	10	pm	pm	NOUN
aiua-13642	205	11	,	,	PUNCT
aiua-13642	205	12	et	et	PROPN
aiua-13642	205	13	al	al	PROPN
aiua-13642	205	14	.	.	PUNCT
aiua-13642	206	1	the	the	DET
aiua-13642	206	2	prisma	prisma	PROPN
aiua-13642	206	3	2020	2020	NUM
aiua-13642	206	4	statement	statement	NOUN
aiua-13642	206	5	:	:	PUNCT
aiua-13642	206	6	an	an	DET
aiua-13642	206	7	updated	update	VERB
aiua-13642	206	8	guideline	guideline	NOUN
aiua-13642	206	9	for	for	ADP
aiua-13642	206	10	reporting	report	VERB
aiua-13642	206	11	systematic	systematic	ADJ
aiua-13642	206	12	reviews	review	NOUN
aiua-13642	206	13	.	.	PUNCT
aiua-13642	207	1	bmj	bmj	PROPN
aiua-13642	207	2	2021	2021	NUM
aiua-13642	207	3	;	;	PUNCT
aiua-13642	207	4	372	372	NUM
aiua-13642	207	5	:	:	PUNCT
aiua-13642	207	6	n71	n71	NOUN
aiua-13642	207	7	.	.	PUNCT
aiua-13642	208	1	13	13	NUM
aiua-13642	208	2	.	.	PUNCT
aiua-13642	209	1	higgins	higgins	PROPN
aiua-13642	209	2	jpt	jpt	PROPN
aiua-13642	209	3	,	,	PUNCT
aiua-13642	209	4	thomas	thomas	PROPN
aiua-13642	209	5	j	j	PROPN
aiua-13642	209	6	,	,	PUNCT
aiua-13642	209	7	chandler	chandler	PROPN
aiua-13642	209	8	j	j	PROPN
aiua-13642	209	9	,	,	PUNCT
aiua-13642	209	10	et	et	PROPN
aiua-13642	209	11	al	al	PROPN
aiua-13642	209	12	.	.	PROPN
aiua-13642	209	13	cochrane	cochrane	PROPN
aiua-13642	209	14	handbook	handbook	NOUN
aiua-13642	209	15	for	for	ADP
aiua-13642	209	16	systematic	systematic	ADJ
aiua-13642	209	17	reviews	review	NOUN
aiua-13642	209	18	of	of	ADP
aiua-13642	209	19	interventions	intervention	NOUN
aiua-13642	209	20	version	version	NOUN
aiua-13642	209	21	6.5	6.5	NUM
aiua-13642	209	22	(	(	PUNCT
aiua-13642	209	23	updated	update	VERB
aiua-13642	209	24	august	august	PROPN
aiua-13642	209	25	2024	2024	NUM
aiua-13642	209	26	)	)	PUNCT
aiua-13642	209	27	.	.	PUNCT
aiua-13642	210	1	cochrane	cochrane	NOUN
aiua-13642	210	2	,	,	PUNCT
aiua-13642	210	3	2024	2024	NUM
aiua-13642	210	4	.	.	PUNCT
aiua-13642	210	5	available	available	ADJ
aiua-13642	210	6	from	from	ADP
aiua-13642	210	7	www.training.cochrane.org/	www.training.cochrane.org/	PROPN
aiua-13642	210	8	handbook	handbook	NOUN
aiua-13642	210	9	.	.	PUNCT
aiua-13642	211	1	14	14	NUM
aiua-13642	211	2	.	.	X
aiua-13642	211	3	ouzzani	ouzzani	PROPN
aiua-13642	211	4	m	m	PROPN
aiua-13642	211	5	,	,	PUNCT
aiua-13642	211	6	hammady	hammady	PROPN
aiua-13642	211	7	h	h	NOUN
aiua-13642	211	8	,	,	PUNCT
aiua-13642	211	9	fedorowicz	fedorowicz	PROPN
aiua-13642	211	10	z	z	NOUN
aiua-13642	211	11	,	,	PUNCT
aiua-13642	211	12	elmagarmid	elmagarmid	PROPN
aiua-13642	211	13	a.	a.	PROPN
aiua-13642	211	14	rayyan	rayyan	PROPN
aiua-13642	211	15	-	-	PUNCT
aiua-13642	211	16	a	a	DET
aiua-13642	211	17	web	web	NOUN
aiua-13642	211	18	and	and	CCONJ
aiua-13642	211	19	mobile	mobile	ADJ
aiua-13642	211	20	app	app	NOUN
aiua-13642	211	21	for	for	ADP
aiua-13642	211	22	systematic	systematic	ADJ
aiua-13642	211	23	reviews	review	NOUN
aiua-13642	211	24	.	.	PUNCT
aiua-13642	212	1	syst	syst	PROPN
aiua-13642	212	2	rev	rev	PROPN
aiua-13642	212	3	.	.	PROPN
aiua-13642	212	4	2016	2016	NUM
aiua-13642	212	5	;	;	PUNCT
aiua-13642	212	6	5:210	5:210	NUM
aiua-13642	212	7	.	.	PUNCT
aiua-13642	213	1	15	15	NUM
aiua-13642	213	2	.	.	PUNCT
aiua-13642	214	1	sterne	sterne	PROPN
aiua-13642	214	2	jac	jac	PROPN
aiua-13642	214	3	,	,	PUNCT
aiua-13642	214	4	savovic	savovic	PROPN
aiua-13642	214	5	j	j	PROPN
aiua-13642	214	6	,	,	PUNCT
aiua-13642	214	7	page	page	NOUN
aiua-13642	214	8	mj	mj	PROPN
aiua-13642	214	9	,	,	PUNCT
aiua-13642	214	10	et	et	PROPN
aiua-13642	214	11	al	al	PROPN
aiua-13642	214	12	.	.	PROPN
aiua-13642	214	13	rob	rob	PROPN
aiua-13642	215	1	2	2	NUM
aiua-13642	215	2	:	:	PUNCT
aiua-13642	215	3	a	a	DET
aiua-13642	215	4	revised	revise	VERB
aiua-13642	215	5	tool	tool	NOUN
aiua-13642	215	6	for	for	ADP
aiua-13642	215	7	assessing	assess	VERB
aiua-13642	215	8	risk	risk	NOUN
aiua-13642	215	9	of	of	ADP
aiua-13642	215	10	bias	bias	NOUN
aiua-13642	215	11	in	in	ADP
aiua-13642	215	12	randomised	randomised	ADJ
aiua-13642	215	13	trials	trial	NOUN
aiua-13642	215	14	.	.	PUNCT
aiua-13642	216	1	bmj	bmj	PROPN
aiua-13642	216	2	2019	2019	NUM
aiua-13642	216	3	;	;	PUNCT
aiua-13642	216	4	366	366	NUM
aiua-13642	216	5	:	:	PUNCT
aiua-13642	216	6	l4898	l4898	PROPN
aiua-13642	216	7	.	.	PUNCT
aiua-13642	217	1	16	16	NUM
aiua-13642	217	2	.	.	PUNCT
aiua-13642	218	1	https://metaanalysisonline.com/	https://metaanalysisonline.com/	NUM
aiua-13642	218	2	17	17	NUM
aiua-13642	218	3	.	.	PUNCT
aiua-13642	219	1	diab	diab	PROPN
aiua-13642	219	2	t	t	PROPN
aiua-13642	219	3	,	,	PUNCT
aiua-13642	219	4	fathi	fathi	PROPN
aiua-13642	219	5	a	a	PROPN
aiua-13642	219	6	,	,	PUNCT
aiua-13642	219	7	el	el	PROPN
aiua-13642	219	8	-	-	PUNCT
aiua-13642	219	9	dakhakhny	dakhakhny	PROPN
aiua-13642	219	10	as	as	ADP
aiua-13642	219	11	,	,	PUNCT
aiua-13642	219	12	abou	abou	PROPN
aiua-13642	219	13	elezz	elezz	PROPN
aiua-13642	219	14	a.	a.	NOUN
aiua-13642	219	15	efficacy	efficacy	PROPN
aiua-13642	219	16	of	of	ADP
aiua-13642	219	17	silodosin	silodosin	NOUN
aiua-13642	219	18	and	and	CCONJ
aiua-13642	219	19	tadalafil	tadalafil	PROPN
aiua-13642	219	20	monotherapy	monotherapy	NOUN
aiua-13642	219	21	versus	versus	ADP
aiua-13642	219	22	combination	combination	NOUN
aiua-13642	219	23	of	of	ADP
aiua-13642	219	24	both	both	DET
aiua-13642	219	25	drugs	drug	NOUN
aiua-13642	219	26	as	as	SCONJ
aiua-13642	219	27	met	meet	VERB
aiua-13642	219	28	for	for	ADP
aiua-13642	219	29	distal	distal	ADJ
aiua-13642	219	30	ureteric	ureteric	ADJ
aiua-13642	219	31	stones	stone	NOUN
aiua-13642	219	32	:	:	PUNCT
aiua-13642	219	33	a	a	DET
aiua-13642	219	34	prospective	prospective	ADJ
aiua-13642	219	35	,	,	PUNCT
aiua-13642	219	36	double	double	ADJ
aiua-13642	219	37	blinded	blind	VERB
aiua-13642	219	38	,	,	PUNCT
aiua-13642	219	39	randomized	randomize	VERB
aiua-13642	219	40	clinical	clinical	ADJ
aiua-13642	219	41	trial	trial	NOUN
aiua-13642	219	42	.	.	PUNCT
aiua-13642	220	1	arab	arab	PROPN
aiua-13642	220	2	journal	journal	PROPN
aiua-13642	220	3	of	of	ADP
aiua-13642	220	4	urology	urology	NOUN
aiua-13642	220	5	2024	2024	NUM
aiua-13642	220	6	;	;	PUNCT
aiua-13642	220	7	1	1	NUM
aiua-13642	220	8	-	-	SYM
aiua-13642	220	9	7	7	NUM
aiua-13642	220	10	.	.	PUNCT
aiua-13642	220	11	available	available	ADJ
aiua-13642	220	12	from	from	ADP
aiua-13642	220	13	https://doi.org/10.1080/20905998.2024.2403274	https://doi.org/10.1080/20905998.2024.2403274	PROPN
aiua-13642	220	14	.	.	PROPN
aiua-13642	220	15	18	18	NUM
aiua-13642	220	16	.	.	PUNCT
aiua-13642	221	1	ahmed	ahmed	PROPN
aiua-13642	221	2	ao	ao	PROPN
aiua-13642	221	3	,	,	PUNCT
aiua-13642	221	4	elsalhy	elsalhy	PROPN
aiua-13642	221	5	ma	ma	PROPN
aiua-13642	221	6	,	,	PUNCT
aiua-13642	221	7	ahmed	ahmed	PROPN
aiua-13642	221	8	ya	ya	PROPN
aiua-13642	221	9	.	.	PROPN
aiua-13642	221	10	efficacy	efficacy	NOUN
aiua-13642	221	11	and	and	CCONJ
aiua-13642	221	12	safety	safety	NOUN
aiua-13642	221	13	of	of	ADP
aiua-13642	221	14	silodosin	silodosin	NOUN
aiua-13642	221	15	,	,	PUNCT
aiua-13642	221	16	mirabegron	mirabegron	PROPN
aiua-13642	221	17	,	,	PUNCT
aiua-13642	221	18	and	and	CCONJ
aiua-13642	221	19	tadalafil	tadalafil	PROPN
aiua-13642	221	20	as	as	ADP
aiua-13642	221	21	medical	medical	ADJ
aiua-13642	221	22	expulsive	expulsive	NOUN
aiua-13642	221	23	therapy	therapy	NOUN
aiua-13642	221	24	for	for	ADP
aiua-13642	221	25	lower	low	ADJ
aiua-13642	221	26	ureteric	ureteric	ADJ
aiua-13642	221	27	stones	stone	NOUN
aiua-13642	221	28	:	:	PUNCT
aiua-13642	221	29	a	a	DET
aiua-13642	221	30	prospective	prospective	ADJ
aiua-13642	221	31	,	,	PUNCT
aiua-13642	221	32	randomized	randomize	VERB
aiua-13642	221	33	,	,	PUNCT
aiua-13642	221	34	comparative	comparative	ADJ
aiua-13642	221	35	study	study	NOUN
aiua-13642	221	36	.	.	PUNCT
aiua-13642	222	1	al	al	PROPN
aiua-13642	222	2	-	-	PUNCT
aiua-13642	222	3	azhar	azhar	PROPN
aiua-13642	222	4	international	international	PROPN
aiua-13642	222	5	medical	medical	ADJ
aiua-13642	222	6	journal	journal	NOUN
aiua-13642	222	7	.	.	PUNCT
aiua-13642	223	1	2023	2023	NUM
aiua-13642	223	2	;	;	PUNCT
aiua-13642	223	3	4:8	4:8	NUM
aiua-13642	223	4	.	.	NOUN
aiua-13642	223	5	19	19	NUM
aiua-13642	223	6	.	.	PUNCT
aiua-13642	224	1	sharma	sharma	PROPN
aiua-13642	224	2	v	v	PROPN
aiua-13642	224	3	,	,	PUNCT
aiua-13642	224	4	thakur	thakur	PROPN
aiua-13642	224	5	aps	aps	PROPN
aiua-13642	224	6	,	,	PUNCT
aiua-13642	224	7	patel	patel	NOUN
aiua-13642	224	8	p	p	NOUN
aiua-13642	224	9	,	,	PUNCT
aiua-13642	224	10	et	et	PROPN
aiua-13642	224	11	al	al	PROPN
aiua-13642	224	12	.	.	PROPN
aiua-13642	224	13	comparison	comparison	NOUN
aiua-13642	224	14	of	of	ADP
aiua-13642	224	15	synergistic	synergistic	ADJ
aiua-13642	224	16	action	action	NOUN
aiua-13642	224	17	of	of	ADP
aiua-13642	224	18	alpha	alpha	NOUN
aiua-13642	224	19	blockers	blocker	NOUN
aiua-13642	224	20	and	and	CCONJ
aiua-13642	224	21	tadalafil	tadalafil	NOUN
aiua-13642	224	22	in	in	ADP
aiua-13642	224	23	the	the	DET
aiua-13642	224	24	management	management	NOUN
aiua-13642	224	25	of	of	ADP
aiua-13642	224	26	lower	low	ADJ
aiua-13642	224	27	ureteric	ureteric	ADJ
aiua-13642	224	28	stones	stone	NOUN
aiua-13642	224	29	as	as	ADP
aiua-13642	224	30	medical	medical	ADJ
aiua-13642	224	31	expulsive	expulsive	PROPN
aiua-13642	224	32	therapy	therapy	NOUN
aiua-13642	224	33	:	:	PUNCT
aiua-13642	224	34	a	a	DET
aiua-13642	224	35	prospective	prospective	ADJ
aiua-13642	224	36	cohort	cohort	NOUN
aiua-13642	224	37	study	study	NOUN
aiua-13642	224	38	.	.	PUNCT
aiua-13642	225	1	j	j	PROPN
aiua-13642	225	2	clin	clin	PROPN
aiua-13642	225	3	of	of	ADP
aiua-13642	225	4	diagn	diagn	PROPN
aiua-13642	225	5	res	re	NOUN
aiua-13642	225	6	.	.	PUNCT
aiua-13642	225	7	2023	2023	NUM
aiua-13642	225	8	;	;	PUNCT
aiua-13642	225	9	17	17	NUM
aiua-13642	225	10	:	:	PUNCT
aiua-13642	225	11	oc37	oc37	PROPN
aiua-13642	225	12	-	-	PUNCT
aiua-13642	225	13	oc41	oc41	PROPN
aiua-13642	225	14	.	.	PUNCT
aiua-13642	226	1	20	20	NUM
aiua-13642	226	2	.	.	PUNCT
aiua-13642	226	3	abdelaal	abdelaal	PROPN
aiua-13642	226	4	ma	ma	PROPN
aiua-13642	226	5	,	,	PUNCT
aiua-13642	226	6	el	el	PROPN
aiua-13642	226	7	-	-	PUNCT
aiua-13642	226	8	dydamony	dydamony	VERB
aiua-13642	226	9	em	em	PRON
aiua-13642	226	10	.	.	PUNCT
aiua-13642	227	1	comparative	comparative	ADJ
aiua-13642	227	2	study	study	NOUN
aiua-13642	227	3	between	between	ADP
aiua-13642	227	4	tamsulosin	tamsulosin	NOUN
aiua-13642	227	5	,	,	PUNCT
aiua-13642	227	6	silodosin	silodosin	NOUN
aiua-13642	227	7	and	and	CCONJ
aiua-13642	227	8	tadalafil	tadalafil	PROPN
aiua-13642	227	9	as	as	ADP
aiua-13642	227	10	a	a	DET
aiua-13642	227	11	medical	medical	ADJ
aiua-13642	227	12	expulsive	expulsive	NOUN
aiua-13642	227	13	therapy	therapy	NOUN
aiua-13642	227	14	for	for	ADP
aiua-13642	227	15	lower	low	ADJ
aiua-13642	227	16	ureteral	ureteral	ADJ
aiua-13642	227	17	stones	stone	NOUN
aiua-13642	227	18	.	.	PUNCT
aiua-13642	228	1	arch	arch	ADJ
aiua-13642	228	2	ital	ital	PROPN
aiua-13642	228	3	urol	urol	PROPN
aiua-13642	228	4	androl	androl	PROPN
aiua-13642	228	5	.	.	PUNCT
aiua-13642	228	6	2023	2023	NUM
aiua-13642	228	7	;	;	PUNCT
aiua-13642	228	8	95:10849	95:10849	NUM
aiua-13642	228	9	.	.	NOUN
aiua-13642	228	10	21	21	NUM
aiua-13642	228	11	.	.	PUNCT
aiua-13642	229	1	gur	gur	PROPN
aiua-13642	229	2	m	m	PROPN
aiua-13642	229	3	,	,	PUNCT
aiua-13642	229	4	ulu	ulu	PROPN
aiua-13642	229	5	mb	mb	ADP
aiua-13642	229	6	,	,	PUNCT
aiua-13642	229	7	caliskan	caliskan	PROPN
aiua-13642	229	8	st	st	PROPN
aiua-13642	229	9	,	,	PUNCT
aiua-13642	229	10	et	et	PROPN
aiua-13642	229	11	al	al	PROPN
aiua-13642	229	12	.	.	PROPN
aiua-13642	229	13	dexketoprofen	dexketoprofen	PROPN
aiua-13642	229	14	vs.	vs.	ADP
aiua-13642	229	15	tamsulosin	tamsulosin	NOUN
aiua-13642	229	16	vs.	vs.	ADP
aiua-13642	229	17	silodosin	silodosin	NOUN
aiua-13642	229	18	vs.	vs.	ADP
aiua-13642	229	19	tadalafil	tadalafil	PROPN
aiua-13642	229	20	as	as	ADP
aiua-13642	229	21	medical	medical	ADJ
aiua-13642	229	22	expulsive	expulsive	NOUN
aiua-13642	229	23	therapy	therapy	NOUN
aiua-13642	229	24	for	for	ADP
aiua-13642	229	25	distal	distal	ADJ
aiua-13642	229	26	ureteral	ureteral	ADJ
aiua-13642	229	27	stones	stone	NOUN
aiua-13642	229	28	in	in	ADP
aiua-13642	229	29	men	man	NOUN
aiua-13642	229	30	.	.	PUNCT
aiua-13642	230	1	j	j	PROPN
aiua-13642	230	2	coll	coll	PROPN
aiua-13642	230	3	physicians	physicians	PROPN
aiua-13642	230	4	surg	surg	PROPN
aiua-13642	230	5	pak	pak	PROPN
aiua-13642	230	6	2021	2021	NUM
aiua-13642	230	7	;	;	PUNCT
aiua-13642	230	8	31:947	31:947	NUM
aiua-13642	230	9	-	-	SYM
aiua-13642	230	10	952	952	NUM
aiua-13642	230	11	.	.	PUNCT
aiua-13642	231	1	22	22	NUM
aiua-13642	231	2	.	.	PUNCT
aiua-13642	231	3	khereddine	khereddine	PROPN
aiua-13642	231	4	md	md	PROPN
aiua-13642	231	5	,	,	PUNCT
aiua-13642	231	6	tieoule	tieoule	PROPN
aiua-13642	231	7	tm	tm	PROPN
aiua-13642	231	8	,	,	PUNCT
aiua-13642	231	9	aziz	aziz	PROPN
aiua-13642	231	10	k	k	PROPN
aiua-13642	231	11	,	,	PUNCT
aiua-13642	231	12	et	et	PROPN
aiua-13642	231	13	al	al	PROPN
aiua-13642	231	14	.	.	PUNCT
aiua-13642	232	1	medical	medical	ADJ
aiua-13642	232	2	expulsive	expulsive	PROPN
aiua-13642	232	3	therapy	therapy	NOUN
aiua-13642	232	4	(	(	PUNCT
aiua-13642	232	5	met	meet	VERB
aiua-13642	232	6	)	)	PUNCT
aiua-13642	232	7	for	for	ADP
aiua-13642	232	8	large	large	ADJ
aiua-13642	232	9	distal	distal	ADJ
aiua-13642	232	10	ureteral	ureteral	ADJ
aiua-13642	232	11	stones	stone	NOUN
aiua-13642	232	12	:	:	PUNCT
aiua-13642	232	13	a	a	DET
aiua-13642	232	14	prospective	prospective	ADJ
aiua-13642	232	15	study	study	NOUN
aiua-13642	232	16	comparing	compare	VERB
aiua-13642	232	17	three	three	NUM
aiua-13642	232	18	drugs	drug	NOUN
aiua-13642	232	19	.	.	PUNCT
aiua-13642	233	1	open	open	ADJ
aiua-13642	233	2	journal	journal	NOUN
aiua-13642	233	3	of	of	ADP
aiua-13642	233	4	urology	urology	NOUN
aiua-13642	233	5	.	.	PUNCT
aiua-13642	234	1	2020	2020	NUM
aiua-13642	234	2	;	;	PUNCT
aiua-13642	234	3	10:152	10:152	NUM
aiua-13642	234	4	-	-	SYM
aiua-13642	234	5	157	157	NUM
aiua-13642	234	6	.	.	PUNCT
aiua-13642	235	1	23	23	NUM
aiua-13642	235	2	.	.	PUNCT
aiua-13642	236	1	çelik	çelik	PROPN
aiua-13642	236	2	s	s	PROPN
aiua-13642	236	3	,	,	PUNCT
aiua-13642	236	4	akdeniz	akdeniz	NOUN
aiua-13642	236	5	f	f	PROPN
aiua-13642	236	6	,	,	PUNCT
aiua-13642	236	7	afsar	afsar	PROPN
aiua-13642	236	8	yildirim	yildirim	PROPN
aiua-13642	236	9	m	m	PROPN
aiua-13642	236	10	,	,	PUNCT
aiua-13642	236	11	et	et	PROPN
aiua-13642	236	12	al	al	PROPN
aiua-13642	236	13	.	.	PUNCT
aiua-13642	237	1	tadalafil	tadalafil	PROPN
aiua-13642	237	2	versus	versus	ADP
aiua-13642	237	3	alpha	alpha	NOUN
aiua-13642	237	4	blockers	blocker	NOUN
aiua-13642	237	5	(	(	PUNCT
aiua-13642	237	6	alfuzosin	alfuzosin	PROPN
aiua-13642	237	7	,	,	PUNCT
aiua-13642	237	8	doxazosin	doxazosin	NOUN
aiua-13642	237	9	,	,	PUNCT
aiua-13642	237	10	tamsulosin	tamsulosin	NOUN
aiua-13642	237	11	and	and	CCONJ
aiua-13642	237	12	silodosin	silodosin	NOUN
aiua-13642	237	13	)	)	PUNCT
aiua-13642	237	14	as	as	ADP
aiua-13642	237	15	medical	medical	ADJ
aiua-13642	237	16	expulsive	expulsive	NOUN
aiua-13642	237	17	therapy	therapy	NOUN
aiua-13642	237	18	for	for	ADP
aiua-13642	237	19	<	<	X
aiua-13642	237	20	10	10	NUM
aiua-13642	237	21	mm	mm	NOUN
aiua-13642	237	22	distal	distal	ADJ
aiua-13642	237	23	and	and	CCONJ
aiua-13642	237	24	proximal	proximal	ADJ
aiua-13642	237	25	ureteral	ureteral	ADJ
aiua-13642	237	26	stones	stone	NOUN
aiua-13642	237	27	.	.	PUNCT
aiua-13642	238	1	arch	arch	ADJ
aiua-13642	238	2	ital	ital	PROPN
aiua-13642	238	3	urol	urol	PROPN
aiua-13642	238	4	androl	androl	PROPN
aiua-13642	238	5	.	.	PROPN
aiua-13642	238	6	2018	2018	NUM
aiua-13642	238	7	;	;	PUNCT
aiua-13642	238	8	90:117	90:117	NUM
aiua-13642	238	9	-	-	SYM
aiua-13642	238	10	122	122	NUM
aiua-13642	238	11	.	.	PUNCT
aiua-13642	239	1	24	24	NUM
aiua-13642	239	2	.	.	PUNCT
aiua-13642	240	1	kumar	kumar	PROPN
aiua-13642	240	2	s	s	PROPN
aiua-13642	240	3	,	,	PUNCT
aiua-13642	240	4	jayant	jayant	PROPN
aiua-13642	240	5	k	k	PROPN
aiua-13642	240	6	,	,	PUNCT
aiua-13642	240	7	agrawal	agrawal	PROPN
aiua-13642	240	8	mm	mm	PROPN
aiua-13642	240	9	,	,	PUNCT
aiua-13642	240	10	et	et	PROPN
aiua-13642	240	11	al	al	PROPN
aiua-13642	240	12	.	.	PUNCT
aiua-13642	240	13	role	role	NOUN
aiua-13642	240	14	of	of	ADP
aiua-13642	240	15	tamsulosin	tamsulosin	NOUN
aiua-13642	240	16	,	,	PUNCT
aiua-13642	240	17	tadalafil	tadalafil	NOUN
aiua-13642	240	18	,	,	PUNCT
aiua-13642	240	19	and	and	CCONJ
aiua-13642	240	20	silodosin	silodosin	VERB
aiua-13642	240	21	as	as	ADP
aiua-13642	240	22	the	the	DET
aiua-13642	240	23	medical	medical	ADJ
aiua-13642	240	24	expulsive	expulsive	NOUN
aiua-13642	240	25	therapy	therapy	NOUN
aiua-13642	240	26	in	in	ADP
aiua-13642	240	27	lower	low	ADJ
aiua-13642	240	28	ureteric	ureteric	ADJ
aiua-13642	240	29	stone	stone	NOUN
aiua-13642	240	30	:	:	PUNCT
aiua-13642	240	31	a	a	DET
aiua-13642	240	32	randomized	randomized	ADJ
aiua-13642	240	33	trial	trial	NOUN
aiua-13642	240	34	(	(	PUNCT
aiua-13642	240	35	a	a	DET
aiua-13642	240	36	pilot	pilot	NOUN
aiua-13642	240	37	study	study	NOUN
aiua-13642	240	38	)	)	PUNCT
aiua-13642	240	39	.	.	PUNCT
aiua-13642	241	1	urology	urology	NOUN
aiua-13642	241	2	.	.	PUNCT
aiua-13642	242	1	2015	2015	NUM
aiua-13642	242	2	;	;	PUNCT
aiua-13642	242	3	85:59	85:59	NUM
aiua-13642	242	4	-	-	SYM
aiua-13642	242	5	63	63	NUM
aiua-13642	242	6	.	.	PUNCT
aiua-13642	243	1	25	25	NUM
aiua-13642	243	2	.	.	PUNCT
aiua-13642	244	1	shimizu	shimizu	PROPN
aiua-13642	244	2	t	t	PROPN
aiua-13642	244	3	,	,	PUNCT
aiua-13642	244	4	miyashita	miyashita	PROPN
aiua-13642	244	5	i	i	PROPN
aiua-13642	244	6	,	,	PUNCT
aiua-13642	244	7	matsubara	matsubara	PROPN
aiua-13642	244	8	y	y	PROPN
aiua-13642	244	9	,	,	PUNCT
aiua-13642	244	10	et	et	PROPN
aiua-13642	244	11	al	al	PROPN
aiua-13642	244	12	.	.	PUNCT
aiua-13642	245	1	pharmacokinetic	pharmacokinetic	ADJ
aiua-13642	245	2	profile	profile	NOUN
aiua-13642	245	3	of	of	ADP
aiua-13642	245	4	silodosin	silodosin	NOUN
aiua-13642	245	5	in	in	ADP
aiua-13642	245	6	clinical	clinical	ADJ
aiua-13642	245	7	practice	practice	NOUN
aiua-13642	245	8	.	.	PUNCT
aiua-13642	246	1	yakugaku	yakugaku	PROPN
aiua-13642	246	2	zasshi	zasshi	PROPN
aiua-13642	246	3	.	.	PUNCT
aiua-13642	247	1	2006	2006	NUM
aiua-13642	247	2	;	;	PUNCT
aiua-13642	247	3	126:257	126:257	NOUN
aiua-13642	247	4	-	-	SYM
aiua-13642	247	5	63	63	NUM
aiua-13642	247	6	.	.	PUNCT
aiua-13642	248	1	26	26	NUM
aiua-13642	248	2	.	.	PUNCT
aiua-13642	249	1	osman	osman	PROPN
aiua-13642	249	2	ni	ni	PROPN
aiua-13642	249	3	,	,	PUNCT
aiua-13642	249	4	chapple	chapple	PROPN
aiua-13642	249	5	cr	cr	PROPN
aiua-13642	249	6	,	,	PUNCT
aiua-13642	249	7	cruz	cruz	PROPN
aiua-13642	249	8	f	f	PROPN
aiua-13642	249	9	,	,	PUNCT
aiua-13642	250	1	et	et	PROPN
aiua-13642	250	2	al	al	PROPN
aiua-13642	250	3	.	.	PROPN
aiua-13642	250	4	silodosin	silodosin	PROPN
aiua-13642	250	5	:	:	PUNCT
aiua-13642	250	6	a	a	DET
aiua-13642	250	7	new	new	ADJ
aiua-13642	250	8	subtype	subtype	NOUN
aiua-13642	250	9	selective	selective	ADJ
aiua-13642	250	10	alpha-1	alpha-1	NOUN
aiua-13642	250	11	antagonist	antagonist	NOUN
aiua-13642	250	12	for	for	ADP
aiua-13642	250	13	the	the	DET
aiua-13642	250	14	treatment	treatment	NOUN
aiua-13642	250	15	of	of	ADP
aiua-13642	250	16	lower	low	ADJ
aiua-13642	250	17	urinary	urinary	ADJ
aiua-13642	250	18	tract	tract	NOUN
aiua-13642	250	19	symptoms	symptom	NOUN
aiua-13642	250	20	in	in	ADP
aiua-13642	250	21	patients	patient	NOUN
aiua-13642	250	22	with	with	ADP
aiua-13642	250	23	benign	benign	ADJ
aiua-13642	250	24	prostatic	prostatic	ADJ
aiua-13642	250	25	hyperplasia	hyperplasia	NOUN
aiua-13642	250	26	.	.	PUNCT
aiua-13642	251	1	expert	expert	NOUN
aiua-13642	251	2	opin	opin	PROPN
aiua-13642	251	3	pharmacother	pharmacother	NOUN
aiua-13642	251	4	.	.	PUNCT
aiua-13642	252	1	2012	2012	NUM
aiua-13642	252	2	;	;	PUNCT
aiua-13642	252	3	13:2085	13:2085	NUM
aiua-13642	252	4	-	-	SYM
aiua-13642	252	5	96	96	NUM
aiua-13642	252	6	.	.	PUNCT
aiua-13642	253	1	27	27	NUM
aiua-13642	253	2	.	.	PUNCT
aiua-13642	254	1	shimizu	shimizu	PROPN
aiua-13642	254	2	f	f	PROPN
aiua-13642	254	3	,	,	PUNCT
aiua-13642	254	4	taguri	taguri	PROPN
aiua-13642	254	5	m	m	PROPN
aiua-13642	254	6	,	,	PUNCT
aiua-13642	254	7	harada	harada	PROPN
aiua-13642	254	8	y	y	PROPN
aiua-13642	254	9	,	,	PUNCT
aiua-13642	254	10	et	et	PROPN
aiua-13642	254	11	al	al	PROPN
aiua-13642	254	12	.	.	PROPN
aiua-13642	254	13	impact	impact	NOUN
aiua-13642	254	14	of	of	ADP
aiua-13642	254	15	dry	dry	ADJ
aiua-13642	254	16	ejaculation	ejaculation	NOUN
aiua-13642	254	17	caused	cause	VERB
aiua-13642	254	18	by	by	ADP
aiua-13642	254	19	highly	highly	ADV
aiua-13642	254	20	selective	selective	ADJ
aiua-13642	254	21	alpha1a	alpha1a	NOUN
aiua-13642	254	22	-	-	PUNCT
aiua-13642	254	23	blocker	blocker	NOUN
aiua-13642	254	24	:	:	PUNCT
aiua-13642	254	25	randomized	randomize	VERB
aiua-13642	254	26	,	,	PUNCT
aiua-13642	254	27	doubleblind	doubleblind	NOUN
aiua-13642	254	28	,	,	PUNCT
aiua-13642	254	29	placebo	placebo	NOUN
aiua-13642	254	30	-	-	PUNCT
aiua-13642	254	31	controlled	control	VERB
aiua-13642	254	32	crossover	crossover	NOUN
aiua-13642	254	33	pilot	pilot	NOUN
aiua-13642	254	34	study	study	NOUN
aiua-13642	254	35	in	in	ADP
aiua-13642	254	36	healthy	healthy	ADJ
aiua-13642	254	37	volunteer	volunteer	NOUN
aiua-13642	254	38	men	man	NOUN
aiua-13642	254	39	.	.	PUNCT
aiua-13642	255	1	j	j	PROPN
aiua-13642	255	2	sex	sex	PROPN
aiua-13642	255	3	med	med	PROPN
aiua-13642	255	4	.	.	PUNCT
aiua-13642	255	5	2010	2010	NUM
aiua-13642	255	6	;	;	PUNCT
aiua-13642	255	7	7:1277	7:1277	NUM
aiua-13642	255	8	-	-	SYM
aiua-13642	255	9	83	83	NUM
aiua-13642	255	10	.	.	PUNCT
aiua-13642	256	1	28	28	NUM
aiua-13642	256	2	.	.	PUNCT
aiua-13642	257	1	huang	huang	PROPN
aiua-13642	257	2	w	w	PROPN
aiua-13642	257	3	,	,	PUNCT
aiua-13642	257	4	xue	xue	PROPN
aiua-13642	257	5	p	p	PROPN
aiua-13642	257	6	,	,	PUNCT
aiua-13642	257	7	xong	xong	PROPN
aiua-13642	257	8	h	h	PROPN
aiua-13642	257	9	,	,	PUNCT
aiua-13642	257	10	zhang	zhang	PROPN
aiua-13642	257	11	y.	y.	PROPN
aiua-13642	257	12	efficacy	efficacy	PROPN
aiua-13642	257	13	and	and	CCONJ
aiua-13642	257	14	safety	safety	NOUN
aiua-13642	257	15	of	of	ADP
aiua-13642	257	16	silodeclarations	silodeclaration	NOUN
aiua-13642	257	17	registration	registration	NOUN
aiua-13642	257	18	:	:	PUNCT
aiua-13642	257	19	study	study	NOUN
aiua-13642	257	20	was	be	AUX
aiua-13642	257	21	registered	register	VERB
aiua-13642	257	22	on	on	ADP
aiua-13642	257	23	prospero	prospero	NOUN
aiua-13642	257	24	carrying	carry	VERB
aiua-13642	257	25	the	the	DET
aiua-13642	257	26	i	i	PROPN
aiua-13642	257	27	d	d	PROPN
aiua-13642	257	28	number	number	NOUN
aiua-13642	257	29	(	(	PUNCT
aiua-13642	257	30	crd42024597302	crd42024597302	NOUN
aiua-13642	257	31	)	)	PUNCT
aiua-13642	257	32	.	.	PUNCT
aiua-13642	258	1	availability	availability	NOUN
aiua-13642	258	2	of	of	ADP
aiua-13642	258	3	data	datum	NOUN
aiua-13642	258	4	and	and	CCONJ
aiua-13642	258	5	material	material	NOUN
aiua-13642	258	6	:	:	PUNCT
aiua-13642	258	7	the	the	DET
aiua-13642	258	8	datasets	dataset	NOUN
aiua-13642	258	9	used	use	VERB
aiua-13642	258	10	and/or	and/or	CCONJ
aiua-13642	258	11	analyzed	analyze	VERB
aiua-13642	258	12	during	during	ADP
aiua-13642	258	13	the	the	DET
aiua-13642	258	14	current	current	ADJ
aiua-13642	258	15	study	study	NOUN
aiua-13642	258	16	are	be	AUX
aiua-13642	258	17	available	available	ADJ
aiua-13642	258	18	upon	upon	SCONJ
aiua-13642	258	19	reasonable	reasonable	ADJ
aiua-13642	258	20	request	request	NOUN
aiua-13642	258	21	from	from	ADP
aiua-13642	258	22	the	the	DET
aiua-13642	258	23	corresponding	corresponding	ADJ
aiua-13642	258	24	author	author	NOUN
aiua-13642	258	25	(	(	PUNCT
aiua-13642	258	26	yousif	yousif	PROPN
aiua-13642	258	27	a.hanafi	a.hanafi	NOUN
aiua-13642	258	28	)	)	PUNCT
aiua-13642	258	29	.	.	PUNCT
aiua-13642	259	1	competing	compete	VERB
aiua-13642	259	2	interests	interest	NOUN
aiua-13642	259	3	:	:	PUNCT
aiua-13642	259	4	the	the	DET
aiua-13642	259	5	authors	author	NOUN
aiua-13642	259	6	declare	declare	VERB
aiua-13642	259	7	that	that	SCONJ
aiua-13642	259	8	there	there	PRON
aiua-13642	259	9	is	be	VERB
aiua-13642	259	10	no	no	DET
aiua-13642	259	11	conflict	conflict	NOUN
aiua-13642	259	12	of	of	ADP
aiua-13642	259	13	interest	interest	NOUN
aiua-13642	259	14	regarding	regard	VERB
aiua-13642	259	15	the	the	DET
aiua-13642	259	16	publication	publication	NOUN
aiua-13642	259	17	of	of	ADP
aiua-13642	259	18	this	this	DET
aiua-13642	259	19	paper	paper	NOUN
aiua-13642	259	20	.	.	PUNCT
aiua-13642	260	1	all	all	DET
aiua-13642	260	2	research	research	NOUN
aiua-13642	260	3	was	be	AUX
aiua-13642	260	4	conducted	conduct	VERB
aiua-13642	260	5	in	in	ADP
aiua-13642	260	6	accordance	accordance	NOUN
aiua-13642	260	7	with	with	ADP
aiua-13642	260	8	ethical	ethical	ADJ
aiua-13642	260	9	standards	standard	NOUN
aiua-13642	260	10	and	and	CCONJ
aiua-13642	260	11	without	without	ADP
aiua-13642	260	12	any	any	DET
aiua-13642	260	13	financial	financial	ADJ
aiua-13642	260	14	or	or	CCONJ
aiua-13642	260	15	personal	personal	ADJ
aiua-13642	260	16	relationships	relationship	NOUN
aiua-13642	260	17	that	that	PRON
aiua-13642	260	18	could	could	AUX
aiua-13642	260	19	influence	influence	VERB
aiua-13642	260	20	or	or	CCONJ
aiua-13642	260	21	affect	affect	VERB
aiua-13642	260	22	the	the	DET
aiua-13642	260	23	results	result	NOUN
aiua-13642	260	24	.	.	PUNCT
aiua-13642	261	1	funding	funding	NOUN
aiua-13642	261	2	:	:	PUNCT
aiua-13642	261	3	none	none	NOUN
aiua-13642	261	4	to	to	PART
aiua-13642	261	5	be	be	AUX
aiua-13642	261	6	reported	report	VERB
aiua-13642	261	7	.	.	PUNCT
aiua-13642	262	1	authors	author	NOUN
aiua-13642	262	2	'	'	PART
aiua-13642	262	3	contributions	contribution	NOUN
aiua-13642	262	4	:	:	PUNCT
aiua-13642	262	5	conception	conception	NOUN
aiua-13642	262	6	:	:	PUNCT
aiua-13642	262	7	ms	ms	PROPN
aiua-13642	262	8	and	and	CCONJ
aiua-13642	262	9	yh	yh	PROPN
aiua-13642	262	10	;	;	PUNCT
aiua-13642	262	11	design	design	NOUN
aiua-13642	262	12	:	:	PUNCT
aiua-13642	262	13	ms	ms	PROPN
aiua-13642	262	14	;	;	PUNCT
aiua-13642	262	15	data	datum	NOUN
aiua-13642	262	16	acquisition	acquisition	NOUN
aiua-13642	262	17	:	:	PUNCT
aiua-13642	262	18	ms	ms	PROPN
aiua-13642	262	19	,	,	PUNCT
aiua-13642	262	20	yh	yh	PROPN
aiua-13642	262	21	and	and	CCONJ
aiua-13642	262	22	km	km	PROPN
aiua-13642	262	23	;	;	PUNCT
aiua-13642	262	24	data	datum	NOUN
aiua-13642	262	25	analysis	analysis	NOUN
aiua-13642	262	26	:	:	PUNCT
aiua-13642	262	27	ms	ms	NOUN
aiua-13642	262	28	,	,	PUNCT
aiua-13642	262	29	yh	yh	PROPN
aiua-13642	262	30	,	,	PUNCT
aiua-13642	262	31	oa	oa	PROPN
aiua-13642	262	32	,	,	PUNCT
aiua-13642	262	33	za	za	PROPN
aiua-13642	262	34	and	and	CCONJ
aiua-13642	262	35	ma	ma	PROPN
aiua-13642	262	36	;	;	PUNCT
aiua-13642	262	37	interpretation	interpretation	NOUN
aiua-13642	262	38	of	of	ADP
aiua-13642	262	39	data	data	PROPN
aiua-13642	262	40	:	:	PUNCT
aiua-13642	262	41	hg	hg	NOUN
aiua-13642	262	42	,	,	PUNCT
aiua-13642	262	43	bh	bh	PROPN
aiua-13642	262	44	,	,	PUNCT
aiua-13642	262	45	ra	ra	PROPN
aiua-13642	262	46	,	,	PUNCT
aiua-13642	262	47	ma	ma	PROPN
aiua-13642	262	48	and	and	CCONJ
aiua-13642	262	49	oa	oa	INTJ
aiua-13642	262	50	;	;	PUNCT
aiua-13642	262	51	drafting	draft	VERB
aiua-13642	262	52	of	of	ADP
aiua-13642	262	53	manuscript	manuscript	NOUN
aiua-13642	262	54	:	:	PUNCT
aiua-13642	262	55	bh	bh	NOUN
aiua-13642	262	56	,	,	PUNCT
aiua-13642	262	57	yh	yh	PROPN
aiua-13642	262	58	,	,	PUNCT
aiua-13642	262	59	km	km	PROPN
aiua-13642	262	60	,	,	PUNCT
aiua-13642	262	61	hg	hg	NOUN
aiua-13642	262	62	and	and	CCONJ
aiua-13642	262	63	ms	ms	NOUN
aiua-13642	262	64	;	;	PUNCT
aiua-13642	262	65	critical	critical	ADJ
aiua-13642	262	66	revision	revision	NOUN
aiua-13642	262	67	of	of	ADP
aiua-13642	262	68	the	the	DET
aiua-13642	262	69	manuscript	manuscript	NOUN
aiua-13642	262	70	:	:	PUNCT
aiua-13642	262	71	bh	bh	PROPN
aiua-13642	262	72	,	,	PUNCT
aiua-13642	262	73	ms	ms	PROPN
aiua-13642	262	74	,	,	PUNCT
aiua-13642	262	75	hg	hg	NOUN
aiua-13642	262	76	and	and	CCONJ
aiua-13642	262	77	yh	yh	INTJ
aiua-13642	262	78	.	.	PUNCT
aiua-13642	263	1	all	all	DET
aiua-13642	263	2	authors	author	NOUN
aiua-13642	263	3	confirm	confirm	VERB
aiua-13642	263	4	that	that	PRON
aiua-13642	263	5	have	have	AUX
aiua-13642	263	6	approved	approve	VERB
aiua-13642	263	7	the	the	DET
aiua-13642	263	8	submitted	submit	VERB
aiua-13642	263	9	version	version	NOUN
aiua-13642	263	10	of	of	ADP
aiua-13642	263	11	the	the	DET
aiua-13642	263	12	paper	paper	NOUN
aiua-13642	263	13	and	and	CCONJ
aiua-13642	263	14	have	have	AUX
aiua-13642	263	15	agreed	agree	VERB
aiua-13642	263	16	both	both	PRON
aiua-13642	263	17	to	to	PART
aiua-13642	263	18	be	be	AUX
aiua-13642	263	19	personally	personally	ADV
aiua-13642	263	20	accountable	accountable	ADJ
aiua-13642	263	21	for	for	ADP
aiua-13642	263	22	the	the	DET
aiua-13642	263	23	author	author	NOUN
aiua-13642	263	24	's	's	PART
aiua-13642	263	25	own	own	ADJ
aiua-13642	263	26	contributions	contribution	NOUN
aiua-13642	263	27	and	and	CCONJ
aiua-13642	263	28	to	to	PART
aiua-13642	263	29	ensure	ensure	VERB
aiua-13642	263	30	that	that	SCONJ
aiua-13642	263	31	questions	question	NOUN
aiua-13642	263	32	related	relate	VERB
aiua-13642	263	33	to	to	ADP
aiua-13642	263	34	the	the	DET
aiua-13642	263	35	accuracy	accuracy	NOUN
aiua-13642	263	36	or	or	CCONJ
aiua-13642	263	37	integrity	integrity	NOUN
aiua-13642	263	38	of	of	ADP
aiua-13642	263	39	any	any	DET
aiua-13642	263	40	part	part	NOUN
aiua-13642	263	41	of	of	ADP
aiua-13642	263	42	the	the	DET
aiua-13642	263	43	work	work	NOUN
aiua-13642	263	44	,	,	PUNCT
aiua-13642	263	45	even	even	ADV
aiua-13642	263	46	ones	one	NOUN
aiua-13642	263	47	in	in	ADP
aiua-13642	263	48	which	which	PRON
aiua-13642	263	49	the	the	DET
aiua-13642	263	50	author	author	NOUN
aiua-13642	263	51	was	be	AUX
aiua-13642	263	52	not	not	PART
aiua-13642	263	53	personally	personally	ADV
aiua-13642	263	54	involved	involve	VERB
aiua-13642	263	55	,	,	PUNCT
aiua-13642	263	56	are	be	AUX
aiua-13642	263	57	appropriately	appropriately	ADV
aiua-13642	263	58	investigated	investigate	VERB
aiua-13642	263	59	,	,	PUNCT
aiua-13642	263	60	resolved	resolve	VERB
aiua-13642	263	61	,	,	PUNCT
aiua-13642	263	62	and	and	CCONJ
aiua-13642	263	63	the	the	DET
aiua-13642	263	64	resolution	resolution	NOUN
aiua-13642	263	65	documented	document	VERB
aiua-13642	263	66	in	in	ADP
aiua-13642	263	67	the	the	DET
aiua-13642	263	68	literature	literature	NOUN
aiua-13642	263	69	.	.	PUNCT
aiua-13642	264	1	acknowledgments	acknowledgment	NOUN
aiua-13642	264	2	:	:	PUNCT
aiua-13642	264	3	not	not	PART
aiua-13642	264	4	applicable	applicable	ADJ
aiua-13642	264	5	.	.	PUNCT
aiua-13642	265	1	archivio	archivio	NOUN
aiua-13642	265	2	italiano	italiano	PROPN
aiua-13642	265	3	di	di	PROPN
aiua-13642	265	4	urologia	urologia	PROPN
aiua-13642	265	5	e	e	PROPN
aiua-13642	265	6	andrologia	andrologia	NOUN
aiua-13642	265	7	2025	2025	NUM
aiua-13642	265	8	;	;	PUNCT
aiua-13642	265	9	97(2):13642	97(2):13642	NUM
aiua-13642	265	10	9	9	NUM
aiua-13642	265	11	tadalafil	tadalafil	NOUN
aiua-13642	265	12	and	and	CCONJ
aiua-13642	265	13	silodosin	silodosin	VERB
aiua-13642	265	14	in	in	ADP
aiua-13642	265	15	ureter	ureter	ADJ
aiua-13642	265	16	stones	stone	NOUN
aiua-13642	265	17	dosin	dosin	NOUN
aiua-13642	265	18	in	in	ADP
aiua-13642	265	19	medical	medical	ADJ
aiua-13642	265	20	expulsive	expulsive	NOUN
aiua-13642	265	21	therapy	therapy	NOUN
aiua-13642	265	22	of	of	ADP
aiua-13642	265	23	distal	distal	ADJ
aiua-13642	265	24	ureteral	ureteral	ADJ
aiua-13642	265	25	calculi	calculi	NOUN
aiua-13642	265	26	.	.	PUNCT
aiua-13642	266	1	br	br	PROPN
aiua-13642	267	1	j	j	PROPN
aiua-13642	267	2	clin	clin	PROPN
aiua-13642	267	3	pharmacol	pharmacol	PROPN
aiua-13642	267	4	.	.	PROPN
aiua-13642	267	5	2016	2016	NUM
aiua-13642	267	6	;	;	PUNCT
aiua-13642	267	7	81:13	81:13	NUM
aiua-13642	267	8	-	-	SYM
aiua-13642	267	9	22	22	NUM
aiua-13642	267	10	.	.	PUNCT
aiua-13642	268	1	29	29	NUM
aiua-13642	268	2	.	.	PUNCT
aiua-13642	269	1	el	el	PROPN
aiua-13642	269	2	hadj	hadj	PROPN
aiua-13642	269	3	sidi	sidi	PROPN
aiua-13642	269	4	a	a	X
aiua-13642	269	5	,	,	PUNCT
aiua-13642	269	6	diab	diab	PROPN
aiua-13642	269	7	t	t	PROPN
aiua-13642	269	8	,	,	PUNCT
aiua-13642	269	9	el	el	PROPN
aiua-13642	269	10	-	-	NOUN
aiua-13642	269	11	shazly	shazly	PROPN
aiua-13642	269	12	a	a	PRON
aiua-13642	269	13	,	,	PUNCT
aiua-13642	269	14	et	et	PROPN
aiua-13642	269	15	al	al	PROPN
aiua-13642	269	16	.	.	PROPN
aiua-13642	269	17	efficacy	efficacy	PROPN
aiua-13642	269	18	of	of	ADP
aiua-13642	269	19	silodosin	silodosin	NOUN
aiua-13642	269	20	versus	versus	ADP
aiua-13642	269	21	sildosin	sildosin	PROPN
aiua-13642	269	22	plus	plus	CCONJ
aiua-13642	269	23	tadalafil	tadalafil	PROPN
aiua-13642	269	24	as	as	ADP
aiua-13642	269	25	medical	medical	ADJ
aiua-13642	269	26	expulsive	expulsive	NOUN
aiua-13642	269	27	therapy	therapy	NOUN
aiua-13642	269	28	for	for	ADP
aiua-13642	269	29	lower	low	ADJ
aiua-13642	269	30	ureteric	ureteric	ADJ
aiua-13642	269	31	stones	stone	NOUN
aiua-13642	269	32	:	:	PUNCT
aiua-13642	269	33	a	a	DET
aiua-13642	269	34	prospective	prospective	ADJ
aiua-13642	269	35	randomized	randomized	ADJ
aiua-13642	269	36	placebo	placebo	NOUN
aiua-13642	269	37	controlled	control	VERB
aiua-13642	269	38	study	study	NOUN
aiua-13642	269	39	.	.	PUNCT
aiua-13642	270	1	benha	benha	VERB
aiua-13642	270	2	medical	medical	ADJ
aiua-13642	270	3	journal	journal	NOUN
aiua-13642	270	4	,	,	PUNCT
aiua-13642	270	5	2023	2023	NUM
aiua-13642	270	6	;	;	PUNCT
aiua-13642	270	7	40	40	NUM
aiua-13642	270	8	:	:	SYM
aiua-13642	270	9	254	254	NUM
aiua-13642	270	10	-	-	SYM
aiua-13642	270	11	263	263	NUM
aiua-13642	270	12	.	.	PUNCT
aiua-13642	271	1	doi	doi	NOUN
aiua-13642	271	2	:	:	PUNCT
aiua-13642	271	3	10.21608	10.21608	NUM
aiua-13642	271	4	/	/	SYM
aiua-13642	271	5	bmfj.2023	bmfj.2023	PROPN
aiua-13642	271	6	.	.	PUNCT
aiua-13642	272	1	201688.1786	201688.1786	NUM
aiua-13642	272	2	.	.	PUNCT
aiua-13642	273	1	correspondence	correspondence	NOUN
aiua-13642	273	2	mohab	mohab	PROPN
aiua-13642	273	3	alsaid	alsaid	PROPN
aiua-13642	273	4	saad	saad	PROPN
aiua-13642	273	5	abdalaziz	abdalaziz	PROPN
aiua-13642	273	6	mohabsaad955@gmail.com	mohabsaad955@gmail.com	PROPN
aiua-13642	274	1	orcid	orcid	NOUN
aiua-13642	274	2	:	:	PUNCT
aiua-13642	274	3	0009	0009	NUM
aiua-13642	274	4	-	-	SYM
aiua-13642	274	5	0000	0000	NUM
aiua-13642	274	6	-	-	PUNCT
aiua-13642	274	7	0802	0802	NUM
aiua-13642	274	8	-	-	SYM
aiua-13642	274	9	4240	4240	NUM
aiua-13642	274	10	faculty	faculty	NOUN
aiua-13642	274	11	of	of	ADP
aiua-13642	274	12	medicine	medicine	NOUN
aiua-13642	274	13	,	,	PUNCT
aiua-13642	274	14	al	al	PROPN
aiua-13642	274	15	-	-	PUNCT
aiua-13642	274	16	azhar	azhar	PROPN
aiua-13642	274	17	university	university	PROPN
aiua-13642	274	18	,	,	PUNCT
aiua-13642	274	19	cairo	cairo	PROPN
aiua-13642	274	20	,	,	PUNCT
aiua-13642	274	21	egypt	egypt	PROPN
aiua-13642	274	22	yousif	yousif	PROPN
aiua-13642	274	23	ahmad	ahmad	PROPN
aiua-13642	274	24	hanafi	hanafi	PROPN
aiua-13642	274	25	(	(	PUNCT
aiua-13642	274	26	corresponding	correspond	VERB
aiua-13642	274	27	author	author	NOUN
aiua-13642	274	28	)	)	PUNCT
aiua-13642	274	29	yousiffahmed3@gmail.com	yousiffahmed3@gmail.com	X
aiua-13642	274	30	orcid	orcid	NOUN
aiua-13642	274	31	:	:	PUNCT
aiua-13642	274	32	0009	0009	NUM
aiua-13642	274	33	-	-	PUNCT
aiua-13642	274	34	0002	0002	NUM
aiua-13642	274	35	-	-	PUNCT
aiua-13642	274	36	4678	4678	NUM
aiua-13642	274	37	-	-	SYM
aiua-13642	274	38	4878	4878	NUM
aiua-13642	274	39	belal	belal	NOUN
aiua-13642	274	40	mohamed	mohamed	PROPN
aiua-13642	274	41	hamed	hamed	PROPN
aiua-13642	274	42	bm030637@gmail.com	bm030637@gmail.com	PROPN
aiua-13642	274	43	orcid	orcid	PROPN
aiua-13642	274	44	:	:	PUNCT
aiua-13642	275	1	0009	0009	NUM
aiua-13642	275	2	-	-	SYM
aiua-13642	275	3	0003	0003	NUM
aiua-13642	275	4	-	-	PUNCT
aiua-13642	275	5	8049	8049	NUM
aiua-13642	275	6	-	-	SYM
aiua-13642	275	7	5209	5209	NUM
aiua-13642	275	8	omar	omar	PROPN
aiua-13642	275	9	fayez	fayez	VERB
aiua-13642	275	10	abbas	abbas	PROPN
aiua-13642	275	11	omarfayez0007@gmail.com	omarfayez0007@gmail.com	PROPN
aiua-13642	276	1	orcid	orcid	NOUN
aiua-13642	276	2	:	:	PUNCT
aiua-13642	276	3	0009	0009	NUM
aiua-13642	276	4	-	-	SYM
aiua-13642	276	5	0003	0003	NUM
aiua-13642	276	6	-	-	PUNCT
aiua-13642	276	7	5255	5255	NUM
aiua-13642	276	8	-	-	PUNCT
aiua-13642	276	9	892x	892x	NUM
aiua-13642	276	10	al	al	PROPN
aiua-13642	276	11	-	-	PUNCT
aiua-13642	276	12	azhar	azhar	PROPN
aiua-13642	276	13	university	university	PROPN
aiua-13642	276	14	faculty	faculty	NOUN
aiua-13642	276	15	of	of	ADP
aiua-13642	276	16	medicine	medicine	NOUN
aiua-13642	276	17	,	,	PUNCT
aiua-13642	276	18	postal	postal	ADJ
aiua-13642	276	19	code	code	PROPN
aiua-13642	276	20	11884	11884	NUM
aiua-13642	276	21	,	,	PUNCT
aiua-13642	276	22	cairo	cairo	PROPN
aiua-13642	276	23	,	,	PUNCT
aiua-13642	276	24	egypt	egypt	PROPN
aiua-13642	276	25	khaled	khaled	PROPN
aiua-13642	276	26	omar	omar	PROPN
aiua-13642	276	27	mahmoud	mahmoud	PROPN
aiua-13642	276	28	khader	khader	PROPN
aiua-13642	276	29	dr.khaledomar2000@gmail.com	dr.khaledomar2000@gmail.com	PROPN
aiua-13642	276	30	orcid	orcid	NOUN
aiua-13642	276	31	:	:	PUNCT
aiua-13642	276	32	0009	0009	NUM
aiua-13642	276	33	-	-	PUNCT
aiua-13642	276	34	0002	0002	NUM
aiua-13642	276	35	-	-	PUNCT
aiua-13642	276	36	9203	9203	NUM
aiua-13642	276	37	-	-	PUNCT
aiua-13642	276	38	3418	3418	NUM
aiua-13642	276	39	intern	intern	NOUN
aiua-13642	276	40	doctor	doctor	NOUN
aiua-13642	276	41	at	at	ADP
aiua-13642	276	42	specialty	specialty	NOUN
aiua-13642	276	43	hospital	hospital	NOUN
aiua-13642	276	44	,	,	PUNCT
aiua-13642	277	1	jordan	jordan	PROPN
aiua-13642	277	2	mohammad	mohammad	PROPN
aiua-13642	277	3	kh	kh	PROPN
aiua-13642	277	4	.	.	PROPN
aiua-13642	277	5	alzawahreh	alzawahreh	PROPN
aiua-13642	277	6	moh.khader_zh@hotmail.com	moh.khader_zh@hotmail.com	PROPN
aiua-13642	277	7	orcid	orcid	NUM
aiua-13642	277	8	:	:	PUNCT
aiua-13642	277	9	0000	0000	NUM
aiua-13642	277	10	-	-	PUNCT
aiua-13642	277	11	0001	0001	NUM
aiua-13642	277	12	-	-	PUNCT
aiua-13642	277	13	7698	7698	NUM
aiua-13642	277	14	-	-	PUNCT
aiua-13642	277	15	4120	4120	NUM
aiua-13642	277	16	urology	urology	NOUN
aiua-13642	277	17	,	,	PUNCT
aiua-13642	277	18	department	department	NOUN
aiua-13642	277	19	of	of	ADP
aiua-13642	277	20	special	special	ADJ
aiua-13642	277	21	surgery	surgery	NOUN
aiua-13642	277	22	,	,	PUNCT
aiua-13642	277	23	ministry	ministry	NOUN
aiua-13642	277	24	of	of	ADP
aiua-13642	277	25	health	health	PROPN
aiua-13642	277	26	,	,	PUNCT
aiua-13642	277	27	saudi	saudi	PROPN
aiua-13642	277	28	arabia	arabia	PROPN
aiua-13642	277	29	hesham	hesham	PROPN
aiua-13642	277	30	ghzayel	ghzayel	PROPN
aiua-13642	277	31	surgeon1130@yahoo.com	surgeon1130@yahoo.com	X
aiua-13642	278	1	orcid	orcid	NOUN
aiua-13642	278	2	:	:	PUNCT
aiua-13642	278	3	0009	0009	NUM
aiua-13642	278	4	-	-	SYM
aiua-13642	278	5	0003	0003	NUM
aiua-13642	278	6	-	-	PUNCT
aiua-13642	278	7	6294	6294	NUM
aiua-13642	278	8	-	-	PUNCT
aiua-13642	278	9	0604	0604	NUM
aiua-13642	278	10	urology	urology	NOUN
aiua-13642	278	11	and	and	CCONJ
aiua-13642	278	12	andrology	andrology	NOUN
aiua-13642	278	13	,	,	PUNCT
aiua-13642	278	14	department	department	NOUN
aiua-13642	278	15	of	of	ADP
aiua-13642	278	16	special	special	ADJ
aiua-13642	278	17	surgery	surgery	NOUN
aiua-13642	278	18	,	,	PUNCT
aiua-13642	278	19	ministry	ministry	NOUN
aiua-13642	278	20	of	of	ADP
aiua-13642	278	21	health	health	PROPN
aiua-13642	278	22	,	,	PUNCT
aiua-13642	278	23	sultanate	sultanate	NOUN
aiua-13642	278	24	of	of	ADP
aiua-13642	278	25	oman	oman	PROPN
aiua-13642	278	26	rashed	rashe	VERB
aiua-13642	278	27	yousef	yousef	PROPN
aiua-13642	278	28	al	al	PROPN
aiua-13642	278	29	sharqi	sharqi	PROPN
aiua-13642	278	30	rashedmed_91@yahoo.com	rashedmed_91@yahoo.com	PROPN
aiua-13642	278	31	orcid	orcid	NOUN
aiua-13642	278	32	:	:	PUNCT
aiua-13642	278	33	0009	0009	NUM
aiua-13642	278	34	-	-	SYM
aiua-13642	278	35	0000	0000	NUM
aiua-13642	278	36	-	-	PUNCT
aiua-13642	278	37	1001	1001	NUM
aiua-13642	278	38	-	-	PUNCT
aiua-13642	278	39	4340	4340	NUM
aiua-13642	278	40	urology	urology	NOUN
aiua-13642	278	41	department	department	NOUN
aiua-13642	278	42	,	,	PUNCT
aiua-13642	278	43	al	al	PROPN
aiua-13642	278	44	nadeem	nadeem	PROPN
aiua-13642	278	45	hospital	hospital	PROPN
aiua-13642	278	46	,	,	PUNCT
aiua-13642	278	47	ministry	ministry	PROPN
aiua-13642	278	48	of	of	ADP
aiua-13642	278	49	health	health	PROPN
aiua-13642	278	50	,	,	PUNCT
aiua-13642	279	1	jordan	jordan	PROPN
aiua-13642	279	2	zaid	zaid	PROPN
aiua-13642	279	3	f.	f.	PROPN
aiua-13642	279	4	altawallbeh	altawallbeh	NOUN
aiua-13642	279	5	zaidtawalbeh25@gmail.com	zaidtawalbeh25@gmail.com	X
aiua-13642	279	6	orcid	orcid	NOUN
aiua-13642	279	7	:	:	PUNCT
aiua-13642	279	8	0009	0009	NUM
aiua-13642	279	9	-	-	PUNCT
aiua-13642	279	10	0004	0004	NUM
aiua-13642	279	11	-	-	PUNCT
aiua-13642	279	12	6130	6130	NUM
aiua-13642	279	13	-	-	SYM
aiua-13642	279	14	3379	3379	NUM
aiua-13642	279	15	internship	internship	NOUN
aiua-13642	279	16	at	at	ADP
aiua-13642	279	17	al	al	PROPN
aiua-13642	279	18	nadeem	nadeem	PROPN
aiua-13642	279	19	hospital	hospital	PROPN
aiua-13642	279	20	,	,	PUNCT
aiua-13642	279	21	madaba	madaba	PROPN
aiua-13642	279	22	,	,	PUNCT
aiua-13642	279	23	jordan	jordan	PROPN